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Infectious diseases are estimated to be the direct cause of more than 25% of all annual 
human deaths worldwide 1. In fact, infection itself exerts a tremendous selective pressure 
that has driven the evolution of resistance mechanisms and, to a large extent, has shaped 
the human genome 2. Infectious diseases are caused by many different organisms from 
several biological taxa. There are more than 1.400 species known to be pathogenic to 
humans 3. Many of these species are associated with emerging diseases and they mainly 
consist of zoonotic pathogens, with 44 % of these agents being viruses and prions 3. RNA 
viruses in particular, are the cause of many of the emerging and re-emerging diseases of 
the last decades 4. RNA viruses have the highest mutation rate among species (estimated 
at 10-3 to 10-5 misincorporations per nucleotide and replication cycle) due to the lack 
(or low efficiency) of proof-reading activity by their RNA-dependent RNA polymerase 
(RdRp). As a consequence, RNA viruses replicate as complex and dynamic swarms of 
virus mutants known as virus quasispecies. In combination with short replication times 
and extremely large populations, this explains why RNA viruses can efficiently adapt 
to new selective pressures in the environment and are able to exploit new ecological 
niches and to jump between host species (reviewed in 5). There are currently 95 virus 
families and unassigned genera approved by the International Committee on Taxonomy 
of Viruses 6; among these, positive-stranded RNA viruses undoubtedly comprise the big-
gest fraction and it is within this group that we encounter the Flaviviruses.
Flavivirus genus 
The family Flaviviridae currently consists of three genera: Flavivirus (from the Latin 
flavus, “yellow”), Pestivirus (from the Latin pestis, “plague”), and Hepacivirus (from the 
Greek hepar, hepatos, “liver”). Besides these genera, two distinct groups of viruses have 
tentatively been assigned to the family, GBV-A and GBV-C 7. All members of the Flaviviri-
dae family share similar characteristics in virion morphology, genome organization, and 
replication strategy. In contrast, members of the three genera are antigenically unrelated 
and exhibit different biological properties, such as host range and transmission 7. The Fla-
vivirus genus contains nearly 80 viruses and its members show a worldwide distribution. 
The majority of Flaviviruses is arthropod-borne and many of them are important human 
pathogens that can cause a variety of diseases including encephalitis and hemorrhagic 
fevers. Flaviviruses of major global concern include dengue virus (DENV), yellow fever 
virus (YFV), Japanese encephalitis virus (JEV), West Nile virus (WNV), and tick-borne 
encephalitis virus (TBEV). Flaviviral infections have dramatically increased in frequency 
8 and the reasons underlying this phenomenon are complex. The decrease in mosquito 
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control measures during the last decades together with social and environmental factors 
such as the unprecedented population growth, increased urbanization, travel, trade, and 
deforestation are believed to be the main reasons for the re-emergence of flaviviruses. 
DENV, for instance, has spread into new areas and is now endemic in more than 100 
countries where 2.5 billion people (40% of the world’s population) are at risk of infection 
and an estimated 50 million people are infected every year 9. YFV appeared to be under 
control in the middle of the previous century due to mass vaccination campaigns and 
eradication of the principal urban vector, Aedes aegypti. However, YFV is re-emerging as 
numerous outbreaks have been registered during the last decades in both Africa and 
South America, due to the declining vaccination coverage and mosquito reinfestation 
10-12. Furthermore, the vectors used by flaviviruses have the ability to infest alternative 
favourable habitats where the viruses can eventually cause an epidemic. WNV had never 
been isolated in the Americas until 1999, when it emerged in New York City 13. By the 
end of 2003, it was present in almost every state of the United States, Mexico, and the 
Caribbean. It has now been detected as far south as Argentina (reviewed in 14). Climate 
changes can also affect vector distribution implying that global warming, for instance, 
could significantly increase the potential for flavivirus dispersal (reviewed in 14,15). As an 
example, Ixodes ricinus, the main vector of TBEV, used to be found in Europe up to 700-
750 m above sea level in the early 1980s, but in 2001 it was found up to 1.000 m 16, and 
in 2009 ticks infected with TBEV were detected up to 1.140 m 17. Global warming was 
suggested to be responsible for this shift in the habitat of ticks.
Vectors of members of the Flavivirus genus
Phylogenetically, the Flavivirus genus is grouped into three clusters based on the 
vector involved in transmission: (i) mosquito-borne, (ii) tick-borne, and (iii) no known 
vector (NKV) viruses 18,19. The evolutionary relationship between these three clusters is 
not clear. Initial phylogenetic analysis using the amino acid sequences of the envelope 
gene established that mosquito- and tick-borne viruses represent two different evolu-
tionary lineages 20. In another study, the flaviviruses NS5 amino acid sequence was used 
for phylogenetic analysis 18. This study included the NKV flaviviruses and postulated that 
the NKV and then the vector-borne flaviviruses have emerged from an ancestral insect-
borne flavivirus. These vector-borne viruses later diverged into the tick-borne and then 
the mosquito-borne virus clusters, suggesting that arthropod-mediated transmission is 
a derived trait within the genus. Other studies supported this topology based on the NS5 
gene 21. However, an alternative phylogenetic tree based on the amino acid sequence 
encoded by either the NS3 gene or the entire open reading frame (ORF) demonstrated 
that the tick-borne and NKV viruses have diverged together and independently from 
the mosquito-borne flaviviruses, suggesting a common ancestor for the tick-borne 





epidemiologically distinct groups: the Culex and the Aedes mosquito clades. A strong 
correlation was observed between the mosquito clade, the mammalian host, and the 
type of disease caused by the virus. In general, flaviviruses transmitted by the Culex 
mosquito are neurotropic viruses associated with neurological diseases in both humans 
and livestock. These viruses usually cycle between mosquitoes and birds. In contrast, 
flaviviruses transmitted by the Aedes mosquito are associated with hemorrhagic fevers 
and are non-neurotropic in humans. These viruses usually cycle between mosquitoes 
and primate hosts 21.
Besides the viruses assigned to one of the three clusters within the Flavivirus genus, 
there are a few viruses that are currently considered tentative species of the flavivirus 
genus. This group includes viruses like cell fusing agent virus (CFAV), Kamiti River virus 
(KRV) and Culex flavivirus (CxFV), which have all been exclusively isolated from mosqui-
toes or insect cell lines 24-26. There is no evidence that these viruses are able to infect a 
vertebrate host and therefore they are also referred to as insect flaviviruses. Interestingly, 
they have been suggested to represent the primordial forms of the Flavivirus genus 18-
20,27, and CFAV- and KRV-related genomic fragments have been found integrated in a 
DNA form in the genome of Aedes mosquitoes 28,29. 
Flaviviruses transmission by arthropods, such as mosquitoes or ticks, requires infec-
tion of the vector’s midgut tissue after the ingestion of an infected blood meal and 
subsequent release of progeny virus. Subsequently, the virus escapes from the midgut 
and spreads to the hemocele, from where the virus is able to infect several other tis-
sues, including the salivary glands. After infection of the salivary glands, the arthropod 
vector is able to transmit the virus via the infected saliva while feeding on a susceptible 
host (reviewed in 30). The arthropod vector usually becomes persistently infected 31. 
Vertebrate hosts that survive a flavivirus infection usually develop lifelong immunity, 
implying that flaviviruses need a constant supply of immunologically naïve hosts. As a 
result, the majority of the flaviviruses is enzootic and infects vertebrate hosts with a high 
reproductive rate like birds or small mammals (reviewed in 32). In the case of DENV, which 
has four distinct serotypes, recovery from infection by one of the serotypes provides 
lifelong immunity against that particular serotype, but only partial and transient protec-
tion against the other three serotypes 9. Except for dengue, humans are only infected 
accidentally when they intrude in the natural cycle of flaviviruses. For most flaviviruses, 
humans are in fact considered “dead end” hosts as these infections do not result in a 
significant viremia; humans are therefore unable to transmit the virus when bitten by 
arthropod vectors. Legendary exceptions are the dengue virus, for which humans actu-
ally seem to be the natural vertebrate host 9, and yellow fever virus (reviewed in 32). 
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Flavivirus RNA genome and life cycle
Flaviviruses are small (~50 nm), enveloped animal viruses containing a single positive-
strand RNA genome of approximately 11 kb with a 5’-cap structure and a 3’ non-poly-
adenylated terminus. The genomic RNA serves as the messenger RNA for translation of 
a single open reading frame (ORF) into a large polyprotein that is subsequently co- and 
post-translationally processed into the functional viral proteins by cellular and viral 
proteases (fig. 1). The flavivirus ORF is flanked by 5’ and 3’ untranslated regions (UTRs) 
of approximately 100 nts and 400 to 700 nts, respectively. The N-terminal region of 
the polyprotein encodes the viral structural proteins core (C), membrane (prM/M), and 
envelope (E), which are involved in the formation of the virus particle (reviewed in 33). 
The core or capsid protein is a small (≈11 kDa) basic protein that forms the icosahedral 
nucleocapsid in which the virus genome is packaged. Nascent C (or anchored C) protein 
contains a COOH-terminal hydrophobic anchor that serves as a signal sequence for ER 
translocation of the prM protein. This hydrophobic domain is cleaved from anchored C 
protein by the viral protease to produce C protein for capsid assembly (reviewed in 33). 
The prM protein is a glycoprotein precursor of the viral M protein. It serves as chaperone 
for the E protein and forms prM-E heterodimers at the envelope of the newly formed, 
immature virions. This prM-E interaction prevents acid-induced conformational changes 
in the E protein during transit through the secretory pathway 34,35. The conversion of 
immature to mature virions requires the cleavage of the prM protein into pr and M 
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Fig. 1. Flavivirus genome organization. 
A) Schematic representation of the flavivirus genome structure. The viral RNA encodes one large open 
reading frame (ORF). The 5’-terminal region of the ORF encodes three viral structural proteins whereas the 
remaining region encodes seven non-structural (NS) proteins. The ORF is flanked by 5’ and 3’ untranslated 
regions (UTR). B) Polyprotein processing and cleavage products. The cleavage sites for the host signal 
peptidase (Δ), the viral serine protease (
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), the furin-like protease (▼), as well as a yet unknown protease 
responsible for the NS1-NS2A cleavage (♦) are indicated. Prot and Hel in NS3 refer to the serine-like protease 
and helicase domains respectively. MTase and RdRp in NS5 reflect the position of the methyltransferase/





fragments by the Golgi-resident protease furin 36. The E protein (≈ 53 kDa) is the most 
prominent protein on the flavivirus surface. It mediates receptor binding and membrane 
fusion and is an important target for the humoral immune response. The E protein struc-
ture as present in the mature virion as well as that of the post-fusion form have been 
determined and the combination of these structural data with cryo-EM studies have 
resulted in fairly detailed models for flavivirus maturation and entry (reviewed in 37). The 
furin-mediated maturation of the virion (see above) catalyzes a major rearrangement 
of the interactions and structure of the E protein. During entry, upon exposure to low 
pH, the E protein homodimers dissociate into monomers which then form trimers. This 
reconfiguration of the E proteins exposes the previously buried fusion peptide that is 
subsequently inserted into the host endosomal membrane to mediate fusion between 
the viral envelope and the endosomal membrane; after fusion the virion RNA is released 
into the cytoplasm (reviewed in 37).
The C-terminal two-thirds of the polyprotein include seven nonstructural (NS) pro-
teins (fig. 1) that are primarily involved in viral RNA replication. NS1 is a glycoprotein of 
approximately 46 kDa that can be excreted from infected cells. The role of this protein in 
the viral life cycle is poorly understood although there is compelling evidence that it is 
required for RNA replication 38-41. NS2A is a small (22 kDa) hydrophobic transmembrane 
protein that is important for assembly and/or release of the newly formed virus particles 
42-44. NS2B serves as an essential cofactor for the viral serine protease activity that is as-
sociated with the N-terminal region of NS3. This protease activity mediates the cleavage 
of the viral polyprotein at the C-terminal side of two highly conserved basic residues 
located at the C-terminal of the capsid protein and at the junctions NS2A/NS2B, NS2B/
NS3, NS3/NS4A, and NS4B/NS5 (reviewed in 45,33) (fig. 1). In addition, the C-terminal half 
of this protein functions as RNA helicase during viral RNA transcription. NS4A is a small 
(16 kDa) integral membrane protein which has been shown to induce membrane rear-
rangements 46,47. An interaction between NS4A and NS1 was reported to be important 
for RNA replication 41. NS4B is a small (27 kDa) hydrophobic protein that colocalizes with 
NS3 and viral double-stranded RNA in membrane-associated replication complexes 48. 
NS5 is the largest viral protein (approximately 103 kDa). The N-terminal region of this 
protein has methyltransferase (MTase) activity and is required for the capping of the 
newly synthesized genomic RNA. The C-terminal part of NS5 contains the viral RdRp 
(reviewed in 33) (fig. 1). The protein structure has been determined for the full-length 
NS3 49,50 and for both MTase and RdRp NS5 domains 51-56 of several flaviviruses. A model 
for the full-length WNV NS5 structure has been proposed based on an in silico docking 
approach 52. These structures are currently used for the rational design of inhibitors to 
block the essential function of these proteins in the virus life cycle. Moreover, NS2A, 
NS4A, NS4B and NS5 were found to be able to inhibit the host-antiviral interferon re-
sponse 57-68.
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Flaviviruses enter the cells by receptor-mediated endocytosis via clathrin-coated 
vesicles (fig. 2). They are then transported to a prelysosomal endocytic compartment. As 
explained in more detail above, acidification of this compartment induces a conforma-
tional change in the envelope protein that activates the fusion domain resulting in the 
fusion between the virus and the endosomal membrane, and ultimately resulting in the 
release of the viral genomic RNA into the cytoplasm. Once in the cytoplasm, the positive-
strand viral RNA serves as mRNA and is translated by the host ribosomes (reviewed in 33). 
Subsequent replication of the viral genome takes place in close association with virus-
induced intracellular membrane structures. These membranes appear to be wrapped 
around the RNA amplification machinery. This replication complex (RC) is associated 
with unique perinuclear structures termed “vesicle packets” (VP) 69. VPs are enriched in 
viral NS proteins (NS1, NS2A, NS3, NS4A, and NS5), dsRNA, and presumably some host 
factors 69-74. While RNA replication takes place in these vesicle packets, translation and 
processing of the flavivirus polyprotein is thought to occur in association with different 
membrane structures designated convoluted membranes/paracrystalline arrays 72,70. 
The suggested shielding of the RC by membranes is thought to prevent or reduce the 
exposure to cytoplasmic sensors like RIG-I or MDA5, and to dsRNA-induced host defence 
mechanisms, like protein kinase R, RNase L or RNA interference 75. Additionally, it could 



















Fig. 2. Schematic representation of the Flavivirus life cycle. 





A role for NS4A was demonstrated in the induction of these membrane alterations 46,47. 
More recently, NS2A was also proposed to be involved in the induction of virus-specific 
membrane structures 44. After the formation of the replication complex, negative-sense 
genome-length RNA is synthesized, which serves as a template for new positive-strand 
genomic molecules. Flavivirus RNA replication is an asymmetric process in which the 
positive-strand RNA is synthesized in 10- to 100-fold excess over the negative-strand 
RNA 77,78. The newly synthesized positive-strand is subsequently used for (i) translation 
into new viral proteins, (ii) synthesis of negative-strand RNA, and/or (iii) encapsidation 
into new viral particles. Virus assembly is thought to occur by budding into the endo-
plasmatic reticulum (ER). The immature viral particles transit through the trans-Golgi 
network. Upon prM cleavage by the Golgi-resident protease furin 36, the immature viral 
particles turn into mature virions, which are released from the cell by the host secretory 
pathway (reviewed in 37, 33) (fig. 2).
Three major viral RNA species have been detected in cells infected with flaviviruses: 
the genomic positive-strand RNA, a double-stranded replicative form (RF), and a hetero-
geneous population of replicative intermediate (RI) RNAs 77,78. Surprisingly, an additional 
positive-sense small viral RNA species was reported to accumulate in both mammalian 
and insect cells and also in mouse brains infected with flaviviruses 79-82. This small RNA 
was found to correspond to the 3’ terminal region of the viral genome 80 and to be gener-
ated by a mechanism independent of the endoribonuclease RNase L 81. Recently, it was 
shown that this small flavivirus (sf ) RNA is actually a product of incomplete degradation 
of the viral genomic RNA by the host 5’-3’ exoribonuclease XRN1 83, the main mediator of 
the 5’ to 3’ mRNA decay that takes place in cytoplasmic processing bodies 84, (reviewed 
in 85-87). Interestingly, production of this sfRNA was shown to be an important parameter 
for viral pathogenicity 83. The molecular basis for the role of the sfRNA in pathogenicity 
has not yet been elucidated.
Flavivirus genomic 3’ UtR
The 3’ UTR of flavivirus genomes is predicted to fold into a complex structure in which, 
despite the generally large sequence variability, a number of small, but well conserved 
RNA sequence elements as well as secondary and tertiary RNA structures have been 
identified (reviewed in 88) (fig. 3.A). Some of these have been identified in all flaviviruses 
studied thus far, whereas others are characteristic for a particular cluster of the genus. 
The flavivirus 3’ UTR can be divided into a proximal part, immediately following the stop 
codon of the NS5 protein, which exhibits extensive heterogeneity in both length and 
sequence, and a more conserved distal part that has been defined as the core element 
of the 3’ UTR as it contains the majority of the elements involved in viral translation, 
replication, and assembly 89-96. The 3’ end of the flavivirus genome is not polyadenylated; 
instead, all flavivirus genomes analyzed to date terminate with a large, stable stem-loop 
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structure (3’ SL) involving 90 to 120 nts. Within the 3’ SL, two small conserved sequence 
motifs were identified and found to be required for viral RNA synthesis. One of these 
motifs is the dinucleotide 5’-CU-3’ at the 3’ end of the genome 97-99. The other conserved 
sequence is the pentanucleotide motif 5’-CACAG-3’ in the top loop of the 3’ SL 97,100,101. 
Upstream of the 3’ SL, there are two conserved sequence elements designated CS1 and 
CS2 that are well conserved among mosquito-borne flaviviruses (fig. 3.A). CS1 is found 
immediately adjacent to the 3’ SL and is involved in a long range RNA-RNA interaction 
with a complementary conserved sequence (5’ CS) near the 5’ end of the genome, 
downstream of the translation initiation codon in the capsid gene 102. Base pairing of 
these two sequence elements allows the formation of a panhandle-like structure that 
























































































































Fig. 3. Schematic model of the predicted RNA structure of the complete 3’ untranslated region (UtR) 
of the prototype flavivirus YFV and of the genome circularization. 
A) The large 3’ terminal stem-loop structure is termed 3’ SL, other secondary RNA structures are indicated 
A through G as in Olsthoorn and Bol 122. Sequences that are predicted to base pair and form an RNA 
pseudoknot (PSK) are connected by a dashed line. The location of conserved RNA sequences within the 3’ 
UTR is indicated by dots. PN, pentanucleotide motif; CS1, conserved sequence 1; CS2, conserved sequence 
2. B) The circular conformation promoted by the long-range RNA interactions between the YFV 5’ and 3’ 





and 5’ CS has been shown to be critical for viral RNA synthesis 103-109. Recent studies have 
demonstrated that, apart from the 5’CS – 3’CS1 interaction, another long-range RNA 
interaction also plays a role in promoting genome cyclization. This interaction involves 
complementary sequences at the 5’ end, located immediately upstream the AUG start 
codon region (UAR) of the ORF, and at the 3’ end within the bottom part of the 3’ SL 
(3’ UAR) 109 (fig. 3.B). This pair of complementary sequences has been shown to be im-
portant for viral replication 108,110-114. In DENV and WNV yet a third interaction important 
for genome circularization and RNA replication was recently identified and involves 
nucleotides downstream of the AUG region (5’ DAR) and nucleotides downstream CS1 
(3’ DAR) 115-117. Similar long-distance RNA interactions involving elements in the terminal 
regions of the genome, but at a different location from 5’CS and CS1, have also been 
shown for the tick-borne 118,104,110,119 and NKV flaviviruses 120,121. 
CS2 is approximately 24 nts in length and is located upstream of CS1. YFV contains 
only one copy of CS2 but the sequence is duplicated (RCS2) in members of the JEV and 
DENV subgroups 102. A sequence motif with high sequence identity and a position that 
resembles the one of CS2 in mosquito-borne flaviviruses has also been identified in the 
3’ UTR of NKV flaviviruses 120,121; while it is apparently absent in tick-borne flaviviruses. 
Deletion of CS2 has little effect on viral RNA synthesis but seems to affect pathogenicity 
of at least YFV and DENV, as mutants lacking CS2 form turbid plaques 107,103. Dengue vi-
ruses lacking this sequence are attenuated in rhesus monkeys 103. The viral 3’ UTR region 
encompassing CS2 in mosquito-borne flaviviruses is predicted to fold into dumbbell-
like structures of which a loop is thought to be involved in the formation of an RNA 
pseudoknot with downstream sequences 122 (fig. 3.A).
Yellow fever 
Yellow fever was the first human disease shown to be caused by a virus and the third 
viral infection (after smallpox and rabies) to be controlled by vaccination 123. Yellow fever 
is a mosquito-borne, viral hemorrhagic fever that is endemic in tropical regions of Africa 
and South America where it affects 45 countries with a combined population of over 900 
million people 124. WHO estimated 200,000 cases of yellow fever worldwide every year, 
resulting in 30.000 deaths. However, as with many diseases in rural Africa, underreport-
ing of the actual number of infections is likely. More than 90% of the YFV cases occur in 
Africa and, according to the WHO, one single confirmed case of YFV in an unvaccinated 
population should be considered an outbreak 124.
YFV probably evolved from ancestral mosquito-borne viruses over 3.000 years ago 
125. It is postulated that the virus originated in Africa and was subsequently introduced 
from the Old World into the Americas during the slave trade period in the 16th century 
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(reviewed in 10). In 1900, an American commission headed by Walter Reed proved that 
yellow fever was caused by a filterable agent and transmitted to humans by mosqui-
toes 126, (reviewed in 127). In 1927 the Rockefeller Foundation’s West Africa Yellow Fever 
Commission isolated the virus by inoculation of a rhesus monkey with blood of an 
YFV-infected Ghanian male named Asibi 128. Theiler and Smith 129 attenuated the YFV 
Asibi strain by serial passage in cultures of mouse brain and modified chick embryo tis-
sues, and demonstrated the use of the resulting attenuated YFV-17D strain as a vaccine 
to protect humans from yellow fever infection. In 1951, Theiler was awarded with the 
Nobel Prize in medicine for this groundbreaking work. In 1985, the complete genome 
sequence of YFV-17D was reported 130. Shortly thereafter, the nucleotide sequence of 
YFV-Asibi was determined and it was shown that the Asibi and 17D strains differ at 
68 nucleotide positions resulting in 32 amino acid changes 131. Despite the fact that 
infectious cDNA clones for both YFV-17D 132,107 and YFV-Asibi 133 (Bredenbeek, Dorner, 
Ploss and Rice, unpublished results) are available, the precise genetic determinants for 
attenuation of YFV-17D are still unknown. Several studies have shown that the flavivirus 
envelope protein contains important determinants for cell tropism, virulence, as well as 
immunity (reviewed in 134). Therefore, it has been suggested that either one or several of 
the eight amino acid differences between the Asibi and 17D E proteins are critical for the 
attenuation of the YFV-Asibi. 
Unfortunately, despite the availability of a very successful vaccine, yellow fever is still a 
major public health concern. Because of the variable clinical presentation of the infected 
individuals, yellow fever can be difficult to differentiate from other hemorrhagic fevers 
(e.g. Lassa fever, Ebola) and diseases like malaria, influenza, and typhoid fever, which 
often also occur in areas where YFV is endemic 12. The liver is the target organ in humans 
and liver dysfunction results in patient’s skin turning yellow, a characteristic from which 
the name of the disease was derived (reviewed in 135). YFV infection presents a broad 
clinical spectrum varying from mild symptoms to a fatal hemorrhagic fever, with a bi-
phasic pattern. The onset of the disease is typically within 3 to 6 days after a bite from an 
infected mosquito. The symptoms during this first phase of the infection include fever, 
headache, backache, myalgia (muscle pain), chills, malaise, nausea, dizziness and vomit-
ing. During this phase, patients are viremic and infectious to mosquitoes. This period 
will last for several days and may be followed by a “period of remission”, with mitigation 
of symptoms lasting up to 24 h. In this phase, the virus is cleared by antibodies and the 
cellular immune response of the individual. Most patients recover at this point without 
further signs or symptoms. However, in approximately 15 to 25% of those infected, 
symptoms reappear in a more severe form with high fever, vomiting, epigastric pain, 
jaundice, renal failure, hemorrhagic diathesis (“black vomit”) and coma. Bleeding can 
occur from the mouth, nose, eyes, or stomach. This is the “period of intoxication”. Viremia 





the virulence of the YFV strain, up to 50% of the patients do not survive this second 
phase and die within 7 to 10 days after the onset of symptoms. Patients that survive 
the infection usually recover without significant organ damage or other lasting effects 
(reviewed in 10,12,124).
There is no cure for yellow fever; vaccination is the single most important preventive 
measure against yellow fever. The YFV-17D vaccine is effective against all African and 
South American YFV genotypes and has an unmatched safety record 12. This excellent 
safety record might be in part explained by the fact that the virus is quite stable as it ac-
cumulates mutations at a very low frequency in healthy vaccinees 136. On the other hand, 
it has been well documented that YFV-17D vaccine preparations consist of a heteroge-
neous population containing a mixture of variants with distinct biological properties, 
such as plaque size in Vero cells, virulence for mice 137,138, and antigenicity 139-141. 
The YFV-17D vaccine is an affordable, highly effective vaccine that is thought to provide 
protection for 30-35 years or more. Severe adverse reactions to vaccination have been 
reported but are extremely rare (reviewed in 135,124,142). Despite its success, the mecha-
nisms by which YF-17D induces protective immunity are not completely understood. 
Vaccination is followed by a rapid activation of both the cellular and humoral arms of the 
adaptive immune response. Long term protection against YFV infection appears to be 
exclusively mediated by neutralizing antibodies (protective levels of neutralizing anti-
body are found in 90% of vaccines within 10 days and in 99% within 30 days) 12. In trying 
to understand the molecular basis of the efficacy of the YFV-17D vaccine, recent research 
has focused on the innate immune response upon infection of dendritic cells 143 and in 
vaccines 144 using gene expression profiling. From these studies it can be concluded that 
YFV-17D activates multiple Toll-like receptors (TLRs) which are likely to activate several 
arms of the innate immune response. A robust activation and upregulation of a complex 
network of genes involving innate sensing receptors (e.g. TLR7, RIG-I, MDA5), IFN-b 
stimulated transcription factors, and pro- and anti-inflammatory cytokines, ultimately 
culminates in a protective immune response 143,144 (reviewed in 142). 
YFV-17D as a platform for developing recombinant vaccines
Despite our expanding knowledge of the molecular biology, immunology and pathol-
ogy of flaviviruses, relatively little progress has been made with respect to treatment 
of infected individuals. Currently, only a limited number of licensed vaccines to protect 
humans against flavivirus infections is available. These include the already discussed 
YFV-17D vaccine, a live attenuated as well as an inactivated JEV vaccine, and a TBEV 
vaccine based on inactivated virus. An inactivated WNV vaccine is also available but only 
licensed for use in livestock 145,146. As for DENV, despite numerous efforts, there is no 
vaccine available; the situation is especially aggravated by the fact that a DENV vaccine 
should be tetravalent, inducing protection against the four dengue serotypes (reviewed 
22
in 145). Recent data indicate an even bigger challenge. DENV-infected cells apparently 
secrete high levels of particles containing prM instead of M due to inefficient cleavage. 
Antibodies against prM are generated and were found to be highly cross-reactive and 
able to promote the antibody-dependent enhancement (ADE) that is often associated 
with severe secondary infections by a different serotype 147,148. These observations imply 
that an effective DENV vaccine should not only be able to offer protection from the four 
different serotypes but also minimize the anti-prM response. 
The ability for genetic manipulation of the flavivirus genome by using available 
infectious cDNAs allowed the construction of live attenuated chimeric viruses. These 
novel recombinant vaccines make use of the fact that prM and E proteins of a particular 
flavivirus can be exchanged for the corresponding genes of another flavivirus, without 
significantly affecting the replication of the new recombinant virus. The expressed prM 
and E of the donor virus will drive the efficient assembly and budding of an enveloped 
virion in which the recombinant RNA is packaged, and will trigger an immune response 
against the donor virus upon vaccination. YFV-17D has been used as a vector backbone 
for the construction of such chimeric viruses due to its unique safety record and efficacy 
as a vaccine for humans. YFV-based chimeric candidate vaccine marketed as Chime-
rivax™ have been constructed for DENV, JEV, and WNV and have now been extensively 
tested in clinical trials with results that demonstrate their immunogenicity and excellent 
safety profile in humans 149 (reviewed in 150). 
Apart from being used as a vector for the construction of chimeric flavivirus vaccine 
candidates, YFV-17D has also been exploited as a vector for the expression of heter-
ologous genes to develop recombinant vaccines against pathogens like malaria 151-153, 
tumours 154, Lassa virus 155,156, and HIV 157,158. Although most of these recombinants show 
promising results in small scale animal experiments, genetic stability is often an issue 
especially with longer inserts 156,159. 
SCoPe AND oUtLiNe oF thiS theSiS
It is generally accepted that the 3’ UTR of positive-strand RNA viruses has an important 
role in several steps of the virus life cycle. RNA sequences and/or structures have been 
implicated in the regulation of translation and replication, as well as encapsidation 
(reviewed in 160,161). Flaviviruses are no exception regarding the importance of the 3’ 
UTR for the virus cycle. Several motifs and RNA structures have been identified in the 
flavivirus 3’ UTR (see fig. 3); most have been predicted based on phylogenetic analysis 
and RNA folding algorithms. Unfortunately, RNA probing data to support the predicted 
structures is scarce. In addition, our knowledge of the biological function of most of 





effect of deleting the predicted RNA structures (e.g., 107). The only exception are the RNA 
sequences involved in genome circularization that have been studied in detail using a 
variety of techniques (e.g. in vitro RdRp assays, mutagenesis, atomic force microscopy, 
RNA structure probing) 103-110,112,113,118,119,162-167.
The major aim of the research described in this thesis was to characterize and further 
understand the sequence and structural requirements as well as the biological function 
of some of these predicted RNA elements in the flavivirus 3’ UTR. The work described in 
chapters 2 and 3 has been performed with the mosquito-borne YFV. The experiments 
in chapter 4 and 5 were carried out with several of the NKV flaviviruses that lack an 
arthropod vector and with the tentative flavivirus CFAV, which is thought to be an insect 
virus unable to infect vertebrate hosts. CFAV and the NKV flaviviruses are particularly 
interesting from the perspective that, as far as it is currently known, they do not cycle 
between different hosts. As a consequence of this apparently simpler life cycle, their 3’ 
UTR and the conserved RNA elements within it, are predicted to have evolved towards 
an optimal function in only one type of host, e.g. mosquitoes, bats, or rodents. This could 
potentially have resulted in a less complex 3’ UTR. These relatively unknown and poorly 
studied NKV- and insect flaviviruses may therefore be excellent tools to provide a better 
understanding of the function of conserved RNA structures and could yield valuable 
insight into virus-host interactions, host range restrictions or specific requirements for 
replication in different hosts.
Chapter 2 describes the importance and the sequence requirements of the penta-
nucleotide motif in the 3’ SL of YFV (see fig. 3). Of the five nucleotides (5’-CACAG-3’), only 
the G nucleotide at the 5th position was indispensable for viral replication. Mutations at 
the other positions were tolerated, although the nucleotide at the 1st position had to 
be able to base pair with the nucleotide four positions downstream of the PN sequence 
(9th position). This result provided experimental support for the predicted structure at 
the top of 3’ SL. Strikingly, YFV replication was found to be less dependent on sequence 
conservation of the pentanucleotide motif than reported for West Nile virus. Nonethe-
less, despite the fact that the majority of the mutations in the YFV PN motif did not seem 
to affect viral RNA synthesis, a clear preference for the wild-type sequence was observed 
when the fitness of these mutant viruses was analyzed in a competition experiment 
against the parental YFV-17D. 
Chapter 3 presents a detailed description of the characteristics of the YFV sfRNA and 
the RNA structure within the viral 3’ UTR that is required for its production. Comple-
mentary in vitro and cell culture experiments confirmed the 5’ – 3’ RNase XRN1 as the 
host protein responsible for sfRNA generation. A predicted RNA pseudoknot with hith-
erto unknown function was shown to be essential for the production of the YFV sfRNA. 
Evidence to support the formation of this particular pseudoknot was obtained by RNA 
structure probing and mutagenesis studies. 
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From published data 79-81,83 and our work it became evident that all arthropod-borne 
flaviviruses produce at least one sfRNA in infected mammalian as well as insect cell lines. 
In addition, sfRNA production was shown to be an important determinant of virulence, 
as viruses that are unable to produce the sfRNA are less pathogenic in mice 83. These data 
provide evidence that the sfRNA has at least a function in the vertebrate host, but do 
not necessarily exclude a function in the arthropod host. If the sfRNA has no function in 
the arthropod host it could be hypothesized that the (tentative) insect flavivirus CFAV 
would not produce an sfRNA whereas the bat- and rodent-infecting NKV flaviviruses 
would produce an sfRNA. Alternatively, sfRNA synthesis could be a unique hallmark of 
arthropod-borne flaviviruses or a characteristic feature of all flaviviruses irrespective 
of their host range. Chapter 4 describes the experiments that were done to verify the 
various possibilities concerning sfRNA production in flaviviruses without a vector. From 
the data presented, it was concluded that all flaviviruses, including the tentative species 
CFAV, produce an sfRNA, suggesting that sfRNA generation is indeed a feature of the 
Flavivirus genus. The mechanism by which these sfRNAs are produced was shown to be 
similar to that of the arthropod-borne flaviviruses. 
In contrast to most of the arthropod-borne flaviviruses, studies with NKV flaviviruses 
are hampered by the lack of infectious cDNA clones. Chapter 5 describes the construc-
tion and characterization of a MODV full-length infectious cDNA clone. The clone was 
constructed in the low copy number vector pACNR that had been used before as a stable 
acceptor for the often “toxic” sequences of the Flaviviridae in Escherichia coli. MODV 
genome-length transcripts were shown to be highly “infectious” when transfected into 
BHK cells. The virus obtained from the transfected cells showed similar characteristics as 
the parental virus in terms of growth kinetics and plaque morphology. This clone can be 
used to study the function of predicted 3’ UTR elements putatively important for NKV 
flaviviruses. Furthermore, the infectious MODV clone offers the possibility to construct 
chimeras with arthropod-borne flaviviruses in order to understand the molecular deter-
minants required for a virus to be able to replicate in insect cells. 
Chapter 6 presents an extensive literature review describing the characteristics and 
function of the RNA structures that were predicted within the Flavivirus 3’ UTR. Data 
available for the well-studied arthropod-borne flaviviruses, as well as for the poorly 
studied NKV flaviviruses, is summarized and discussed. Emphasis was given to structures 
that were shown to be involved in viral replication and pathogenicity. 
Chapter 7 is an epilogue in which the results of the experimental work are briefly 
summarized and discussed in a broader context. Potential functions and future research 
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The pentanucleotide sequence (PN) 5’-CACAG-3’ at the top of the 3’ stem-loop struc-
ture of the flavivirus genome is well conserved in the arthropod-borne viruses but is 
more variable in flaviviruses with no known vector. In this study, the sequence require-
ments of the PN motif for yellow fever virus 17D (YFV) replication were determined. 
In general, individual mutations at either the 2nd, 3rd or 4th positions were tolerated 
and resulted in replication-competent virus. Mutations at the 5th position were lethal. 
Base pairing of the nucleotide at the 1st position of the PN motif and a nucleotide four 
positions downstream of the PN (9th position) was a major determinant for replication. 
Despite the fact that the majority of the PN mutants were able to replicate efficiently, 
they were outcompeted by parental YFV-17D virus following repeated passages in 
double-infected cell cultures. Surprisingly, some of the virus mutants at the 1st and/or 
the 9th position that maintained the possibility of forming a base pair were found to have 
a similar fitness to YFV-17D under these conditions. Overall, these experiments suggest 
that YFV is less dependent on sequence conservation of the PN motif for replication in 
animal cells than West Nile virus. However, in animal cell culture, YFV has a preference for 
the wt CACAG PN sequence. The molecular mechanisms behind this preference remain 
to be elucidated.
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The genus Flavivirus consists of nearly 80 RNA viruses that are distributed worldwide. 
Many of these viruses are transmitted by mosquito or tick species to their vertebrate 
hosts. However, there are also flaviviruses for which no arthropod vector has been identi-
fied 1,2. Phylogenetic analysis of the genus Flavivirus has grouped these viruses into three 
major clusters: (i) the mosquito-borne viruses; (ii) the tick-borne viruses; and (iii) the no 
known vector (NKV) viruses 1,3. It is unknown whether the inability of NKV flaviviruses to 
infect arthropod vectors is due to a block at the level of entry, replication or assembly 4.
Flaviviruses are small, enveloped viruses containing a positive, single-stranded RNA 
genome of approximately 11 kb in length with a 5’ cap structure and a 3’ non-polyadenyl-
ated terminus. The genomic RNA encodes a single large open reading frame flanked by 
5’ and 3’ untranslated regions (UTRs) of approximately 100 and 400 – 600 nt, respectively. 
Translation of the genome results in the synthesis of a large polyprotein, which is co- 
and post-translationally processed by viral and cellular proteases into three structural 
proteins (C, prM and E) and seven non-structural proteins that are primarily involved in 
the replication of the viral RNA (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) 5. 
The 3’ UTR of the mosquito-borne flaviviruses contains several conserved sequences 
and is predicted to fold into a complex structure including well-conserved secondary 
and tertiary RNA elements that are involved in the initiation and regulation of genome 
amplification and translation (reviewed by 6). This conservation of RNA structure is espe-
cially obvious in the stem-loop (SL) that is predicted to be formed at the 3’ end of every 
flavivirus genome. This structure involves 80 - 90 nucleotides that are not well conserved 
in primary sequence, except for the pentanucleotide (PN) CACAG 7-9 in the bulge at the 
top of the SL and the dinucleotide CU at the end of the genome (fig. 1.A). Deletion of the 
SL is lethal for flavivirus RNA synthesis 10-13. The SL structure is also required for efficient 
translation of the flavivirus genome 14,15.
Specific binding of the viral polymerase (NS5) of Japanese encephalitis virus (JEV) to 
the SL has been demonstrated 16. In addition, several host proteins such as translation 
elongation factor-1α 17,18, Mov34 19 La and PTB 18,20 have been shown to interact with the 
SL of several flaviviruses.
Sequence comparison within the genus Flavivirus reveals that the CACAG sequence 
is only well conserved when the vector-borne viruses are aligned (fig. 1.B, numbering 
according to fig. 1.A). When the NKV flaviviruses are included in this comparison the PN 
sequence was shown to be more variable. Rio Bravo virus (RBV) contains a C residue at 
the 2nd position, whereas Montana myotis leukoencephalitis virus (MMLV) and Modoc 
virus (MODV) have a U 21. In addition to the sequence variation at the 2nd position, Apoi 
virus (APOIV) and Yokose virus (YOKV) also contain different nucleotides at the 3rd and 
4th positions (CCUAG and CGCCG, respectively) 21,22. 
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The conservation of the PN motif suggests that it is an important element for the 
replication of arthropod-borne flaviviruses. Mutagenesis of this CACAG sequence in 
replicons of West Nile virus (WNV) revealed that only the A at the 4th position could be 
replaced by another nucleotide without affecting virus replication 13. These data were 
partially confirmed in a study using a full-length WNV cDNA instead of a replicon 11. 
However, in contrast to the results obtained using the WNV replicon, mutagenesis of 
the A residue at the 2nd position of the PN motif did not impair RNA synthesis in the 
background of WNV full-length genomic RNA. 
In view of the observed sequence variation in the PN motif of the NKV flaviviruses and 
the contradicting results concerning the PN sequence requirements in WNV replicon 
RNA versus genomic RNA, we performed an extensive mutagenesis of the PN motif of 
yellow fever virus (YFV) using an infectious full-length YFV and replicon RNA to deter-
















A) Secondary structure model for the YFV 3’ terminal SL. The pentanucleotide motif is boxed. The numbering 
of the nucleotides used throughout this study is indicated. B) Sequence comparison of the PN motif and 
surrounding nucleotides of representatives of the genus Flavivirus. The PN motif and the 9th position are 
shaded. Conserved nucleotide residues are indicated in bold. TBEV, Tick-borne encephalitis virus; LGTV, 
Langat virus; POWV, Powassan virus; YFV-17D, Yellow fever virus; DENV-1, Dengue virus; WNV, West Nile 
virus; KUNV, Kunjin virus; JEV, Japanese encephalitis virus; MVEV, Murray Valley encephalitis virus; RBV, Rio 
Bravo virus; MODV, Modoc virus; MMLV, Montana myotis leukoencephalitis virus; APOIV, Apoi virus; YOKV, 
Yokose virus. 
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Vero E6 cells were kindly provided by Professor A. Osterhaus (Rotterdam, The Nether-
lands). BHK-21J 23 and Vero E6 cells were grown at 37 ºC in 5 % CO2 in Dulbecco’s modi-
fied Eagle’s medium (DMEM; Cambrex) supplemented with 8 % fetal calf serum (FCS; 
Bodinco). 
Recombinant DNA techniques and plasmid constructions
Standard nucleic acid methodologies were used 24,25. Chemically competent Esch-
erichia coli DH5a cells 26 were used for cloning. Plasmid pACNR-MODV/YFV-pnMODV, 
a derivative of pACNR-MODV/YFV 27 in which the YFV PN motif CACAG was mutated 
to CUCAG, mimicking the sequence found in MODV, was digested with Sfi I and Xho 
I. The 644 bp fragment corresponding to the MODV/YFV cDNA 3’ end was cloned into 
pBluescript-YFV9845-10861 to yield pBlscrpt-3’YFV-pnCUCAG. This plasmid was used as 
template for mutagenesis of the PN sequence using the QuickChange Site-directed Mu-
tagenesis strategy (Stratagene). The inserts were sequenced to verify the mutations and 
to exclude unintended mutations. The mutant pBlscrpt-3’YFV derivatives were digested 
with Xba I and Xho I and the DNA fragment containing the mutated PN motif was cloned 
into pACNR-FLYF17Dx 10. 
Renilla luciferase-expressing YFV replicons containing a mutated PN motif were cre-
ated by cloning YFV 3’ UTR from the full–length YFV cDNA harboring the mutated PN 
motif with Sfi I and Xho I into pYF-R.luc2A-RP 28.
RNA secondary structure prediction
RNA secondary structure was predicted using MFOLD version 3.1 29,30.
In vitro RNA transcription
Plasmid DNA for in vitro run-off RNA transcription was purified with a Qiagen Plasmid 
Midi kit. YF-R.luc2A-RP or pACNR-FLYF17Da 31 and their derivatives containing the mu-
tated PN sequence were linearized with Afl II and purified by proteinase K digestion and 
phenol/chloroform extraction. Approximately 1 – 2 μg DNA was used as a template for 
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in vitro transcription using the mMESSAGE mMACHINE SP6 kit (Ambion). Trace amounts 
of [3H]UTP were added to the reaction mixture to determine the yield 10. Genomic full-
length transcripts were used for transfection without any additional purification. In 
vitro-transcribed replicon RNA was purified according to the protocol supplied with the 
mMessage mMACHINE kit and the yield was quantified using a Nanodrop photospec-
trometer. 
RNA transfections
BHK-21J cells were prepared for electroporation as described by Lindenbach and Rice 
23. Immediately after preparation, 5 μg of in vitro-transcribed RNA was mixed with 600 
μl cell suspension and electroporated using an Easyject electroporator (Eurogentec) 32.
Labelling and analysis of viral RNAs
Viral RNA synthesis was analyzed by in vivo labeling of the transfected cells with [3H]
uridine at 18 to 24 hours post-electroporation (p.e.) 10. At 24 h, total RNA was isolated, 
denatured with glyoxal and analyzed on a 0.8 % MOPS/agarose gel 25.
Virus stocks, infections and plaque assays
Medium was harvested from transfected cells to obtain virus stocks when complete 
cytopathogenic effect (CPE) was observed. For infections, the cells were washed once 
with PBS and infected with virus using the m.o.i. indicated in the relevant figure legends. 
After 1 h, the inoculum was replaced by DMEM containing 2 % FCS. For analysis of virus 
growth kinetics, the medium was collected and replaced by the same volume of fresh 
medium at the indicate times. Virus titers were determined as described previously 10 
except that Vero cells were used instead of SW13 cells in the plaque assays.
Rt-PCR
Total RNA was isolated using Trizol at 30 h p.i. from a 10 cm2 dish containing Vero or 
BHK-21 cells infected with either YFV-17D or the mutant viruses. RNA was dissolved in 30 
ml H2O and 5 ml was used for RT-PCR to amplify the 3’ UTR of the YFV genome using the 
ThermoScript RT-PCR system (Invitrogen). Primer sequences are available on request. 
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Eletroporated BHK cells (800 ml) were seeded per well of a 12-well plate. At 2 and 18 h 
post-transfection, the cells were lysed in 200 ml passive lysis buffer (Promega). Lucifer-
ase activity was determined using the Renilla luciferase assay system (Promega) and a 
LB9507 luminometer (Berthold). Protein concentrations of the lysates were determined 
using the Bradford method (Bio-Rad Laboratories). 
Virus competition experiments
Vero E6 cells were infected simultaneously with the mutant virus and YFV-17D at an 
m.o.i. of 5 and 0.5, respectively (ratio 10:1). After 72 h, 200 ml medium was used to infect 
fresh Vero cells. Intracellular RNA was isolated from the infected Vero cells at the 10th 
passage and used for RT-PCR. The RT-PCR products were cloned using the TA Cloning 
kit (Invitrogen). Plasmid DNA was isolated from bacteria cultures and sequenced to 
determine the nucleotide sequence of the PN motif.
ReSULtS
the PN motif is required for YFV replication
Two YFV-17D mutants were constructed to determine whether the PN motif was es-
sential for virus replication. In YFV-ΔpnCACAG, the complete PN sequence was deleted. 
Computer-aided RNA folding indicated that this deletion could significantly change the 
RNA structure at the top of the 3’ SL. Therefore, an additional mutant was constructed in 
which the CACAG sequence was changed to UGUGA. RNA modeling predicted that the 
3’ SL structure of this mutant would adopt a similar structure to the wt YFV-17D (fig. 2.A). 
Viral RNA synthesis was detected only in BHK-21J cells transfected with YFV-17D RNA 
(fig. 2.B). No viral RNA was detected in cells electroporated with either YFV-ΔpnCACAG 
or YFV-pnUGUGA RNA. Even after prolonged incubation (96 – 120 hrs), no virus could 
be detected in the medium of cells transfected with YFV-pnΔCACAG or YFV-pnUGUGA 
RNA by plaque assay (data not shown). These results demonstrated that the PN motif is 
absolutely required for YFV replication. 
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mutations at the 2nd, 3rd and 4th position of the PN motif are tolerated
As illustrated in fig. 1.B, the PN sequence is not absolutely conserved in flaviviruses. 
Variation is observed in the 2nd, 3rd and 4th positions. To verify whether other nucleotides 
were tolerated at these positions in the YFV PN motif, a set of mutants was created in 
which the A at the 2nd position, the C at the 3rd position or the A at the 4th position 
was replaced by the alternative nucleotides. Some of these mutations resulted in PN 
motifs mimicking the sequence of NKV flaviviruses such as MODV and MMLV (CUCAG) or 
RBV (CCCAG). In addition to these YFV mutants containing a single mutation, a mutant 
was created in which the nucleotides at the 2nd and 3rd position were mutated, thereby 
mimicking the PN motif of the NKV APOIV (CCUAG).
Chapter 2
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A) Secondary RNA structure model for the top of the 3’ SL structure of YFV-17D, YFV-ΔpnCACAG and 
YFV-pnUGUGA as predicted by MFOLD. B) Viral RNA synthesis in BHK-21J cells transfected with in vitro-
transcribed RNA of YFV-17D, YFV-ΔpnCACAG and YFV-pnUGUGA. 
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As shown in fig. 3.A, the mutants in which the A residue at the 2nd position was re-
placed by either a C, G or U synthesized RNA at a similar rate to YFV-17D. In addition, 
the viral growth curves of these viruses showed similar growth kinetics when compared 
with YFV-17D (fig. 3.D).
A slightly different picture arose when the C at the 3rd position was mutated. Chang-
ing it to either an A or a U had no significant effect on viral RNA synthesis. However, a 
significant decrease in RNA synthesis was observed when this C was replaced by a G (fig. 
3.B). The titer in the medium of cells transfected with YFV-pnCAGAG RNA was approxi-
mately 105 p.f.u./ml when CPE was complete. In addition, heterogeneity in plaque size 
was observed. Most of the plaques were small and turbid and therefore hardly visible, 
but larger plaques were also observed. RT-PCR on RNA isolated from Vero cells infected 
with this virus revealed that the introduced G at the 3rd position was replaced by a U. The 
original PN sequence contains a C residue at this position. However, YFV-pnCAUAG was 
also shown to replicate efficiently (fig. 3.B and E). Given the limited genetic stability of 
YFV-pnCAGAG, this mutant was excluded from the growth curves. The growth kinetics 
of YFV-pnCAUAG did not differ significantly from the parental virus, whereas the growth 
of YFV-pnCAAAG was slightly delayed (fig. 3.E). 
In agreement with the above results, the mutant YFV-pnCCUAG mimicking the PN 
motif of APOIV was able to synthesize viral RNA efficiently and showed similar growth 
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Fig. 3. 
Effect of mutations at the 2nd, 3rd and 4thpositions of the PN motif on YFV replication. (A – C) Analysis of RNA 
synthesis in BHK-21J cells transfected with RNA of mutants at the 2nd, 2nd and 3rd, and 4th PN positions. The 
mutants tested are indicated above each lane. (D – F) Viral growth kinetics of the indicated YFV mutants. 
BHK cells were infected at an m.o.i. 1; the medium of the infected cells was sampled at the indicated times 
post-infection. Titers were determined by plaque assays on Vero cells. 
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Mutagenesis of the A residue at the 4th position had no significant effect on virus rep-
lication. The mutants YFV-pnCACCG, YFV-pnCACGG and YFV-pnCACUG all synthesized 
RNA at comparable levels (fig. 3.C) and showed similar growth kinetics (fig. 3.F) when 
compared with YFV-17D. 
To analyze whether reversion of the introduced mutations to the original YFV-17D PN 
sequence could have influenced the outcome of these experiments, mutant viruses from 
the 60 h time point of the growth curves were used to infect Vero cells. At 30 h p.i., total 
RNA was isolated and used for RT-PCR. All viruses had maintained the original mutation. 
However, second-site reversions in other regions of the genome could not be excluded. 
mutational analysis of the 1st position of the PN motif reveals the 
importance of base pairing
The C residue at the 1st position of the PN motif appears to be truly conserved in all 
flaviviruses. This C residue is predicted to base pair with an equally well conserved G four 
positions downstream the PN motif (fig. 1.B). This position will be referred to as the 9th 
position. To determine the importance of this C residue and the potential role of the C-G 
base pair in YFV replication, the C was replaced by each of the other three nucleotides. 
Mutagenesis to either an A (YFV-pnAACAG9G) or G (YFV-pnGACAG9G) was predicted to 
disrupt the base pairing, whereas this base pair was predicted to be maintained when 
the C was replaced by a U (YFV-pnUACAG9G). As shown in fig. 4, no RNA synthesis was 
detected in cells transfected with YFV-pnAACAG9G, whereas viral RNA synthesis was 
significantly impaired in cells transfected with YFV-pnGAGAC9G. YFV-pnUACAG9G 
synthesized RNA with an efficiency that was similar to the parental virus. These data 
suggested that the formation of the base pair between the 1st and 9th positions is more 
important than the actual nucleotides. To verify this hypothesis, additional mutants 
were created by introducing mutations at the 9th position in combination with the 1st 
position mutants described above. This resulted in YFV-pnAACAG9A, YFV-pnCACAG9C, 
YFV-pnUACAG9U, YFV-pnGACAG9C, YFV-pnAACAG9U and YFV-pnUACAG9A. In the first 
three mutants, the G residue at the 9th position was changed to the same nucleotide 
as in the 1st position of the mutated PN motif, thus impairing base pair formation. In 
the last three mutants, the potential for base pairing was restored, albeit it with differ-
ent nucleotides compared with the parental virus. No YFV RNA was detected in cells 
transfected with either YFV-pnAACAG9A or YFV-pnCACAG9C, and viral RNA synthesis 
was significantly impaired in cells transfected with YFV-pnUACAG9U (fig. 4.A). In con-
trast to the above mutants, the mutant viruses YFV-pnGACAG9C, YFV-pnAACAG9U and 
YFV-pnUACAG9A in which base pairing was restored, showed efficient RNA synthesis 
and viral growth kinetics similar to that of the parental virus (fig. 4). Taken together, 
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these data clearly demonstrated that base pair formation between the 1st nucleotide of 
the PN motif and the nucleotide at the 9th position is more important for efficient virus 
replication than the nature of the nucleotides at these positions. 
Analysis of the 3’UTR of viruses with mutations at either the 1st and/or the 9th position 
obtained at the 60 h time point of the growth curves showed no evidence for primary 
site reversion. Despite the fact that no RNA synthesis could be detected in cells trans-
fected with YFV-pnAACAG9G and YFV-pnAACAG9A, these cells eventually developed 
CPE. Sequencing of the 3’ UTR of these virus stocks revealed reversion to the wt virus and 
the mutant YFV-pnAACAG9U. Interestingly, the latter was actually shown to replicate 
efficiently in this study (fig. 4). Second-site reversions in other regions of the genome 
could not be excluded.
Fig. 4
Fig. 4. 
Characterization of YFV with mutations at the 1st PN position and the 9th position. A) RNA synthesis in 
BHK-21J cells transfected with RNA of mutants: YFV-pnAACAG9G, YFV-pnGACAG9G, YFV-pnUACAG9G, 
YFV-pnAACAG9A, YFV-pnCACAG9C, YFV-pnUACAG9U, YFV-pnGACAG9C, YFV-pnAACAG9U and YFV-
pnUACAG9A. B) Viral growth kinetics of the indicated YFV mutants. BHK cells were infected at an m.o.i. of 
1. The medium of the infected cells was harvested at the indicated times post-infection. Plaque assays on 
Vero cells were used to determine the virus titer. 
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the G residue at the 5th position is essential for virus replication
The well-conserved G residue at the 5th position of the PN motif was replaced by one 
of the other nucleotides. As shown in fig. 5, viral RNA synthesis was only detected in cells 
transfected with the parental YFV-17D transcript; no RNA was detected in cells electro-
porated with YFV-pnCACAA, YFV-pnCACAC or YFV-pnCACAU RNA, and no virus could be 
detected by plaque assay in the medium of the transfected cells (data not shown). These 
data demonstrated that the G at the 5th position of the PN motif is absolutely required 
for YFV replication.
Competition between mutant virus and YFV-17D
The results presented so far in this study have demonstrated that, except for the 5th 
position, point mutations are generally well tolerated within the PN motif. Many of 
these PN mutant viruses replicated with an efficiency that was comparable to YFV-17D, 
indicating that they were just as fit as the parental virus in animal cells. This suggested 
that conservation of the wt CACAG sequence is not that important in an animal cell 
culture system. To test this hypothesis, Vero cells were simultaneously infected with ef-
ficiently replicating representatives of the PN mutant viruses and YFV-17D at a ratio of 
10:1. Intracellular RNA was isolated after ten passages and used to determine the ratio 
of mutant to parental virus by sequencing the PN motif.
Viruses with a mutation at the 2nd position of the PN motif, such as YFV-pnCCCAG and 
YFV-pnCUCAG, were clearly outcompeted by YFV-17D within ten passages (Table 1). A 
similar result was also obtained for the 3rd position mutant YFV-pnCAUAG. These results 
were supported by the fact that the virus mimicking the APOIV PN motif (YFV-pnCCUAG) 
was also not detected after ten passages. Compared with viruses with mutations at the 
2nd and 3rd positions, YFV-pnCACCG replicated relatively well and was still the dominant 
virus after ten passages. However, the ratio of 12:7 for YFV-pnCACCG versus YFV-17D at 
the 10th passage indicated that the parental virus was slowly outcompeting the mutant 
virus. These data demonstrated that viruses with a mutation at the 2nd, 3rd or 4th position 
Fig. 5
Fig. 5. 
RNA synthesis in BHK-21J cells transfected 
with in vitro-transcribed YFV RNA containing 
mutations at the 5th position of the PN motif. 
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of the PN motif were less fit than the parental YFV-17D in Vero cells, despite the fact 
that these mutant viruses showed similar replication efficiency and growth kinetics in 
individual infection experiments.
Mutant viruses that contained an alternative base pair at the 1st position of the PN motif 
and the 9th position were also analysed. After ten passages, the mutant YFV-pnUACAG9G 
was completely outcompeted by the parental virus (Table 1). The result obtained for YFV-
pnUACAG9A was essentially similar to that of the mutant virus YFV-pnCACCG. At the 10th 
passage, the YFV-pnUACAG9A was still the dominant virus, but the ratio indicated that 
the mutant would eventually be outcompeted. A more interesting picture was observed 
for both YFV-pnGACAG9C and YFV-pnAACAG9U. At the 10th passage, they were clearly 
the dominant viruses, suggesting that equilibrium was possible between the mutant 
and the wt virus. As expected, a poorly replicating mutant such as YFV-pnUACAG9U, in 
which the base pairing was disrupted, was easily outcompeted by YFV-17D. 
Although the results obtained with YFV-pnGACAG9C and YFV-pnAACAG9U indicated 
that some of the mutants were as fit as the wt virus, it was obvious that the wt PN se-
quence still had an as yet undefined advantage over most of the mutant PN sequences 
when analyzed in animal cells. 
table 1. Competition experiment in Vero E6 cells simultaneously infected with efficiently 
replicating representatives of the PN mutant viruses and YFV-17D at a ratio of 10:1. 
Intracellular RNA was isolated after ten passages and used to determine the ratio of PN 
mutant virus to parental virus by sequencing.




1 pnCCCAG 20 3 17 3:17 YFV
2 pnCUCAG 18 1 17 1:17 YFV
3 pnCAUAG 22 0 22 0:22 YFV
4 pnCCUAG 19 0 19 0:19 YFV
5 pnCACCG 19 12 7 12:7 CACCG
6 pnGACAG9C 26 20 6 10:3 GACAG9C
7 pnUACAG9G 20 0 20 0:20 YFV
8 pnUACAG9U 19 0 19 0:19 YFV
9 pnAACAG9U 29 27 2 27:2 AACAG9U
10 pnUACAG9A 26 18 8 9:4 UACAG9A
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mutations in the PN motif do not affect translation
To analyze whether the effect of the PN mutations was due to a direct effect on RNA 
synthesis or an indirect effect by influencing virus RNA translation, a selected set of 
mutations was cloned into pYF-R.luc2A-RP. RNA transcribed from these plasmids was 
transfected into BHK cells, which were subsequently analysed for Renilla luciferase ex-
pression at 2 h (the peak time for translation of input RNA) and 18 h p.e. (when only virus 
synthesized RNA is translated). At 2 h p.e., all of the replicons expressed luciferase at a 
comparable level (fig. 6) including replicons such as YFRP-pnUGUGA, YFRP-pnCAGAG, 
YFRP-pnCACAU and YFRP-pnGACAG9G for which no or hardly any RNA synthesis could 
be detected in the background of the full-length YFV RNA (fig. 2, 3, 4 and 5). From 
these data, it was concluded that the mutations in the PN motif had at best a relatively 
minor effect on translation. No luciferase was detected in cells transfected with YFRP-
pnUGUGA, YFRP-pnCAGAG, or YFRP-pnCACAU at 18 h p.e., whereas YFRP-pnGACAG9G 
showed low luciferase activity. The replicons YFRP-pnCCCAG, YFRP-pnCACCG, YFRP- 
pnUACAG9G and YFRP-pnAACAG9U showed a high level of luciferase activity. These 
mutations also allowed efficient replication in the background of the full-length clone, 
demonstrating that mutagenesis of the PN motif in either the replicon or the full-length 
YFV RNA yielded identical results. 
Fig. 6
Fig. 6. 
Luciferase expression of YFV replicons containing mutations in the PN motif at 2 and 18 h post-
electroporation. The following replicons were analyzed: YFRP-17D (pnCACAG), YFRP-pnUGUGA, YFRP-
pnCCCAG, YFRP-pnCAGAG, YFRP-pnCACCG, YFRP-pnCACAU, YFRP-pnUACAG9G, YFRP-pnAACAG9U and 
YFRP-pnGACAG9G. Results are given as relative luciferase units (RLU) relative to the activity measured 
in mock-transfected cells. No significant luciferase activity was detected in cells transfected with YFRP-
pnUGUGA, YFRP-pnCAGAG or YFRP-pnCACAU at 18 h p.e. 
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Sequence comparison of the PN motif and the surrounding nucleotides has shown 
that the PN sequence 5’-CACAG-3’ is well conserved within the vector-borne flaviviruses 
(fig. 1.B). However, when the NKV flaviviruses are included in this comparison, the PN 
sequence is far less conserved. None of the NKV viruses sequenced to date contains the 
sequence CACAG as the PN motif. Other nucleotides are observed at either the 2nd or 3rd 
position and some viruses even contain substitutions at the 2nd and 3rd or the 2nd and 
4th positions 21,22. These nucleotide substitutions in the NKV viruses are rather surprising 
and suggest that mutations of some PN positions may be tolerated in arthropod-borne 
flaviviruses. These observations prompted us to analyze the requirement for the YFV PN 
sequence. 
YFV mutants in which the PN sequence CACAG is either deleted or completely 
changed (YFV-pnUGUGA) were unable to replicate, demonstrating that at least part of 
this sequence is absolutely required for YFV replication. These data are in agreement 
with the observation for WNV in which deletion of the PN motif is also lethal 13.
To determine whether other nucleotides are tolerated in the YFV PN motif, we per-
formed an extensive mutagenesis study using in vitro-transcribed YFV genomic and 
replicon RNA. Our data showed that mutations at either the 2nd, 3rd or 4th positions of 
the PN motif had no significant effect on YFV replication, except when the C at the 3rd 
position was replaced by a G, which severely impaired viral RNA synthesis and growth. 
Except for the 4th position, our data are clearly different from the published results on 
the WNV PN motif 13. Using WNV replicon RNA, it was shown that the A and C residues at 
the 2nd and 3rd positions were absolutely required for WNV RNA synthesis. Another study 
using full-length WNV genome RNA transcripts instead of a replicon RNA confirmed the 
data of Tilgner et al. 13 concerning the 3rd position of the PN motif. However, in contrast to 
the WNV replicon, replacement of the A at the 2nd position by a U residue was tolerated 
in the complete WNV genome 11. 
In addition to these point mutations, a YFV mutant mimicking the NKV APOIV PN motif 
(CCUAG) was constructed. This mutant replicated efficiently and showed only slightly 
slower growth kinetics compared to the YFV-17D. As a control for these results on the 
2nd, 3rd and 4th positions, the mutant YFV-pnCGUGG was created. As expected from our 
previous observations this mutant was able to replicate, although less efficiently than 
YFV-17D (data not shown). These results confirm our initial finding that point mutations 
at the 2nd, 3rd or 4th position of the YFV PN motif are tolerated, although the almost un-
detectable effects of individual mutations become more obvious when mutations were 
combined.
Only the 1st and 5th positions of the PN motif appear to be truly conserved among all 
flaviviruses. Replacing the G at the 5th position of the YFV PN motif for another nucleo-
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tide was lethal. A similar result was obtained for the WNV PN motif 11,13, suggesting that 
this G residue has a critical role in the replication of all flaviviruses. 
Analysis of the sequence surrounding the PN motif revealed that the G residue at 
the 9th position is also strictly conserved. RNA folding of the flavivirus 3’ SL structure 
predicted that this G will base pair with the well-conserved C residue at the 1st position 
of the PN motif, suggesting that the formation of this base pair is essential. Mutants at 
the 1st and/or the 9th position that disrupted this predicted base pair were either unable 
to replicate or were significantly impaired in virus replication, whereas mutants that 
allowed the formation of this base pair showed RNA synthesis and viral growth with 
similar kinetics to the parental virus. From these data, we concluded that the formation 
of a base pair between the 1st nucleotide of the PN motif and the nucleotide at the 9th 
position is a critical determinant for efficient virus replication. The importance of this 
base pair was also recognized for WNV 13. However, WNV replicons with an alternative 
base pair showed only 10 – 20% of the luciferase activity of the wt replicon, whereas the 
comparable YFV mutants in this study were virtually indistinguishable from the wt virus 
or replicon. Using these luciferase-expressing YF replicons, we also demonstrated that 
the PN mutations only had a direct effect on viral RNA synthesis and did not affect virus 
RNA translation. 
Flavivirus RNA replicons have been used extensively to study virus replication 31,33-37 
and so far no significant differences have been observed when analyzing the effect of 
3’ UTR mutations on virus replication using flavivirus RNA replicons versus full-length 
genomic RNA. This is also true for the data presented in this study and we have no expla-
nation as to why the sequence requirements of the YFV PN motif are so different from 
those determined using either a WNV replicon or a full-length RNA.
It has been stated that the C at the 8th position in WNV replication 11 is critical for 
replication. Substitution of the U at this position in YFV for a C yielded a virus with similar 
characteristics to wt YFV-17D, indicating that in YFV the nucleotide at this position is not 
critical for replication (data not shown).
The variability that can be introduced in the YFV PN sequence is somewhat surprising 
when we take into account the fact that the PN CACAG is well conserved within the 
arthropod-borne flaviviruses. To evaluate the importance of the wt sequence for replica-
tion in animal cells, competition experiments between YFV-17D and a set of mutants 
were performed. Although the results showed that some of the base pair mutants ap-
peared to be as fit as the parental virus, the wt PN sequence had an advantage over most 
of the mutant PN sequences in animal cells. These results are to some extend similar to 
what has been observed for tick-borne encephalitis virus mutants where point muta-
tions that seem to have little or no effect in animal cell culture were shown to have a 
clearly different phenotype in a relevant small animal model 38.
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Taken together, our data support the fact that the PN CACAG is quite variable in se-
quence when analyzed in animal cell culture systems. Individual point mutations at the 
2nd, 3rd and 4th positions are generally well tolerated in the YFV PN motif, whereas the G 
residue at the 5th position is truly conserved. In addition to this G, base pairing between 
the nucleotides at the 1st and 9th positions is also essential for efficient replication. De-
spite this sequence variability that can be introduced, there appears to be a preference 
for the parental CACAG sequence in animal cell culture. The reason for this is currently 
unclear. The PN motif may be part of either a host or viral protein RNA binding site. The 
G at the 5th position would then be crucial for protein binding, whilst the formation of 
the base pair might be required to form the proper RNA structure. Given the mutations 
that can be introduced into the PN sequence, it is unlikely that the PN motif is involved 
in an RNA-RNA interaction. 
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Cells and mice infected with arthropod-borne flaviviruses produce a small subgenomic 
RNA that is collinear with the distal part of the viral 3’ untranslated region (UTR). This 
small subgenomic flavivirus RNA (sfRNA) results from the incomplete degradation of the 
viral genome by the host 5’-3’ exonuclease XRN1. Production of the sfRNA is important 
for the pathogenicity of the virus. This study not only presents a detailed description of 
the yellow fever virus (YFV) sfRNA but, more importantly, describes for the first time the 
molecular characteristics of the stalling site for XRN1 in the flavivirus genome. Similar to 
the case for West Nile virus, the YFV sfRNA was produced by XRN1. However, in contrast 
to the case for other arthropod-borne flaviviruses, not one but two sfRNAs were detected 
in YFV-infected mammalian cells. The smaller of these two sfRNAs was not observed in 
infected mosquito cells. The larger sfRNA could also be produced in vitro by incubation 
with purified XRN1. These two YFV sfRNAs formed a 5’ nested set. The 5’ ends of the YFV 
sfRNAs were found to be just upstream of the previously predicted RNA pseudoknot 
PSK3. RNA structure probing and mutagenesis studies provided strong evidence that 
this pseudoknot structure was formed and served as the molecular signal to stall XRN1. 
The sequence involved in PSK3 formation was cloned into the Sinrep5 expression vector 
and shown to direct the production of a sfRNA-like RNA. These results underscore the 
importance of the RNA pseudoknot in stalling XRN1 and also demonstrate that it is the 
sole viral requirement for sfRNA production. 
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The Flavivirus genus contains nearly 80 viruses distributed worldwide and includes 
important human pathogens such as dengue virus (DENV), yellow fever virus (YFV), 
Japanese encephalitis virus (JEV), West Nile virus (WNV), and tick-borne encephalitis 
virus (TBEV). Phylogenetic analysis clustered flaviviruses into the following three major 
groups, based on the vector of transmission: (i) mosquito-borne viruses, (ii) tick-borne 
viruses, and (iii) viruses with no known vector (NKV) 1,2. 
Flaviviruses are small enveloped viruses containing a positive-sense single-stranded 
RNA genome of approximately 11 kb in length, with a 5’-cap structure and a 3’ non-
polyadenylated terminus. The genomic RNA is flanked by 5’ and 3’ untranslated regions 
(UTRs) and encodes a single polyprotein that is co- and posttranslationally processed 
by viral and cellular proteases into three structural proteins (C, prM and E) and seven 
nonstructural proteins (NSs) (reviewed in reference 3). Apart from the viral genome RNA 
and the replication-related replicative-form and intermediate RNAs 4,5, an additional 
small flavivirus RNA (sfRNA) has been detected in mice and both mammalian and insect 
cells infected with flaviviruses belonging to the JEV serogroup 6-8. Recently, it was shown 
that production of sfRNA is not unique to JEV and closely related viruses but that all 
arthropod-borne flaviviruses generate an sfRNA upon infection of mammalian cells 9,10. 
The lengths of these sfRNAs vary from 0.3 kb to 0.5 kb and are related to the length of 
the viral 3’ UTR. Surprisingly, these sfRNAs are not direct products of the viral transcrip-
tion mechanism but result from incomplete degradation of the viral genomic RNA by 
the host 5’-3’ exonuclease XRN1, as shown for Kunjin virus (KUNV) by in vitro assays 
and RNA interference (RNAi) experiments. Although the exact role of the sfRNA in the 
viral life cycle is still elusive, production of sfRNA was shown to be essential for KUNV 
cytopathogenicity in cell culture and for viral pathogenicity in infected mice 10. 
XRN1 is well conserved among eukaryotes and is the main cytoplasmic RNase as-
sociated with 5’-3’ mRNA decay that takes place in cytoplasmic processing bodies (P 
bodies), where the mRNA is decapped by the enzymes DCP1 and -2 and subsequently 
degraded 5’ to 3’ by XRN1 (reviewed in references 11-14). XRN1 acts in a processive manner 
by hydrolyzing RNA with 5’-monophosphate end groups to 5’-mononucleotides 15,16. 
Based on fluorescence in situ hybridization (FISH) analysis in KUNV-infected cells, the 
sfRNA was reported to colocalize with XRN1 in P bodies 10. Interestingly, the role of XRN1 
in a viral life cycle is not limited to flaviviruses. XRN1 has also been shown to have an 
antiviral activity by virtue of its exonuclease activity 17 and to act as a potent suppressor 
of viral RNA recombination in viruses such as tomato bushy stunt virus 18. Studies have 
shown that XRN1 can be blocked to some degree by elements such as a poly(G) tract se-
quence or large, stable RNA stem-loop structures 19-21. The 3’ UTR of the mosquito-borne 
flaviviruses is predicted to fold into a highly complex structure involving well-conserved 
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RNA sequences as well as strong secondary structures, such as the long 3’ stem-loop (3’ 
SL) and one or two dumbbell-like RNA structures 22,23; for a review, see reference 24. In 
addition, several RNA pseudoknots are predicted within the mosquito-borne flavivirus 
3’ UTR 23,25. Sequence alignments and computer-aided folding of several flavivirus 3’ UTRs 
indicated that the production of sfRNA most likely results from the stalling of XRN1 at a 
conserved RNA stem-loop structure designated SL-II. Deletions in the KUNV 3’ UTR that 
include SL-II abolished the production of KUNV sfRNA 10.
To determine the involvement of the flavivirus 3’ UTR SL-II structure in sfRNA gen-
eration, we performed a detailed analysis of sfRNA production in YFV-infected cells and 
mapped the XRN1 stalling site by using site-directed mutagenesis of a YFV-17D infec-
tious clone and RNA structure probing. From our data, we concluded that YFV infection 
of mammalian cells results in the XRN1-mediated production of two sfRNAs that form 
a 5’ nested set. More importantly, we demonstrated that an RNA pseudoknot involv-
ing the YFV equivalent of SL-II is required for stalling XRN1 and therefore crucial for the 
generation of the flavivirus sfRNAs.
mAteRiAL AND methoDS
Cell culture
The origin and culture conditions of the BHK-21J, Vero E6, and SW13 cells used in this 
study have been described before 26,27. C6/36 cells 28 were obtained from the ATCC and 
grown in Eagle’s minimal essential medium (EMEM) supplemented with 8% fetal calf 
serum (Bodinco, Netherlands) and 5% nonessential amino acids. 
Recombinant DNA techniques and plasmid construction
Unless explained in more detail, standard nucleic acid methodologies were used 29,30. 
Chemically competent Escherichia coli DH5a cells 31 were used for cloning. YFV-17D 
nucleotide numbering was according to Rice et al. 32 (GenBank accession no. X03700).
Plasmid pBlsrcptSK-YFV9845-10861 (R. Molenkamp et al., unpublished data), which contains 
the complete 3’ UTR of YFV-17D, was used as a template for site-directed mutagenesis 
using the QuikChange strategy (Stratagene) to introduce mutations into the sequences 
of stem-loop E (SL-E) or in the nucleotides predicted to be involved in the formation of 
RNA pseudoknot 3 (PSK3) 23. After sequencing to verify the presence of the introduced 
mutations and to exclude unintended nucleotide changes, the mutant pBlsrcptSK-
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YFV9845-10861 derivatives were digested with Sfi I and Xba I, and the 492-bp DNA fragments 
containing the mutated SL-E or PSK3 sequences were cloned into pACNR-FLYF17Da 33. 
A 194-bp Hind III – Xba I fragment encompassing the region between nucleotides (nt) 
10,520 and 10,714 in the 3’ UTR of YFV was isolated from pHYF5’3’IV∆RS 26 and cloned into 
pBluescript SK(-). The resulting plasmid, pBlscrptSK-YFV10520-10714, was used as a template 
to generate a minus-strand YFV RNA fragment for use as a probe in RNase protection 
assays.
Plasmid pSinrep5-YFV10531-10611 was constructed by inserting a linker encompassing nt 
10,531 to 10,611 of YFV flanked by a Mlu I and Sph I adapter into Mlu I and Sph I digested 
pSinrep5eGFP. The pSINrep5-YFV10521-10662 recombinant was constructed by PCR. Plasmid 
pBlsrcptSK-YFV9845-10861 was used as a template with oligonucleotides that contained 
either an Mlu I site (forward primer) or an Sph I site (reverse primer). The resulting PCR 
product was cloned into Mlu I and Sph I digested pSinrep5-eGFP 34.
Plasmid DNA of the pACNR-FLYF17Da mutants and recombinant pSinrep5 were linear-
ized with Afl II and Xho I, respectively, and used for in vitro RNA transcription 27.
XRN1 RNA silencing
Stocks of lentivirus particles, each expressing a short hairpin RNA (shRNA) (TRCN-
049675, TRCN-049676, or TRCN-049677) against the human XRN1 gene (GenBank acces-
sion no. NM_ 019001.3), and a lentivirus expressing the scrambled shRNA SHC-002 were 
prepared from the MISSION®TRC-Hs1.0 library (Sigma) according to the manufacturer’s 
recommendations. The particle titers of the lentivirus stocks were determined using a 
p24 enzyme-linked immunosorbent assay (ELISA) (Zeptometrix). 
To analyze the effect of XRN1 silencing on YFV sfRNA production, 5 x 105 SW13 cells 
were transduced with a combination of two different lentiviruses expressing one of the 
shRNAs specified above at a multiplicity of infection (MOI) of 5 (each) or with the SHC-
002-expressing virus at an MOI of 10. At 72 h posttransduction, the cells were infected 
with YFV-17D at an MOI of 5, and 30 h later, the cells were lysed 35 and analyzed for the 
expression of the host XRN1 protein and actin by Western blotting 36 after PAGE on 5 and 
10% gels, respectively. Antibodies directed against human XRN1 (Bethyl Laboratories) 
and actin (Santa Cruz) were used at dilutions of 1:5000 and 1:2000, respectively. Viral 
sfRNA production was analyzed by Northern blotting as described below. 
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In vitro XRN1 assay
Plasmid pYF-R.luc2A-RP 37 was linearized with Xho I and used as template for in vi-
tro transcription of YFV replicon RNA in the absence of cap analogue. To remove the 
5’ triphosphate, 7 µg of transcript was incubated with tobacco acid pyrophosphatase 
(TAP; Epicentre) as specified by the manufacturer. The TAP-treated RNA was purified 
by phenol-chloroform extraction and ethanol precipitation. The pellet was dissolved 
in 16 μl H2O and used for digestion with XRN1 (Terminator 5’-phosphate-dependent 
exonuclease; Epicentre) under the conditions described by the manufacturer. The units 
of XRN1 are indicated in the relevant figure. 
RNA transfection and analysis of viral RNA synthesis
BHK-21J cells were transfected with 5 µg of full-length YFV-17D or Sinrep5 transcripts 
as described previously 27. In general, 2.5 ml (approximately 1.5 x 106 cells) of the trans-
fected BHK-21J cell suspension was seeded in a 35-mm plate. Total RNA was isolated 
from the transfected cells at 8 h postelectroporation (p.e.) for the recombinant Sinrep5-
transfected cells and at 24 h p.e. for the YFV-transfected cells. Analysis of RNA synthesis 
by [3H]uridine labeling was performed as described previously 26. Trizol (Invitrogen) 
was used for cell lysis and subsequent RNA purification. [3H]uridine-labeled RNAs were 
denatured with glyoxal and analyzed in 0.8% agarose gels 30.
For Northern blotting, samples containing 10 µg of total RNA from electroporated 
cells or in vitro-transcribed XRN1-treated RNA mixed with 5 µg total RNA from BHK cells 
were denatured using formaldehyde, separated in a formaldehyde-containing 1.5% 
agarose gel, and blotted onto a Hybond-N+ membrane (GE-Healthcare) 30. The blots were 
hybridized with 32P-labeled oligonucleotides as described previously 38,39, except for the 
analysis of sfRNA production in the XRN1 silencing experiments, in which case randomly 
primed, [a-32P]dATP-labeled cDNA fragments directed against the YFV 3’ UTR (nt 10,555 
to 10,862) and the human glyceraldehydes-3-phosphate dehydrogenase (GAPDH) gene 
(GenBank accession no. NM_00246; nt 321 to 724) were used as probes in 5 x SSC and 
50% formamide at 42°C 38. 
Virus stocks, infections and plaque assays
Medium was harvested from transfected cells to obtain virus stocks when a complete 
cytopathic effect (CPE) was observed. YFV-17D infections and plaque assays were per-
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formed essentially as described before 27, except for the agarose in the overlay, which 
was replaced by 1.2% Avicel 40.
Primer extension assay
Primer extension analysis was performed as described by Sambrook et al. 30, with 
minor modifications. Total RNA (5 to 7 µg) from YFV or recombinant Sinrep5 RNA-
transfected cells or XRN1-treated pYF-R.luc2A-RP transcript was annealed to 32P-labeled 
oligonucleotide 1632 or 1648. Oligonucleotide 1632 is complementary to YFV nt 10,690 
to 10,708, and oligonucleotide 1648 is complementary to YFV nt 10,580 to 10,598. After 
hybridization and subsequent ethanol precipitations, primer extension reactions were 
performed using 200 U of RevertAid H Minus Moloney murine leukaemia virus reverse 
transcriptase (Fermentas) as described by the manufacturer. After 1 h of incubation at 
42°C, the samples were treated with RNase A (10 μg/μl; Qiagen) and purified by phenol-
chloroform extraction and ethanol precipitation. The primer extension products were 
analyzed in a denaturing 5% polyacrylamide–8M urea sequencing gel. A 33P-labeled 
Cycle Reader (Fermentas) sequence reaction mix using oligonucleotide 1632- or 
1648-primed pBlsrcptSK-YFV9845-10861 as a template was run on the same gel as the primer 
extension products and served as a size and sequence marker.
RNase protection assay
pBlscrptSK-YFV10520-10714 was linearized using Hind III, purified by phenol-chloroform 
extraction, and used as a template for T7 RNA polymerase-mediated in vitro transcrip-
tion to yield a 229-nt probe that contains 34 nt derived from the vector and 195 nt that 
are complementary to the YFV 10,520 to 10,714. The RNA probe was purified from a 6% 
polyacrylamide gel and hybridized overnight at 42°C to 10 µg of total RNA from mock- or 
YFV-infected BHK cells, using the solutions and protocols supplied with an RPAIII RNase 
protection assay kit (Ambion). As a positive control, 10 ng of a positive-strand T7 RNA 
polymerase transcript containing the 3’ 1 kb of the YFV genome was mixed with 10 µg 
of total BHK cell RNA and treated similarly to the samples containing the YFV- or mock-
infected total BHK cell RNA. After hybridization, the samples were treated with RNase 
A/T1, ethanol precipitated, and subsequently analyzed in a 6% denaturing sequencing 
gel. A sequence reaction mix that served as a size marker was run in parallel with the 
samples in the RNase protection assay.
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RNA structure determination by selective 2’-hydroxyl acylation and 
primer extension (ShAPe) probing
A DNA template containing a T7 RNA polymerase promoter fused to the 3’ terminal 
342 nt of YFV was generated by PCR, using Pfu DNA polymerase (Fermentas) as described 
by the manufacturer. The template was digested with Eco RI and Hind III and cloned in 
pUC9. After linearization with Xba I, the plasmid was used for in vitro RNA transcription 
(T7 MEGAscript kit; Ambion) to obtain a YFV RNA fragment of 188 nt (YFV nt 10,520 to 
10,708) for probing of the RNA structure in the region encompassing the predicted RNA 
pseudoknot 23. RNA was purifi ed as described by the manufacturer (Ambion), and the 
yield was determined by spectrophotometry.
Probing was performed essentially as previously described 41. Briefl y, RNA (20 pmol) in 
6 μl H2O was heated at 95°C for 3 min, cooled down on ice, and subsequently incubated 
with 3 μl folding buff er at 37°C. After 25 min of incubation, 1 μl of 65 mM N-methylisatoic 
anhydride (NMIA; Sigma) in anhydrous dimethyl sulfoxide (DMSO) was added to the RNA 
and allowed to react for 60 min at 35°C. The control reaction mixture contained 1 μl of 
anhydrous DMSO and no NMIA. To determine the NMIA-induced modifi cations in the 
188-bp YFV transcript, 4 pmol (2 µl) of the NMIA-treated RNA was annealed to 10 pM 
32P-labeled oligonucleotide 1632 and used for primer extension without any further 
purifi cation. 
ReSULtS
Small virus-specifi c RNAs can be detected in YFV-infected mammalian 
and insect cells
Recent work 10 demonstrated that cells infected with arthropod-borne fl aviviruses 
produced a small, virus-specifi c RNA derived from the 3’ UTR. To analyze whether the 
YFV sfRNA is also produced in infected cells other than BHK-21 cells 10, the mammalian 
cell lines Vero-E6 and SW13 and the mosquito cell line C6/36 were infected with YFV-
17D. At 30 h postinfection (p.i.) (mammalian cell lines) or 36 h p.i. (insect cell line), total 
RNAs were isolated and analyzed by Northern blotting for YFV sfRNA production, using 
32P-labeled oligonucleotide 1632, complementary to nt 10,690 to 10,708 in the YFV 3’ 
UTR, as a probe. Apart from the YFV genomic RNA, three smaller YFV-specifi c RNAs were 
detected in the infected mammalian cells (fi g. 1). Using in vitro RNA transcripts of various 
lengths as size markers (data not shown), these RNAs were estimated to be 630 nt (RNA 
A), 330 nt (RNA B), and 235 nt (RNA C) in length. Based on their estimated sizes and 
assuming that the RNAs were colinear with the 3’ end of the genome, the 5’ end of RNA A 
63




would be located within the carboxy-terminal coding region of NS5, whereas the 5’ ends 
of RNAs B and C would be in the 3’ UTR. RNA B was the most abundant of these RNAs, 
and the concentrations of RNA A and RNA C varied depending on the cell line studied. 
Hardly any RNA A was detected in the infected BHK cells, in which RNA C was relatively 
abundant, whereas the reverse was true for SW13 cells (fi g. 1, lanes 1 and 3). Surprisingly, 
RNA B was the only small YFV-related RNA detected in the mosquito (C6/36 cells) (fi g. 
1). Of the three RNAs detected in the analyzed mammalian cell lines, RNA B appeared to 
be similar to the recently described YFV sfRNA 10. To keep in line with the nomenclature 
used in previously published work, RNA B was named sfRNA1. The slightly smaller RNA 
C was named sfRNA2, which does not imply that this sfRNA is similar to WNV sfRNA2, 
which can be detected only when the XRN1 stalling site for WNV sfRNA1 is deleted 10. 
Fig. 1 
Chapter 3 
Fig. 1. YFV-17D sfRNA production in mammalian and insect cell lines. 
The mammalian cell lines BHK-21J, Vero E6, and SW13 and the mosquito cell line C6/36 were infected with 
YFV-17D at an MOI of 10. At 30 h (mammalian cell lines) or 36 h (mosquito cell line) p.i., total RNA was 
isolated and analyzed by Northern blotting for the production of YFV-17D sfRNA. Lane M, total RNA isolated 
from mock-infected BHK-21J cells. Oligonucleotide 1632, complementary to nt 10,690 to 10,708 of the YFV 
3’ UTR, was used as a probe. Size markers are indicated on the left. Bands corresponding to the YFV-17D 
genome and to three small viral RNAs (A, B, and C) are indicated by arrows. RNA B and RNA C are referred to 
as sfRNA1 and sfRNA2, respectively.
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YFV sfRNA1 and sfRNA2 have identical 5’ ends
Oligonucleotide 1632 (fig. 2.A), which was expected to bind to both sfRNA1 and 
sfRNA2, was used for primer extension analysis of total RNA isolated from YFV-infected 
or mock-infected BHK cells. As an additional control, a reaction was performed with 
a sample containing total RNA of uninfected cells mixed with 1 µg of full-length YFV 
genome transcript to detect products that resulted from strong stops of the reverse 
transcriptase on the YFV genome. As shown in fig. 2.B, lane 1, primer extension of oli-
gonucleotide 1632 on total RNA of YFV-infected cells yielded a product that was not 
present in the RNA of uninfected cells (fig. 2.B, lane 2) or in the sample containing the 
full-length YFV transcript (fig. 2.B, lane 3). Two primer extension products were observed 
that differed in size by only one nucleotide. The 5’ ends of these primer extension 
products were mapped to the A residues at positions 10,532 and 10,533 by use of an 
oligonucleotide 1632-primed sequence reaction with pBluescript-YFV9845-10861 as a size 
marker. Based on these results, the length of the YFV sfRNA is 329 or 330 nt, which is in 
agreement with the size estimate for sfRNA1 based on the Northern blots. The result 
of the primer extension analysis was verified using an RNase protection assay with a 
gel-purified, 32P-labeled probe that is complementary to 34 nt of the vector and to YFV 
nt 10,520 to 10,714. This probe has extra YFV nucleotides at the 3’ end relative to the 
predicted 5’ end of the sfRNA to discriminate between YFV genome and sfRNA protected 
fragments. As shown in fig. 2.C, some large YFV genome-derived bands were detected 
in both total RNA of YFV-infected cells and the control sample (fig. 2.C, lanes 2 and 4, 
respectively). In addition, the probe protected a unique 181 or 182 nt fragment in the 
total RNA of YFV-infected BHK cells (fig. 2.C, lane 2). The size of the protected RNA frag-
ment agreed with that predicted based on the results of the primer extension analysis 
and confirmed that the 5’ end of sfRNA1 is at position 10,532 or 10,533. 
The most surprising result of these assays was that only these primer extension prod-
ucts and these RNase-resistant RNA fragments were detected, suggesting that sfRNA1 
and sfRNA2 have a common 5’ end and that the observed difference in size between 
the two RNAs was due to a truncation at the 3’ end of sfRNA2. To verify this hypothesis, 
total RNAs were isolated from YFV-infected BHK-21, Vero E6, SW13 and C6/36 cells and 
analyzed by Northern blotting, using oligonucleotides 1648 and 1296 as probes. Oli-
gonucleotide 1648 was complementary to nt 10,580 to 10,597 of the YFV genome (fig. 
3.A), near the predicted 5’ end of the sfRNAs. Oligonucleotide 1296 should bind to the 
3’ terminal 32 nt of the YFV genome (fig. 3.A). As shown in fig 3.B, oligonucleotide 1648 
hybridized to both sfRNA1 and sfRNA2, whereas oligonucleotide 1296 only detected 
sfRNA1 (fig. 3.C.). These results demonstrated that the two YFV sfRNAs have a common 5’ 
end and that sfRNA2 is indeed truncated at the 3’ end.
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Fig. 2 1027 
1028 
Fig. 2. Determining the 5’ end of the YFV 3’ UtR-specific sfRNAs produced in BhK-21J cells. 
A) Schematic diagram of the predicted secondary structure of the YFV 3’ UTR 23. B) Primer extension 
analysis using oligonucleotide 1632, which is complementary to YFV nt 10,690 to 10,708 (see panel A). 
pBluescript-YFV9,845-10,861, containing the COOH-terminal part of the YFV NS5 gene and the complete 3’ UTR, 
was sequenced with oligonucleotide 1632 to obtain a sequencing ladder for determination of the 5’ end 
of the sfRNAs. Lanes 1 and 2, primer extension on total RNAs isolated from YFV-infected and uninfected 
BHK-21J cells, respectively; lane 3, primer extension on a full-length in vitro YFV transcript mixed with total 
RNA from uninfected BHK-21J cells. The underlined T residues of the depicted sequence correspond to 
the 5’ ends of the primer extension products and map the 5’ ends of the YFV sfRNAs to the A residues at 
positions 10,532 and 10,533 of the YFV genome. C) RNase protection assay using a 229-nt antisense RNA 
probe encompassing nt 10,520 to 10,714 of the YFV-17D 3’ UTR. Lane 1, 32P-labeled RNA transcript used as 
the probe; lane 2, RNA fragments that were protected from RNase digestion after hybridization of the probe 
to total RNA isolated from YFV-17D-infected cells; lane 3, RNase protection assay on total RNA of mock-
infected cells; lane 4, protected RNA fragments obtained when pBluescript-YFV9,845-10,861 transcripts mixed 
with total RNA from mock-infected BHK-21J cells were analyzed. Bands corresponding to the protected 
fragments derived from either the YFV-17D genome or the sfRNA are indicated. pBluescript-YFV9,845-10,861 
was sequenced with oligonucleotide 1632 to obtain a marker to determine the sizes of the protected RNA 
fragments. 
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YFV sfRNA is generated by the host enzyme XRN1
As recently shown, the host exoribonuclease XRN1 hydrolyzes the WNV genome in a 
5’-3’ direction until it is stalled by a currently unknown signal yielding the WNV sfRNA 
10. To determine whether XRN1 was also involved in the production of the YFV sfRNAs, 
the effects of silencing of XRN1 expression on sfRNA production in YFV-infected cells 
and the in vitro production of sfRNA by incubation of YFV transcripts with purified XRN1 
were studied. The human-derived SW13 cell line was used in the XRN1 silencing experi-
ments because the nucleotide sequence of the human XRN1 gene is the only one known 
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Fig. 3. YFV sfRNA2 is truncated at the 3’ end. 
A) Scheme of the YFV 3’ UTR. The two possible orientations of the sfRNAs relative to the YFV 3’ UTR are 
depicted. The positions of oligonucleotides 1648 and 1296, used to determine the orientation of the 
sfRNAs, are indicated. Total RNAs were isolated from the indicated YFV-infected cell lines or from mock-
infected BHK-21J cells and subsequently analyzed by Northern blotting. B) Northern blot analysis using 
oligonucleotide 1648, complementary to YFV-17D nt 10,580 to 10,598. C) Northern blot analysis using 
oligonucleotide 1296, complementary to YFV-17D nt 10,830 to 10,862. 
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were transduced with lentiviruses expressing shRNA direct against the XRN1 transcript 
or a control shRNA, infected with YFV, and analyzed for XRN1 expression and YFV sfRNA 
production by Western and Northern blotting. Expression of each combination of two of 
the three shRNAs, TRCN-049675, TRCN-049676, and TRCN-049677, in SW13 cells resulted 
in significantly less production of XRN1 (fig. 4.A, lanes 2, 3, and 4) than that in cells trans-
duced with a similar lentiviral vector expressing a scrambled shRNA (fig. 4.A, lane 1). The 
silencing of XRN1 expression by the indicated shRNAs was likely specific, since no effect 
on the expression of actin was observed in these cell lysates (fig. 4.A, bottom panel). 
As shown by the Northern blot analysis, silencing of XRN1 decreased the production 
of the YFV sfRNA by approximately 90% for all three combinations of shRNAs tested 
when compared to that in cells transduced with a lentivirus expressing a scrambled 
shRNA (fig. 4.B). The signals for the host cell GAPDH gene were similar in all these lysates, 
indicating that the observed differences in sfRNA production were not due to significant 
experimental error. Visual inspection of the cells expressing the shRNAs directed against 







Fig. 4 1042 
1043 
Fig. 4. shRNA-mediated XRN1 silencing decreases 
YFV sfRNA production. 
SW13 cells were transduced with an shRNA-expressing 
lentivirus from the MISSION®TRC-Hs1.0 library (Sigma) 
and then infected with YFV-17D as described in Material 
and Methods. Lentiviruses expressed the following 
shRNAs: lane 1, scrambled shRNA (SHC-002); lane 
2, shRNAs TRCN-049675 and TRCN-049676; lane 3, 
shRNAs TRCN-049675 and TRCN-049677; and lane 4, 
shRNAs TRCN-049676 and TRCN-049677. A) XRN1 and 
actin expression in Western blots. Rel. %, percentage 
of XRN1 expression in cells transduced with shRNAs 
against XRN1 compared to that in cells expressing 
the scrambled shRNA. B) YFV sfRNA production and 
GAPDH mRNA expression by Northern analysis. Rel. %, 
expression of YFV sfRNA in cells transduced with shRNAs 
against XRN1 compared to that in cells expressing the 
scrambled shRNA.
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why the hybridization signal for the YFV genome was also somewhat weaker than that 
in cells transfected with the scrambled shRNA (fig. 4.B). 
To determine whether purified XRN1 was able to produce YFV sfRNA in vitro, linear-
ized pYF-R.luc2A-RP 37 was used as a template for the production of an uncapped YFV 
transcript. After treatment with TAP to remove the XRN1-blocking 5’-triphosphate, this 
RNA was incubated with 0.1 or 1 unit of XRN1 and analyzed by Northern blot analy-
sis for sfRNA production. Incubation of YF-R.luc2A-RP RNA with XRN1 resulted in the 
production of a small YFV-specific RNA that comigrated with the sfRNA1 produced in 
YFV-infected BHK-21J cells (fig. 5.A). Primer extension analysis was performed to provide 
additional evidence that this small RNA produced in vitro truly reflected the YFV sfRNA. 
As shown in fig. 5.B, primer extension using oligonucleotide 1632 resulted in similarly 
sized products for both XRN1-treated YF-R.luc2A-RP RNA transcript and total RNA from 
YFV-infected BHK cells. The fact that the smaller sfRNA2 was readily detectable in YFV-
infected BHK-21J cells and not in the in vitro XRN1 assays is in line with our previous 
findings that sfRNA1 and sfRNA2 have a common 5’ end and suggests that additional 







Fig. 5 1049 
1050 
Fig. 5. In vitro production of YFV-17D sfRNAs by the host 
exoribonuclease XRN1. 
TAP-treated in vitro RNA transcripts of YF-R.luc2A-RP were 
incubated with the indicated units of XRN1 and analyzed 
by hybridization after denaturing gel electrophoresis (A) 
and primer extension (B), using oligonucleotide 1632, 
complementary to YFV-17D nt 10,690 to 10,708, as a probe 
and primer, respectively. RNAs isolated from mock (M) and/
or YFV-infected BHK-21J cells were used as controls in both 
experiments. 
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From the results obtained with the RNA silencing experiments and the in vitro YFV 
sfRNA production by purified XRN1, it was concluded that similar to the case for WNV, 
the host RNase XRN1 is responsible for the production of YFV sfRNAs. 
An RNA pseudoknot in the YFV 3’ UtR is required for production of sfRNAs
Compared to the predicted RNA structure of the YFV 3’ UTR 23, the 5’ end of sfRNA1 
and sfRNA2 is located just a few nucleotides upstream of SL-E (fig. 2.A), which is part 
of an RNA pseudoknot. To determine whether the predicted RNA structures that form 
this pseudoknot (PSK3) are required for YFV sfRNA production, site-directed mutagen-
esis was used to construct pACNR-FLYF-17DΔSL-E, which lacked nt 10,537 to 10,596 
(which form SL-E) and was therefore unable to form PSK3. In vitro-transcribed RNA of 
AflII-linearized pACNR-FLYF-17DΔSL-E was electroporated into BHK-21J cells that were 
subsequently analyzed for viral RNA replication by [3H]uridine labeling and for sfRNA 
synthesis by Northern blotting. Despite the relatively minor effects on viral replication 
(fig. 6.A), no YFV sfRNA could be detected in the cells transfected with YFV-ΔSL-E RNA (fig. 
6.B). To demonstrate that the lack of sfRNA production in the cells transfected with YFV-
ΔSL-E RNA was due to disruption of the XRN1 stalling site, transcripts of this mutant were 
incubated in vitro with purified XRN1. As shown in fig. 6.C, XRN1 was not stalled when 
SL-E was deleted and therefore no sfRNA was produced. These in vitro and in vivo results 
together demonstrate that SL-E encompasses RNA structures and/or sequences that are 
essential for stalling XRN1 and therefore for YFV sfRNA production. The YFV-ΔSL-E mutant 
virus was delayed in inducing CPE in BHK cells. It also showed a slight delay in initial virus 
production but reached a similar maximum titer to that of the parental virus (fig. 6.D). 
Two sets of additional mutants were constructed to dissect the role of SL-E in YFV 
sfRNA synthesis in more detail. The first set of mutants focused on the role of the top 
stem structure of SL-E (referred to as e2) 23. In mutant YFV-e2AA, the right arm of the 
stem (5’-GCAGU-3’; YFV nt 10,583 to 10,587) was replaced by the sequence of the left 
part of the stem (5’-ACUGC-3’) (fig. 7.A). Due to these mutations, the formation of SL-E 
e2 was expected to be disrupted. YFV-e2BB was the opposite of the YFV-e2AA mutant. 
In this mutant, the left part of the e2 stem (5’-ACUGC-3’; YFV nt 10,567 to 10,571) was 
replaced by the nucleotide sequence of the right arm of SL-E e2 (5’-GCAGU-3’) (fig. 7.A). 
In the YFV-e2BA mutant, the possibility to form stem e2 was restored by switching the 
parental YFV-17D original sequences of the left and right arms of the stem. BHK-21J cells 
were electroporated with in vitro-transcribed RNAs of the parental YFV-17D strain and 
the YFV-e2 stem mutants. Cells were analyzed for genome RNA synthesis by [3H]uridine 
labeling and for sfRNA production by Northern blotting with oligonucleotide 1632. As 
shown in fig. 7.B, all three YFV-e2 mutants were able to synthesize viral genomic RNA 
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efficiently. Strikingly, neither YFV-e2AA nor YFV-e2BB was able to produce detectable 
amounts of sfRNA (fig. 7.C). Restoring the possibility to form stem e2, as in YFV-e2BA, also 
restored the production of YFV sfRNA. Although in comparison to YFV-17D YFV-e2BA 
produced less sfRNA, both viruses induced CPE in the cells about 48 h after electropora-
tion, whereas YFV-e2AA and YFV-e2BB were clearly delayed in CPE induction compared 
to the parental virus. The kinetics of virus production in BHK-21 cells were similar to that 
shown for YFV-ΔSL-E (e.g., YFV-e2AA) or closer to that for the parental virus (data not 
shown). The fact that the YFV sfRNAs were produced in cells infected with YFV-e2BA 
indicated that the SL-E structure was more important than the primary sequence for 
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Fig. 6. Stem-loop structure SL-e in the 
YFV 3’ UtR is required for the production 
of sfRNA. 
A) Viral RNA synthesis in BHK-21J cells 
transfected with in vitro-transcribed 
genome-length RNAs of YFV-17D and YFV-
ΔSL-E. Transfected cells were labelled with 
[3H]uridine from 18 to 24 h posttransfection. 
Total RNAs were isolated and analyzed 
after denaturation by agarose gel 
electrophoresis, as described in Materials 
and Methods. B) sfRNA production in BHK-
21J cells transfected with YFV-17D and YFV-
ΔSL-E transcripts. Total RNAs were isolated 
at 24 h posttransfection and analyzed by 
Northern blotting and hybridization with 
oligonucleotide 1632 (complementary to 
YFV-17D nt 10,690 to 10,708). The sfRNAs 
are indicated by arrows. C) In vitro RNA 
transcripts of YFV-17D and YFV-ΔSL-E were 
incubated in the presence or absence 
of 1 unit of XRN1 and analyzed for the 
production of sfRNA by Northern blotting, 
using oligonucleotide 1632 as a probe. 
The sfRNA is indicated by an arrow. D) Viral 
growth kinetics of YFV-17D and the YFV-
ΔSL-E mutant. BHK-21J cells were infected at 
an MOI of 5, and the medium of the infected 
cells was sampled at the indicated times 
postinfection. Titers were determined by 
plaque assays on BHK-21J cells.
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SL-E is predicted to be part of a more complex RNA structure in which the sequence 
5’-GCUGU-3’ (pk3’; YFV nt 10,575 to 10,579) in the top loop of e2 is predicted to base pair 
with the sequence 3’-CGACA-5’ (pk3; YFV nt 10,598 to 10,602) immediately downstream 
of SL-E, forming an RNA pseudoknot (PSK3) (fig. 7.A) 23. A second set of YFV mutants 
was constructed to determine whether the pk3’-pk3 interaction is important for YFV 
sfRNA production. In YFV-pk3’pk3’ and YFV-pk3pk3, the downstream pk3 sequence or 
the upstream pk3’ sequence was replaced by the complementary sequence. For both of 
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Fig. 7. YFV-17D RNA pseudoknot 3 is required for 
sfRNA production. 
A) Schematic diagram of the YFV 3’ UTR SL-E 
structure. The primary sequences involved in stem-
loop e2 (sequences A and B) and in the pseudoknot 
interaction (sequences pk3’ and pk3) are depicted. 
B and D) Viral RNA synthesis in BHK-21J cells 
transfected with in vitro-transcribed genomic RNAs 
of YFV-17D and YFV mutant viruses (at SL-E-e2 [B] 
and at PSK3 [D]). Transfected cells were labeled 
with [3H]uridine from 18 to 24 h posttransfection. 
Total RNAs were isolated and analyzed after 
denaturation by agarose gel electrophoresis, as 
described in Materials and Methods. YFV(AB) and 
YFV(pk3’3) indicate wild-type YFV-17D for these 
different groups of mutants. C and e) Northern 
blot analysis of RNAs isolated from BHK-21J cells 
30 h posttransfection with YFV-17D and YFV 
mutant viruses (at SL-E e2 [C] and at PSK3 [e]). 
Oligonucleotide 1632 (complementary to YFV-17D 
nt 10,690 to 10,708) was used as a probe. In panel 
E, the dotted line separates the wild-type YFV-17D 
and mock lanes from the same Northern blot at a 
higher exposure. 
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bility to form PSK3 was restored, albeit with the positions of the pk3’ and pk3 sequences 
reversed in comparison to those in YFV-17D. [3H]uridine labeling of BHK cells transfected 
with in vitro-transcribed full-length RNAs of these mutants demonstrated that they rep-
licated quite efficiently (fig. 7.D). More importantly, no sfRNA could be detected in cells 
transfected with YFV-pk3’pk3’ or YFV-pk3pk3, whereas YFV sfRNA could be detected in 
cells electroporated with the YFV-pk3pk3’ mutant, in which the ability to form PSK3 was 
restored (fig. 7.E). However, the amount of sfRNA produced by YFV-pk3pk3’ was far less 
than that observed for the parental YFV-17D strain and required contrast enhancement 
of the phosphorimager data, which changed only the view of the data, not the data 
themselves. All three pk3-pk3’ mutant viruses showed a significant delay in the onset of 
CPE in BHK cells compared to YFV-17D. The kinetics of virus production in BHK-21J cells 
were similar to that for YFV-17D, except for YFV-pk3’pk3’, whose kinetics was like that of 
YFV-ΔSL-E (data not shown). 
The combined results of the mutagenesis of the SL-E e2 stem and the pk3’-pk3 se-
quences strongly suggest that the predicted H-type RNA pseudoknot PSK3 is required 
to stall XRN1, resulting in the production of YFV sfRNA. 
insertion of the PSK3 sequence into a heterologous RNA results in 
production of an sfRNA-like RNA
The fact that the base pairings in SL-E stem e2 and between pk3’ and pk3 are impor-
tant determinants of YFV sfRNA synthesis did not exclude the possibility that this region 
is part of a more complex RNA structure, including additional elements downstream of 
PSK3. To address this possibility, a synthetic Mlu I – Sph I DNA mimicking YFV nt 10,521 to 
10,662 and YFV nt 10,531 to 10,611 was inserted into a Sinrep5 vector 34 that contained 
an enhanced green fluorescent protein (GFP) gene just upstream of the insertion site (fig. 
8.A). This resulted in two constructs: pSinrep5-eGFP-YFV10,521-10,662, encoding the SL-E to 
SL-C fragment of the YFV 3’ UTR, and pSinrep5-eGFP-YFV10,531-10,611, encoding the YFV SL-E/
PSK3 region. The GFP gene allowed for easy determination of the transfection efficiency 
and for discrimination between the Sindbis virus subgenomic RNA and a potentially 
produced sfRNA-like RNA. BHK-21J cells were transfected with in vitro-transcribed RNAs 
of the Sinrep5-eGFP and Sinrep5-eGFP-YFV mutants. RNAs were isolated at 8 h p.e. and 
analyzed for sfRNA-like RNA production by Northern blotting and hybridization, with 
two oligonucleotides as probes. Probe 1674 was complementary to nt 7,601 to 7,625 of 
Sindbis virus and was expected to hybridize to both the Sinrep5 genomic and subge-
nomic mRNAs, whereas probe 1648, which was complementary to YFV SL-E (nt 10,580 to 
10,597), was expected to hybridize not only to Sinrep5 mRNAs but also to any sfRNA-like 
RNA produced in the transfected cells. As shown in fig. 8.B, hybridization of total RNA 
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of the transfected cells with oligonucleotide 1674 demonstrated that Sinrep5-eGFP and 
both Sinrep5-eGFP-YFV10,521-10,622 and pSinrep5-eGFP-YFV10,531-10,611 replicated efficiently 
and produced a subgenomic mRNA of the expected size in the transfected BHK cells. In 
addition to the recombinant Sinrep5 genomic and subgenomic mRNAs, hybridization 
with oligonucleotide 1648 revealed the production of an additional small RNA that was 
unique for the cells transfected with Sinrep5-eGFP-YFV10,521-10,662 and pSinrep5-eGFP-
YFV10,531-10,611 (fig. 8.B, lanes 6 and 7). The size of this RNA was in agreement with what was 
expected for the production of an sfRNA-like RNA in pSinrep5-eGFP upon insertion of 
the YFV sequences. Primer extension of total RNAs from cells transfected with Sinrep5-









Fig. 8 1073 
1074 
Fig. 8. insertion of sequences required for the formation of PSK3 is sufficient to produce an sfRNA-
like RNA in the context of a Sindbis virus replicon. 
A) Scheme of the characteristics of the pSinrep5 vector and the predicted structures of the YFV-17D regions 
that were inserted into the vector. The YFV 3’ UTR nucleotides cloned into pSinRep5-eGFP are indicated in 
the name of each construct. The promoter for the enhanced GFP (eGFP)-expressing subgenomic Sinrep 
mRNA and the binding sites for oligonucleotides 1674 and 1648 are indicated. B) Northern blot analysis of 
RNAs isolated from BHK-21J cells 8 h p.e. with Sinrep5-eGFP (lanes 1 and 5), Sinrep5-eGFPYFV10,521-10,662 (lanes 
2 and 6), and Sinrep5-eGFPYFV10,531-10,611 (lanes 3 and 7) RNAs; lanes 4 and 8 correspond to uninfected BHK-
21J cells. Oligonucleotide 1674 and oligonucleotide 1648 were used as probes, as specified in the figure. 
The Sindbis virus genomic (gRNA) and subgenomic (sgRNA) RNAs and the sfRNA-like RNAs are indicated. 
C) Primer extension analysis with oligonucleotide 1648 to determine the 5’ end of the sfRNA-like RNAs 
produced with the Sinrep5 mutants. pBluescript-YFV9,845-10,861 was sequenced with oligonucleotide 1648 to 
obtain a sequencing ladder. RNAs isolated from BHK-21J cells transfected with YFV-17D (lane 1), Sinrep5-
eGFPYFV10,521-10,662 (lane 2), and Sinrep5-eGFPYFV10,531-10,611 (lane 3) were analyzed; lane 4 corresponds to 
mock-transfected cells. 
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the sfRNA-like RNA produced in these transfected cells was similar to that of the sfRNA 
produced in YFV-infected cells. Taken together, these results clearly demonstrate that 
the YFV nt 10,531 to 10,611, containing the region that allows the formation of PSK3, 
are sufficient to stall XRN1. Furthermore, these results also indicate that RNA structures 
downstream of PSK3 are not required for the production of sfRNA.
Chemical RNA probing provides evidence of the formation of PSK3
To obtain additional evidence to support the formation of PSK3, in vitro structure 
probing by SHAPE with NMIA 41 was performed on an in vitro-synthesized RNA template 
containing YFV 3’ UTR nt 10,520 to 10,708, encompassing PSK3. As shown in fig. 9.B, 
chemical probing of this region of the wild-type YFV-17D genome essentially confirmed 
the previously predicted RNA structure model 23. Apart from the nucleotides predicted 
to form the top loop of the side stem SL-E e3 (fig. 9.A), most of the other nucleotides 
did not react with NMIA, indicating that they were in a double-stranded conformation. 
This observation also includes the nucleotides of the pk3’ and pk3 sequences (fig. 9.B). 









Fig. 9 1082 
 1083 
Fig. 9. the predicted pseudoknot PSK3 at the wild-type YFV 3’ UtR is genuine. 
A) Schematic diagram of the minimal YFV 3’ UTR region (nt 10,531 to 10,611) required for stalling of XRN1. 
Sequences involved in the pseudoknot interaction are depicted. B) In vitro structure probing by SHAPE 
with wild-type YFV and the PSK3 mutants YFV-pk3’pk3’, YFV-pk3pk3, and YFV-pk3pk3’. After treatment 
with NMIA, which preferentially reacts with bases in a single-stranded conformation, in vitro-synthesized 
RNA templates (YFV nt 10,520 to 10,708) were analyzed by primer extension with oligonucleotide 1632 
(complementary to YFV nt 10,690 to 10,708). Samples were treated with either 65 mM NMIA in DMSO (+) 
or, as a control, DMSO only (-). The different substructures of SL-E and the pk3 and pk3’ sequences are 
indicated on the right relative to their positions in the NMIA reactivity pattern. pBluescript-YFV9,845-10,861 was 
sequenced with oligonucleotide 1632 to obtain a sequencing ladder.
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the prediction that these complementary sequences could base pair to form the PSK3 
pseudoknot. 
The mutants that should have disrupted (YFV-pk3’pk3’ and YFV-pk3pk3) or restored 
(YFV-pk3pk3’) PSK3 formation were also subjected to RNA structure probing. The NMIA 
reactivity patterns of these mutant RNAs showed that the overall SL-E structure was 
maintained but that especially the pk3’ sequence, and to a somewhat lesser extent 
the pk3 sequence, were now susceptible to modification by NMIA (fig. 9.B), indicating 
that these sequences were no longer base pairing to form PSK3. Surprisingly, a similar 
result was also obtained for the putatively restored YFV-pk3pk3’ mutant RNA, indicating 
that despite the nucleotide complementarity between the pk3 and pk3’ sequences, the 
formation of PSK3 was not restored in this mutant. 
Nonetheless, the structural probing data obtained with the RNA fragment encompass-
ing YFV-17D nt 10,520 to 10,708 provided strong support for the previously proposed 
structural model 23.
DiSCUSSioN
The generally accepted concept that the viral genome, which also serves as the viral 
mRNA, and the genome-length, minus-strand RNA are the only RNA species that can be 
detected in cells infected with flaviviruses was recently challenged. Several studies have 
now shown that in addition to these genome-length viral RNAs, a small, positive-strand 
viral RNA (sfRNA) is produced in cells infected with arthropod-borne flaviviruses 6-10. 
Recently, the sfRNA was shown to be a product of incomplete 5’ to 3’ degradation of the 
viral genome by the host exoribonuclease XRN1 and to serve as an important determi-
nant of viral pathogenicity 10. This study describes the production of sfRNA by XRN1 in 
YFV-infected cells and, more importantly, defines an RNA pseudoknot in the viral 3’ UTR 
as a prerequisite for stalling of XRN1, resulting in the production of the sfRNA.
Not one but two sfRNAs are detected in YFV-infected cells. Another, larger YFV-specific 
RNA was also detected in infected mammalian cell lines, especially in SW13 cells. This 
RNA is likely an instable intermediate of 5’ to 3’ XRN1-mediated decay of the viral ge-
nome. Silencing of XRN1 in YFV-infected SW13 cells resulted in a significant decrease of 
YFV sfRNA1 as well as the larger YFV-specific RNA A. Digestion of YFV genome transcripts 
with purified XRN1 resulted in the in vitro production of sfRNA1, providing the ultimate 
proof for the role of XRN1 in YFV sfRNA production.
Mapping of the positions of sfRNA1 and sfRNA2 in the 3’ UTR of the YFV genome 
revealed that sfRNA1 was colinear with the distal part of the 3’ UTR. Both sfRNAs had 
the same 5’ end, and the smaller size of sfRNA2 was due to a truncation at the 3’ end. 
sfRNA2 was never detected upon in vitro digestion of YFV genome transcripts with puri-
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fied XRN1. One hypothesis that could explain this truncation is that sfRNA2 is derived 
by XRN1 digestion of a YFV genomic RNA template that is already truncated at the 3’ 
end. Alternatively, sfRNA2 could be the result of additional processing by an exo- or 
an endoribonuclease at the 3’ end of sfRNA1. Currently, we have no evidence to favour 
one of these hypotheses. Interestingly, it has been shown that in insect cells the 5’ to 3’ 
decay pathway is the dominant route for overall RNA turnover 42, while in mammalian 
cells the relative contributions of 5’ to 3’ and 3’ to 5’ RNA degradation pathways to RNA 
turnover are still a subject of debate (reviewed in reference 13). The fact that sfRNA2 was 
not detected in infected mosquito cells thus supports the hypothesis that sfRNA2 is the 
result of 3’ to 5’ processing.
Both the primer extension and RNase protection assays mapped the 5’ end of the YFV 
sfRNAs to nucleotide 10,532 or 10,533, which is just upstream of a predicted H-type RNA 
pseudoknot (PSK3) 23 that includes SL-E. The inability of XRN1 to produce an sfRNA both 
in vivo and in vitro when SL-E was disrupted strongly indicates that this region contains 
essential elements for the stalling of this host RNase. XRN1 can be blocked by elements 
such as strong secondary structures or G-track sequences 17,19-21. The YFV PSK3 region 
is not particularly G rich but adopts a complex RNA structure. So far, no experimental 
evidence supporting the formation of PSK3 has been presented, nor has this structure 
been implicated in any biologically relevant function. Our RNA structure probing of the 
PSK3 region provided unequivocal evidence of the presence of this RNA pseudoknot 
in YFV 3’ UTR. Disruption of the SL-E structure resulted in viruses that replicated with a 
similar efficiency to that of YFV-17D but did not produce detectable amounts of sfRNA. 
Reconstituting the SL-E structure in a YFV mutant, albeit with different base pairs, 
resulted in sfRNA production in cells infected with this mutant. On the other hand, 
disrupting the predicted PSK3 resulted in mutant viruses that replicated efficiently but 
were no longer able to produce sfRNA. Surprisingly, when the base pairing possibility 
was restored (YFV-pk3pk3’), sfRNA production was hardly detectable. These data are 
supported by the probing results showing that although the overall SL-E structure was 
maintained in all PSK3 mutants, none of them showed any significant base pairing of 
the nucleotides involved in the equivalent of the parental pk3’ – pk3 interaction. Al-
though restoration of the pseudoknot was expected in the YFV-pk3pk3’ mutant, this 
seemed to occur in only a minor fraction of the RNA molecules, which explains why they 
were not detected in the probing experiments and why enhancement of the contrast 
in the picture of the Northern blot was required. The experiments using the Sinrep5 
expression system demonstrated that YFV nt 10,531 to 10,611, predicted to form PSK3, 
contain all of the RNA sequences and structures that are needed to stall XRN1. In an 
attempt to restore PSK3 interaction and subsequent sfRNA production, an additional 
YFV mutant was constructed in which the pk3’ and pk3 sequences were replaced by 
5’ CCCGC 3’ and 5’ GCGGG 3’ sequences, respectively, to enhance the thermodynamic 
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stability of this interaction. Although this mutant was viable, it did not produce any 
sfRNA (data not shown), and probing provided no evidence of a pk3’-pk3 interaction 
(data not shown). Taken together, our mutational analysis and probing results support 
the actual formation of PSK3 in the 3’ UTR of YFV but also indicate that the formation 
of this pseudoknot is sequence dependent. For many viral pseudoknots, the primary 
sequence is unimportant for function, as long as the conformation and overall stability 
of the structure are maintained (reviewed in reference 43). Nonetheless, there are other 
pseudoknots in which subtle nucleotide changes interfere with pseudoknot thermody-
namic stability and are deleterious for pseudoknot function 44,45. Examples of viruses in 
which the primary sequence proved to be important for RNA pseudoknot stability and/
or function include tobacco mosaic virus 46, beet western yellow virus 47, severe acute re-
spiratory syndrome (SARS) coronavirus 48,49, and Visna-Maedi virus 50. A similar situation 
can also be envisioned for YFV, in which specific constraints to sustain the overall stabil-
ity/conformation of the higher-order RNA structure of PSK3 can be fulfilled only by the 
wild-type sequence. The fact that the pk3’ and pk3 sequences are well conserved among 
the different YFV strains 51,52 supports this idea. The observation that disruption of PSK3 
allows XRN1 to degrade the viral genome completely implies that the YFV genome has 
one unique stalling site for XRN1 within the 3’ UTR. This observation differs from the case 
for KUNV, in which more than one stalling site was found 10.
It was shown that KUNV viruses deficient in sfRNA production are significantly more 
attenuated in cell culture and in mice than viruses that produce the sfRNA, suggesting 
an important role for the sfRNA in viral pathogenicity 10. A similar observation was made 
with our YFV mutants: viruses that were unable to produce sfRNA were also unable to 
form plaques on SW13 cells, despite the fact that they were able to replicate efficiently 
in these cells (data not shown). Interestingly, it has previously been hypothesized that 
there is a correlation between the structure of the YFV region predicted to form PSK3 
and the degree of virulence exhibited by the virus 53. Although these observations for 
KUNV and YFV may hint at a function of the sfRNA, it is still unclear how sfRNA synthesis 
relates to viral pathogenesis. It has been suggested that the sfRNA could modulate the 
host antiviral responses by antagonizing or inactivating certain cellular RNA sensors 
(e.g., TLR3, RIG-I, and MDA5) or that it could act as a decoy for cellular microRNAs 54. Since 
KUNV sfRNA was reported to be generated by XRN1 in P bodies 10, and since these P bod-
ies contain, besides 5’-3’ degradation components, proteins involved in translational re-
pression, mRNA surveillance and RNA-mediated gene silencing (reviewed in references 
11-13,55), one could speculate that the sfRNA could indeed be involved in a pathway linked 
to P bodies, such as RNA-mediated gene silencing. However, a progressive decrease in 
the number of P bodies during the time course of DENV-2 and WNV infections of BHK 
cells has been reported 56. Alternatively, either free in the cytoplasm or associated with 
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cellular structures, the sfRNA could also act as a decoy to sequester a host protein(s) that 
would otherwise bind to the genomic 3’ UTR and exert a negative effect on the virus. 
Additional studies are needed to determine the kinetics of sfRNA production, its 
subcellular localization, and potential sfRNA-interacting host factors. Previous studies 
with flaviviruses containing mutations or deletions in the genomic 3’ UTR region should 
be re-evaluated in light of the potential effect of such mutations on the production and 
function of the sfRNA. For instance, deletions involving the SL-II region of DENV (which 
is comparable to the YFV SL-E) that resulted in restricted growth in cell culture, different 
plaque phenotypes and viral attenuation 57,58 could be explained by the lack of sfRNA 
production, illustrating the importance of the sfRNA in viral pathogenesis. 
From this study and those of others, it is obvious that a simple deletion that disrupts 
the stalling site for XRN1 may be used to construct attenuated flaviviruses that could 
be considered vaccine candidates. However, it remains to be established whether the 
reduced pathogenicity of sfRNA-deficient viruses interferes with the broad immune 
response that is required to induce protection against wild-type virus infection or, even 
worse, results in persistent infections after administration of the vaccine. 
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ABStRACt
A virus-specific, non-coding RNA of 0.3 – 0.5 kb, co-linear with the genomic 3’ UTR 
can be detected in cells and mice infected with arthropod-borne flaviviruses. This small 
flavivirus RNA (sfRNA) results from incomplete degradation of the viral genome by the 
host 5’ – 3’ exonuclease XRN1 and was shown to be important for viral pathogenicity. To 
determine whether sfRNA production is a unique feature of the Flavivirus genus or only 
restricted to vector-borne flaviviruses, flaviviruses with no known vector (NKV) and the 
insect flavivirus cell fusing agent virus (CFAV) have been analyzed for the production of 
the sfRNA. The data presented in this study clearly demonstrate that the XRN1-mediated 
production of sfRNA is not limited to the vector-borne flaviviruses and most likely is 
an unique common feature of all flaviviruses, implying that it could be considered an 
additional determinant to assign viruses to this genus. Computer-aided RNA structure 
predictions combined with in vitro XRN1 assays and cell culture experiments defined 
an RNA pseudoknot as the XRN1 stalling site for the production of these sfRNAs in 
NKV flaviviruses and CFAV. These data imply that the sfRNA is likely to be important for 
the flavivirus life cycle in both the mammalian host and the arthropod vector, as NKV 
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iNtRoDUCtioN
The genus Flavivirus of the Flaviviridae family contains nearly 80 viruses, including many 
important human pathogens such as dengue virus (DENV), yellow fever virus (YFV), and 
West Nile virus (WNV). Based on phylogenetic analysis, flaviviruses were grouped into 
three major clusters that correlate with the type of vector used for their transmission: (i) 
mosquito-borne, (ii) tick-borne, and (iii) no known vector (NKV) flaviviruses 1,2. No arthro-
pod vector has yet been implicated in the transmission of NKV viruses. NKV flaviviruses 
have been isolated exclusively from rodents or bats and are divided into three groups: i) 
the Entebbe bat virus group which includes viruses like the Entebbe bat and Yokose virus 
(YOKV), ii) the Modoc virus group that comprises Modoc virus (MODV) and Apoi virus 
(APOIV) and iii) the Rio Bravo virus group which includes viruses like Rio Bravo virus (RBV) 
and Montana myotis leukoencephalitis virus (MMLV) 3. In contrast to the MODV and RBV 
groups, whose members are unable to replicate in the mosquito C6/36 cell line, viruses 
belonging to the Entebbe bat group can replicate in these cells albeit to low titers 4.  
Apart from the viruses that are assigned to one of the clusters within the Flavivirus 
genus, there are viruses like cell fusing agent virus (CFAV) that are considered tentative 
flaviviruses 5. CFAV was isolated from a cell line derived from laboratory-reared Aedes 
aegypti mosquitoes 6 and has been classified as a tentative insect flavivirus with genome 
organization and gene expression strategy similar to that of the flaviviruses. However, 
CFAV can only be propagated in mosquito cells and not in cell lines of vertebrate origin 
6,7. Although CFAV has never been found in nature, CFAV-related viruses like Kamiti River 
virus (KRV) have been isolated from field-collected mosquitoes 8-10.
All flaviviruses have a positive single-stranded RNA genome of approximately 11 kb, 
with a 5’ cap structure and a 3’ non-polyadenylated end. The genome encodes one large 
open reading frame that is flanked by 5’ and 3’ untranslated regions (UTRs) that contain 
several conserved RNA sequences and structures that are involved in the regulation of 
translation and viral genome amplification. Translation of the viral genome results in a 
polyprotein that is co- and post-translationally processed by viral and cellular proteases 
into the individual viral proteins 11. Northern blot analysis of viral RNA isolated from 
mammalian and insect cell lines or mice infected with arthropod-borne flaviviruses has 
revealed the production of a small, positive-stranded, non-coding flavivirus RNA (sfRNA) 
in addition to the viral genome 12-17. This sfRNA is 0.3 – 0.5 kb long, co-linear with the 3’ 
end of the viral genome and originates from incomplete degradation of the viral ge-
nomic RNA by the host 5’-3’ exonuclease XRN1, due to stalling of this nuclease upstream 
an RNA pseudoknot located in the viral 3’ UTR 15,17,18. 
Although the precise role of the sfRNA in the viral life cycle still needs to be elucidated, 
current data suggest that it is important for viral pathogenicity in the mammalian host 
15,18, (Silva, Pereira, Dalebout, and Bredenbeek, unpublished results). Despite the fact that 
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sfRNA production has also been described in mosquito cells infected with mosquito-
borne flaviviruses 13,15,17, nothing is known about the potential role of the sfRNA in the 
arthropod host. If production of the sfRNA is only required for efficient completion of the 
viral life cycle in either the mammalian or the arthropod host, it is not unlikely that the 
ability to produce an sfRNA might be lacking in either the NKV flaviviruses or CFAV. To ad-
dress this hypothesis, the production of sfRNA in mammalian cells infected with several 
NKV flaviviruses and of mosquito cells infected with CFAV was analyzed. Surprisingly, all 
the flaviviruses that were included in this study produced at least one sfRNA that was 
co-linear with the 3’ end of the viral genome. As has been shown for arthropod-borne 
flaviviruses, production of sfRNA by these NKV viruses and CFAV is also mediated by the 
host 5’ – 3’ exoribonuclease XRN1, which is well conserved in eukaryotes. In addition, the 
minimal sequence within the viral 3’ UTR required for the stalling of XRN1 on the genome 
of MODV, MMLV and also CFAV was determined and found to form an RNA pseudoknot. 
mAteRiAL AND methoDS
Cell culture
The origin and culture conditions of the BHK-21J cells have been described before 19,20. 
C6/36 cells 21 were obtained from the ATCC and grown in EMEM supplemented with 8% 
fetal calf serum (Bodinco, The Netherlands) and 5% none-essential amino acids. 
Recombinant DNA techniques and plasmid constructions 
Unless described in more detail, standard nucleic acid methodologies were used 
22,23. Chemically competent E. coli DH5a cells 24 were used for cloning. The nucleotide 
numbering was according to the sequence files for which the accession numbers can 
be found in table 1. 
Infections were performed essentially as described before 20. Total RNA was isolated 
with Trizol (Invitrogen) at 30 hr p.i. from BHK-21J cells infected with MODV, APOIV, MMLV 
or RBV or at 36 hr p.i. from CFAV infected C6/36 cells. RNA was dissolved in 30 ml H2O 
and 5 mg was used for first strand cDNA synthesis using M-MuLV reverse transcriptase 
(Fermentas). The PCR was performed with GoTaq Flexi DNA Polymerase (Promega) as 
described by the manufacturer. Oligonucleotides used in the PCR contained either a Mlu 
I site (forward primer) or a Sph I site (reversed primer). The RT-PCR products were cloned 
using the TOPO TA Cloning system (Invitrogen). Inserts with the correct sequence were 




 production in N
KV flaviviruses and CFAV
Chapter 4
25,17. Plasmid DNAs of these pSinrep5eGFP recombinants containing either a MODV, 
MMLV or CFAV insert were linearized with Not I and used for in vitro RNA transcription 20.
In vitro XRN1 assay
Plasmid DNA of the pSinrep5eGFP recombinants was prepared for in vitro RNA tran-
scription without the addition of a cap analog as described above. The RNA transcripts 
were pre-treated with tobacco acid pyrophosphatase (TAP, Epicentre) to create a 5’ 
mono-phosphate and incubated with 1 unit of XRN1 (available as Terminator 5’-phos-
phate-dependent exonuclease, Epicentre) as described before 17. 
RNA transfection and analysis of viral RNA
BHK-21J cells were transfected with 5 or 20 µg of Sinrep5eGFP and recombinant RNAs 
as described before 20. In general, 2.5 ml (approximately 1.5 x 106 cells) of the transfected 
BHK-21J cell suspension was seeded in a 35 mm plate. Total RNA was isolated from the 
transfected cells at 8 hr post electroporation (p.e.). Trizol (Invitrogen) was used for cell 
lysis and subsequent RNA purification. 
table 1. oligonucleotides that were used to identify and characterize the sfRNAs of NKV 
flaviviruses and CFAV. The oligonucleotides that were used in this study, the virus to 
which they were directed, the NCBI accession number used to obtain the sequence and 
the actual nucleotide sequence are indicated. All oligonucleotides are complementary to 
the viral genome. Abbreviations in the column “Purpose” refer to Northern blotting and 
hybridizations (Hyb.), primer extension (Prim.Ex.) and DNA sequencing (Seq.).  
oligo Virus NCBi Number Sequence (5’ to 3’) Purpose
NKV2 MMLV AJ299445 CCGCTCAATCTCGAGAGGAGCGA Hyb/Prim.Ex.
NKV3 APOIV AF452050 CTCAGGCGCTAAAGGATGCCGCTA Hyb.
NKV4 MODV AJ242984 GGGTCTCCACTAACCTCTAGTCCT Hyb.
NKV6 APOIV AF452050 CGCTCAAAGAGAGAAGGGTCGC Hyb.
NKV19 RBV AF452049 ACTCGGTCAGTTGGGATCATCCCAC Hyb.
NKV20 MODV AJ242984 CCCTAACCTATTTACAATGACTGGC Hyb./Prim.Ex.
NKV21 CFAV NC_008604 AGATGGGCCGCCACCACCATCTTAG Hyb./Prim.Ex.
NKV24 YOKV NC_005039 TCCATGCGTAGGAGAGGGTCTCC Hyb.
NKV31 RBV AF452049 CACCCTATCAGGGTTGACTGGCTCA Prim.Ex.
NKV33 APOIV AF452050 CCCACTGGAATGCAATGCTGGCC Prim.Ex.
YFV1632 YFV-17D X03700 ACCCCGTCTTTCTACCACC Seq.
YFV1676 SinV NC_001547 GTACCAGCCTGATGCATTATGCACATC Hyb.
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For Northern blotting, samples containing 7.5 – 10 µg of total RNA isolated from either 
infected or electroporated cells, or obtained from in vitro XRN1 assays, were denatured 
using formaldehyde and separated on a formaldehyde containing 1.5% agarose gel 
and blotted to Hybond-N+ (GE-Healthcare) 23. The blots were hybridized with random 
hexameer primed cDNA probes or 32P-labelled oligonucleotides 26,23,27 that were targeted 
at the 3’ UTR of the virus under study.   
Primer extension assay
Primer extension analysis was performed as reported by Sambrook et al. 23 with minor 
modifications 17. Briefly, 5 – 7 µg total RNA from virus infected cells or XRN1-treated 
recombinant SINrep5 transcripts, were annealed to a 32P-labeled oligonucleotide that 
was specific for the studied viral RNA. The primer extension products were analyzed on 
a denaturing 5% polyacrylamide/8M urea sequence gel. A 33P-labeled Cycle Reader se-
quence reaction (Fermentas) using oligonucleotide 1632 primed pBlsrcptSK-YFV9845-10861 
as a template served as a sequence marker.
RNA structure prediction
RNA structure was predicted as described by Olsthoorn and Bol 28. The viruses included 
in this analysis were: MODV, MMLV, RBV, APOIV and CFAV. The NCBI accession numbers 
for the sequences can be found in table 1. 
ReSULtS 
Production of a small 3’ subgenomic RNA is a unique feature of all 
Flaviviruses 
Recently it was shown that many, if not all, of the arthropod-borne flaviviruses produce 
an sfRNA that is collinear with the distal part of the viral 3’ UTR 13,15-17. These sfRNAs were 
generated in infected mammalian as well as in insect cells. BHK-21J cells were infected 
with the NKV flaviviruses MODV, APOIV, RBV, MMLV and YOKV to determine whether 
such sfRNAs were also produced by the flaviviruses that lack an arthropod vector. Total 
RNA was isolated from the infected cells at 30 hr p.i. and analyzed for sfRNA production 
by Northern blot analysis using 32P-labelled oligonucleotides directed against the distal 
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a small virus-specific RNA was detected for the NKV flaviviruses MODV, RBV, MMLV and 
YOKV (fig. 1.A; lanes 1, 3, 4 and 6), whereas two small virus-specific RNAs were detected 
in cells infected with APOIV (fig. 1.A; lane 2).   
Apart from these NKV flaviviruses, the tentative insect flavivirus CFAV was also tested 
for the production of a small virus specific RNA originating from the viral 3’ UTR. Mosquito 
C6/36 cells were infected with CFAV and at 36 hr p.i. total RNA was isolated and analyzed 
by Northern blotting and hybridization. As shown in fig. 1.B, a small RNA was readily 
detected in CFAV-infected C6/36 cells. From these results it was concluded that, similar 
to the arthropod-borne flaviviruses, MODV, APOIV, RBV, MMLV and YOKV, representing 
the three different groups of NKV flaviviruses, produced at least one sfRNA. These data 
demonstrated that sfRNA production is a distinguishing feature for all Flaviviruses. Even 




APOIVMODV MMLVRBV CFAVMM YOKV
Fig. 1
Fig. 1. sfRNA production in mammalian and insect cells infected with NKV flaviviruses and CFAV. A) 
Northern blot analysis of viral RNAs isolated at 30 hr p.i. from BHK-21J cells infected with MODV, APOIV, RBV, 
MMLV and YOKV respectively. Kinased oligonucleotides complementary to the distal part of the respective 
virus 3’ UTR were mixed and used as probes. B) Northern blot analysis of CFAV RNAs isolated from infected 
C6/36 cells at 36 hr p.i. A 32P-labelled oligonucleotide complementary to the distal part of the CFAV 3’ UTR 
was used as a probe. Lane M corresponds to total RNA isolated from mock-infected cells. 
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Determining the 5’ end of the sfRNAs from flaviviruses with no known 
vector and CFAV 
Primer extension analysis on total RNA isolated from infected cells was used to de-
termine the 5’ end of the sfRNA of MODV, APOIV, MMLV, RBV and CFAV. As shown in fig. 
2.A, primer extension on total RNA isolated from MODV-infected BHK-21J cells (lane 1) 
resulted in the production of two unique cDNA products that were only one nucleotide 
apart in length and not present in total RNA isolated from uninfected cells (lane 2). Using 
the sequence ladder that was run in parallel as a marker, the 5’ end of the MODV sfRNA 
was mapped to nt position 10.262 or 10.263. Based on these results, the MODV sfRNAs 
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APOIV CFAV
Fig. 2
Fig. 2. mapping the relative position of the NKV and CFAV sfRNAs to the viral genome. Primer extension 
analysis was performed to determine the 5’ end of the sfRNAs produced by the rodent NKV viruses MODV 
and APOIV (panel A), the bat NKV viruses MMLV and RBV (panel B), and the tentative insect flavivirus CFAV 
(panel C). RNA was isolated from infected BHK-21J cells at 30 hr p.i. for the NKV flaviviruses and at 36 hr p.i. 
from CFAV-infected C6/36 cells. For panels A to C, lanes 1 and 2 correspond to primer extension on total 
RNA isolated from infected and uninfected cells, respectively. Information on the oligonucleotides that 
were used as probes for these viruses is presented in table 1. A sequence reaction using oligonucleotide 
YFV1632 on pBluescript-YFV9,845-10,861 
17 was used as a DNA size marker. D) Northern blot analysis of viral RNA 
isolated from APOIV-infected BHK-21J cells to determine the relative orientation on the viral genome of the 
two APOIV sfRNAs using oligonucleotides NKV3 and NKV6 (see table 1) as a probe. Lane M corresponds to 
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were calculated to be 337 to 338 nts in length. Primer extension on APOIV RNA also 
resulted in two cDNA products; however, in contrast to MODV, these products showed a 
significant size difference. This was actually expected given the results of the hybridiza-
tion presented in fig. 1.A. Based on the length of the primer extension products, the 
longest sfRNA was calculated to be approximately 566 nts, whereas the smaller sfRNA 
was predicted to have a length of approximately 371 nts. Primer extension analysis on 
MMLV, RBV and CFAV RNA resulted in unique products (fig. 2, panels B and C). The 5’ ends 
were mapped to positions 10.285 in the MMLV genome, 61 nts into the 3’ UTR of RBV, 
and positions 10.182 – 10.183 in the genome of CFAV. Based on these primer extension 
results, the sfRNAs of MMLV, RBV and CFAV were calculated to be 405 nt, 425 nt, and 
512 – 513 nt, respectively.   
The combined results of the Northern blot (fig. 1.A, lane 2) and primer extension (fig. 
2.A), suggested that the two detected APOIV sfRNAs would form a 3’ nested set. To deter-
mine whether this hypothesis was correct, the position of the APOI sfRNAs relative to the 
viral genome was analyzed by Northern blotting using oligonucleotides NKV3 and NKV6 
as probes. Oligonucleotide NKV3 is complementary to the 3’ end of the viral genome 
and will recognize both APOIV sfRNAs if they form a 3’ nested set. Oligonucleotide NKV6 
hybridizes to a position upstream of the determined 5’ end of the smaller APOIV sfRNA 
and is predicted to detect only the larger sfRNA if the hypothesis is correct. The results 
presented in fig. 2.D clearly demonstrated that the APOIV sfRNAs form a 3’ nested set. 
Both sfRNAs hybridized to the 3’ end-specific oligonucleotide NKV3, whereas only the 
largest APOIV sfRNA hybridized with oligonucleotide NKV6. 
the host exoribonuclease XRN1 is required for sfRNA production of NKV 
flaviviruses and CFAV 
It has now been firmly established that the sfRNAs of WNV and YFV are produced 
by incomplete degradation of the viral genome by the host 5’ – 3’ exoribonuclease 
XRN1 15,17. To analyze whether XRN1 was also required for the production of the NKV 
flaviviruses sfRNAs, MODV and MMLV were selected to represent two different groups 
of NKV flaviviruses that are associated with rodents and bats, respectively. In addition, 
whenever possible, the tentative flavivirus species CFAV was included in these stud-
ies. Unfortunately, no full-length cDNA clone for the transcription of infectious RNA is 
available for any of these three viruses. To circumvent this handicap, cDNA fragments 
encompassing the XRN1 stalling site were cloned into the Sindbis virus derived RNA 
driven expression vector Sinrep5eGFP 25. This strategy allowed the use of the same RNA 
templates for both in vivo and in vitro studies. A schematic representation and relevant 


























Region I Region II Region III Region IV
Insert:
eGFPSin.rep. NS genes









MODVA C G T MMLV CFAVSin 
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CFAV
10.182/10.183 nt10.141 to 10.553 ntsSinrep5eGP-CFAV
10.285 nt10.265 to 10.583 ntsSinrep5eGP-MMLV
10.262/10.263 nt10.247 to 10.494 ntsSinrep5eGP-MODV
5’ end sfRNAInsert
Fig. 3. insertion of the moDV, mmLV and CFAV 3’ UtR sequence directs the in vivo and in vitro 
production of an sfRNA-like RNA in the context of a Sindbis replicon RNA. A) Schematic representation 
of the pSinrep5eGFP vector characteristics and the predicted general RNA folding of the NKV 3’ UTR 
according to Charlier and colleagues 29. The 5’ end of the sfRNAs relative to this RNA structure is indicated 
by an arrow. The box below the structure indicates the region of the MODV, MMLV or CFAV 3’ UTR cloned 
into the Sinrep5eGFP vector. The names of the constructs and the exact nucleotide numbers of the cDNA 
fragments cloned into Sinrep5eGFP are indicated in the table in panel A. B) Northern blot analysis of total 
RNA isolated from BHK-21J cells transfected with Sinrep5eGFP-MODV (lane 1), Sinrep5eGFP-MMLV (lane 
2), Sinrep5eGFP-CFAV (lane 3), mock transfected cells (lane 4) and Sinrep5eGFP (lane 5). Oligonucleotide 
1676 complementary to Sinrep5eGFP nucleotides downstream of the insertion site of flavivirus 3’ UTR was 
used as probe. C) In vitro production of the MODV, MMLV and CFAV sfRNA-like RNA by incubation with 
XRN1. The “-” symbol refers to incubation without the enzyme, while the “+” signal corresponds to the 
addition of XRN1. D) Primer extension using oligonucleotide 1676 to determine the 5’ end of the sfRNA-like 
RNAs produced by in vitro incubation of RNA transcribed from the Sinrep5eGFP constructs with XRN1. “Sin” 
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vitro transcribed RNA of these Sinrep constructs to demonstrate that an sfRNA-like RNA 
could be produced in cell culture. As shown in fig. 3.B, Northern blotting of total RNA 
isolated from these transfected cells using oligonucleotide 1676 as a probe revealed 
that Sinrep5eGFP-MODV, Sinrep5eGFP-MMLV and Sinrep5eGFP-CFAV produced an 
sfRNA-like RNA. This additional RNA was not detected in cells that were transfected with 
Sinrep5eGFP that did not contain any flavivirus sequences (lane Sin) or mock transfected 
cells (lane M). RNA transcripts of Sinrep5eGFP, Sinrep5eGFP-MODV, Sinrep5eGFP-MMLV 
and Sinrep5eGFP-CFAV, were incubated in vitro with commercially available purified 
XRN1 and analysed by Northern blotting to demonstrate that this enzyme was also 
responsible for the production of the NKV and CFAV sfRNAs. The results showed that 
an sfRNA-like RNA was generated upon incubation with XRN1 of the Sinrep5eGFP tran-
scripts that contain either the MODV, MMLV or CFAV insert encompassing the predicted 
XRN1 stalling site (fig. 3.C). Primer extension analysis on these sfRNA-like RNAs produced 
in vitro demonstrated that the 5’ ends that were produced using this heterologous ex-
pression system were identical to the 5’ ends of the sfRNAs as detected in BHK-21J cells 
infected with either MODV, MMLV or CFAV (fig. 3.D). The combined data of the in vivo 
and in vitro experiments using the Sinrep5eGFP templates provided strong evidence 
that XRN1 is also responsible for the production of the sfRNA in cells infected with NKV 
flaviviruses or CFAV.      
An RNA pseudoknot in the 3’ UtR of NKV flaviviruses and CFAV is 
required for the production of the sfRNAs
Current data for YFV and WNV strongly suggest that the stalling of XRN1 that is re-
quired for the production of sfRNA in arthropod-borne flaviviruses is directed by an RNA 
pseudoknot within the viral 3’ UTR 17,18. Therefore, the nucleotide sequences immedi-
ately downstream of the predicted 5’ end of the NKV flaviviruses and CFAV sfRNAs were 
analyzed for their potential to fold into an RNA pseudoknot structure. An alignment of 
the primary sequence in this region of the NKV flaviviruses genomes showed significant 
sequence similarity interspaced by insertions or deletions of a few nucleotides (fig. 4.A). 
A similar result was obtained when CFAV was compared to KRV and Aedes virus. The lat-
ter two viruses were recently isolated from mosquitoes and shown to be closely related 
to CFAV. Subsequent extensive RNA structure modelling predicted the formation of RNA 
pseudoknots for all the NKV flaviviruses as well as for CFAV and the related KRV and 
Aedes virus. The predicted RNA pseudoknot structures for MODV, MMLV and CFAV that 
could potentially serve as stalling sites for XRN1 are depicted in fig. 4.B. The structure for 
MODV and MMLV was predicted to be very similar. Compared to the structure for YFV 
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(nomenclature according to Olsthoorn and Bol 28), is located further downstream of 
the stem. For both MODV and MMLV, the presumed pk’ – pk interaction comprised five 
nucleotides, which is similar to the YFV pseudoknot that was proven to act as a stalling 
signal for XRN1 17. The initial impression of the folding for the comparable region of the 
CFAV RNA suggested that it was rather different from the proposed RNA pseudoknots 
for YFV, MODV and MMLV. However, closer inspection revealed that the overall folding 
was actually relatively similar to the proposed structures for NKV flaviviruses and YFV. 
The main differences of the CFAV structure versus that of the other viruses were in the 
length of the depicted stem structures and the pk’ – pk interaction, which was proposed 
to involve only three nucleotides. Interestingly, the formation of a second, very similar 
RNA pseudoknot structure was predicted for the nucleotide sequence just downstream 
of the first predicted pseudoknot (fig. 4.B).
To provide support for the actual formation of these predicted RNA pseudoknots, two 
cDNA fragments of MODV, MMLV and CFAV were cloned into Sinrep5eGFP (fig. 5.A). The 
cDNA fragment A of MODV, MMLV and CFAV contained all the nucleotides that were 
predicted to be involved in the formation of the RNA pseudoknot required to stall XRN1. 
Fragment B contained a 3’ deletion compared to the sequences contained in fragment 
A. This 3’ truncation was expected to disrupt the pseudoknot formation by deletion of 
the pk sequence. The ability of the cDNA fragments A and B of MODV, MMLV and CFAV 
to direct the production of an sfRNA-like RNA was analyzed in vivo as well as in vitro 
using the Sinrep5eGFP based expression system. RNA transcripts of the NKV virus and 
CFAV Sinrep5eGFP constructs containing cDNA fragment A or B were electroporated 
into BHK-21J cells. At 8 hrs. p.e., total RNA was isolated and analyzed by Northern blot-
ting using the Sindbis virus 3’ UTR specific oligonucleotide 1676 as a probe. As shown in 
fig. 5.B, all the cells transfected with Sinrep5eGFP RNA containing cDNA fragment A of 
MODV, MMLV or CFAV were able to produce an sfRNA-like RNA in the transfected cells. 
As expected, this sfRNA-like RNA was not detected in BHK cells that were either mock 
transfected (lane M) or electroporated with Sinrep5eGFP RNA lacking any flavivirus 
insert (lane Sin). More importantly, this sfRNA-like RNA was not detected in cells that 
were transfected with RNA of the Sinrep5eGFP recombinants containing cDNA fragment 
B of MODV, MMLV, and CFAV.
In vitro experiments were performed with purified XRN1 and RNA transcribed from 
the Sinrep5eGFP recombinants containing the MODV, MMLV or CFAV cDNA fragments 
A and B to provide additional evidence for the role of the predicted RNA pseudoknot 
in the stalling of XRN1. Sinrep5eGFP RNA containing the NKV flavivirus or CFAV cDNA 
fragment A, did produce an sfRNA-like RNA after incubation with XRN1, whereas Sin-
rep5eGFP constructs encompassing cDNA fragment B were completely degraded and 
did not yield this additional subgenomic RNA (fig. 5.C). The outcome of the in vivo and 
in vitro experiments presented in fig. 5 supports the predicted model in which an RNA 
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pseudoknot is required to stall XRN1 for the production of an sfRNA-like RNA. In contrast 
to the Sinrep5eGFP recombinants containing MODV, MMLV or CFAV cDNA fragment A, 
formation of the RNA pseudoknot that stalls XRN1 was no longer possible in fragment B 
due to deletion of the pk sequence, explaining why an sfRNA-like RNA was not produced.
A) B)












Si A B A B A B
MODV MMLV CFAV




- + - + - + +- - + - + - +XRN1:
10 265 to 10 358 nts10 265 to 10 367 ntsSinrep5eGFP MMLV
10.247 to 10.334 nts10.247 to 10.343 ntsSinrep5eGFP-MODV
BA
10.141 to 10.226 nts10.141 to 10.275 ntsSinrep5eGFP-CFAV
.   .  .   .  -
Fig. 5
Fig. 5. RNA sequences that are predicted to be involved in the formation of an RNA pseudoknot in 
the 3’ UtR of moDV, mmLV and CFAV are required for the production of an sfRNA. A) Generalized 
overall RNA folding of the NKV 3’ UTR based on Charlier and colleagues 29. The relative position of the RNA 
pseudoknot that is predicted to be involved in sfRNA production is indicated by a dashed line. The 5’ end of 
the sfRNAs relative to this RNA structure is indicated with an arrow. The boxes below the structure indicate 
the regions of the flavivirus 3’ UTR that were cloned into the Sinrep5eGFP vector from MODV, MMLV and 
CFAV. The exact nucleotide numbers of the cDNA fragments cloned into Sinrep5eGFP are indicated in the 
table. B) Northern blot analysis of RNA isolated from BHK-21J cells transfected with Sinrep5eGFP (Sin) 
and Sinrep5eGFP with the 3’ UTR A and B inserts of MODV, MMLV and CFAV, respectively. M corresponds 
to uninfected BHK-21J cells. Oligonucleotide 1676 was used as probe. C) Northern blot analysis of RNA 
transcripts of Sinrep5eGFP and derivatives containing fragment A or B of MODV, MMLV or CFAV incubated 
with XRN1. The “-” symbol refers to incubation without the enzyme, while the “+” signal corresponds to the 
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DiSCUSSioN 
The family Flaviviridae comprises three genera: Flaviviruses, Pestiviruses, and 
Hepaciviruses 5. All the members of this virus family are enveloped, positive-stranded 
RNA viruses with a similar genome organization and expression strategy. Despite their 
evolutionary relatedness, these viruses show significant differences in host range, tro-
pism, pathogenicity, and various aspects of their molecular biology. Over the last few 
years it has been shown that arthropod-borne Flaviviruses produce a small flavivirus 
RNA (sfRNA) in addition to their genome-length negative- and positive-stranded RNAs 
12-17. This RNA results from partial 5’ to 3’ degradation of the viral genome by the host 
exoribonuclease XRN1 15,17. No such small viral subgenomic RNA has been detected in 
cells infected with Pestiviruses and Hepaciviruses 15, suggesting that the production 
of the sfRNA might be a new feature specific for Flaviviruses. However, flaviviruses are 
divided into three groups and the previous studies only analyzed sfRNA production in 
cells and mice infected with either mosquito- or tick-borne viruses. In this study, viruses 
that belong to the third, poorly studied cluster of Flaviviruses with no known vector, 
were analyzed for their ability to direct sfRNA synthesis. The analysis included MODV 
and APOIV from the rodent-associated MODV-related flaviviruses and MMLV and RBV, 
along with YOKV, representing the bat-associated RBV and Entebbe bat virus subgroup 
of the NKV flaviviruses, respectively 3. In addition to these NKV flaviviruses, the mosquito 
cell-infecting virus CFAV, which has been tentatively assigned to the Flavivirus genus, 
was also included in this study. The results of this analysis showed that all NKV flavi-
viruses as well as CFAV are able to produce at least one sfRNA in infected cells. APOIV 
even generates two sfRNAs that form a 3’ nested set. Primer extension analysis on total 
RNA mapped the 5’ end of the NKV sfRNAs to an internal bulge in the Y-structure that is 
indicated as region I in the 3’ UTR of NKV flaviviruses 29. Due to recombination, deletions 
and sequence duplications, the length of the Flavivirus 3’ UTR is rather heterogeneous 
(reviewed in 30). This size heterogeneity is also reflected in the length of the sfRNAs. In 
general, the sfRNAs are co-linear with the 3’ distal part of the viral 3’ UTR and contain all 
the conserved RNA elements that are present in this region of the genome. These results 
demonstrate that production of a subgenomic sfRNA is a new feature of viruses that be-
long to the genus Flavivirus and that it can be considered as an additional characteristic 
to the established ICTV criteria for classification of newly discovered viruses into the 
genus Flavivirus. 
Using mutagenesis of the available infectious cDNA clones, in vitro assays and RNA 
silencing experiments, previous studies on WNV and YFV have demonstrated that the 
sfRNAs of the arthropod-borne flaviviruses are produced by  incomplete degradation 
of the viral genomic RNA by the host 5’-3’ exoribonuclease XRN1 15,17. No infectious 
cDNA clone is currently available for any of the NKV flaviviruses or CFAV. Therefore, a 
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Sindbis virus-based  expression system 25 was used to determine whether XRN1 was also 
required for the production of sfRNA in cells infected with NKV flaviviruses or CFAV. The 
cDNA fragments that contained the nearly complete distal part of the MODV, MMLV or 
CFAV 3’ UTR were cloned into the Sinrep5-eGFP and analyzed for their ability to direct 
the synthesis of an sfRNA-like RNA in vitro and in vivo. Transfection of BHK-21J cells 
with RNA transcribed from these constructs did indeed result in the production of an 
sfRNA-like RNA. An identical RNA was detected upon incubation of the Sinrep5eGFP 
recombinants containing the MODV, MMLV or CFAV insert with purified XRN1. Further-
more, the in vitro produced sfRNA-like RNAs have an identical 5’ end as the sfRNAs that 
are produced during infection of cell cultures with MODV, MMLV or CFAV. These results 
strongly suggest that XRN1 is also required for the production of the sfRNA in NKV 
flaviviruses and CFAV. These results are actually not very surprising since XRN1 is well 
conserved among eukaryotes as it plays a vital role in 5’ to 3’ mRNA decay (reviewed 
in 31-34), and therefore in the homeostasis of the host. Several experiments have been 
performed to provide additional proof for the role of XRN1 in the sfRNA production of 
MODV and MMLV by using lentiviruses expressing small-hairpin RNAs to silence human 
XRN1 expression. However, silencing of XRN1 has a significant impact on the condition 
of the cells and this, together with the relatively poor replication of MODV and MMLV 
in the tested SW13 and Huh7 cells, unfortunately resulted in inconclusive data (Silva, 
Dalebout and Bredenbeek, unpublished results).
It has previously been shown that XRN1 is stalled by an RNA pseudoknot in the 3’ UTR 
of YFV and WNV to produce the sfRNA 17,18. However, no RNA pseudoknot structure has 
been suggested in the 3’ UTR region predicted to stall XRN1 in either the NKV flaviviruses 
or CFAV 29,7. Sequence alignment combined with RNA structure modelling have been 
used in this study to predict an RNA pseudoknot just downstream of the mapped 5’ 
end of the sfRNA for every NKV virus, similar to what has been encountered in WNV 
and YFV. Unfortunately, the limited amount of sequence data available for these NKV 
flaviviruses does not allow for co-variance analysis to obtain additional support for the 
predicted structures. An RNA pseudoknot that can serve as a stalling site for XRN1 has 
also been predicted for CFAV. On first sight, this RNA structure may seem rather unlikely, 
due to the relatively short stem-loop structures and a pseudoknot interaction that only 
involves three nucleotides. A nearly perfect duplication of this pseudoknot was pre-
dicted downstream of the first pseudoknot (fig. 4, panels A and B). Careful inspection of 
the data presented in fig. 3, where the stalling of XRN1 was analyzed in the background 
of the Sindbis expression system, reveals a minor, slightly smaller sfRNA-like RNA that 
can be explained by the XRN1 stalling on the second, more downstream located pseu-
doknot. This minor band is no longer detected in the data presented in fig. 5, because 
the sequence involved in the formation of this second pseudoknot is not present in 
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provide support for the proposed CFAV pseudoknot. The sequence of the CFAV, KRV and 
Aedes virus 3’ UTR in the region in which the pseudoknot structure is predicted is nearly 
identical (fig. 4.A); therefore any co-variance in the primary sequence to support this 
structure is very limited. 
The sequence that encompasses the 5’ end of the sfRNA and the predicted RNA pseu-
doknots of MODV, MMLV and CFAV was cloned into the Sinrep5eGFP expression vector 
and shown to be capable of producing an sfRNA-like RNA. These results demonstrate 
that the ability for stalling XRN1 is contained within a relatively small sequence of MODV, 
MMLV, and CFAV and that no other sequences are required to produce the sfRNA. Dele-
tion of the pk sequence, which is predicted to interact with the pk’ sequence to form 
the RNA pseudoknot, from the flavivirus insert in the Sinrep5eGFP constructs abolished 
the production of the sfRNA-like RNA. This result supports the model in which, similar 
to what was found in arthropod-borne flaviviruses, RNA pseudoknots are required to 
stall XRN1. In addition, N-methylisatoic anhydride (NMIA) based chemical probing of the 
RNA structure required for stalling XRN1 showed that the pk’ and pk sequences were in 
a double-stranded conformation, which is in agreement with the predicted RNA pseu-
doknots. The RNA probing results of the sequences that encompass the XRN1 stalling 
sites of MODV, MMLV, and CFAV, however, did not fully support the stem-loop part of 
the predicted pseudoknots, suggesting that a more complex structure might actually 
be present (Silva, Dalebout and Bredenbeek, unpublished results). Unfortunately, NMIA-
based probing only discriminates between single- and double-stranded nucleotides 
and does not allow identification of individual nucleotides within a structure.  
Although the precise function of the sfRNA in the virus life cycle remains to be eluci-
dated, current evidence for WNV and YFV have shown that it is an important determinant 
for the pathogenicity of these viruses in their mammalian hosts 15,18 (Silva, Pereira, Dale-
bout, and Bredenbeek, unpublished results). Nothing is known about the requirement 
of the sfRNA of these viruses in the arthropod host. The fact that the ability to produce 
the sfRNA is maintained in flaviviruses that have a more limited host range, like the NKV 
flaviviruses and CFAV, strongly suggest that the sfRNA is essential for successful survival 
of these viruses in the mammalian or the insect host. However, this does not necessarily 
imply that the function of the NKV virus or CFAV sfRNA is similar to that of the sfRNA of 
the arthropod-borne viruses in either their vertebrate or arthropod host. Determining 
the function of these Flavivirus sfRNAs in the various virus-host systems and unravelling 
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ABStRACt
The Flavivirus genus can be divided into three different groups depending on the 
vector of transmission: i) mosquito-borne, ii) tick-borne, and iii) no known vector 
(NKV) flaviviruses. The third group is less-well studied, which in part is due to the lack 
of full-length cDNA clones that can be used for the transcription of infectious RNA. In 
this chapter the construction and characterization of a stable infectious full-length 
cDNA clone of the NKV Modoc virus (MODV) is described. The full-length MODV cDNA 
was constructed in the low copy number plasmid pACNR1180. An initial screening of 
plasmids containing full-length MODV cDNAs for the production of infectious RNA tran-
scripts resulted in four plasmids whose transcripts yielded immunofluorescent positive 
cells. Subsequent analysis revealed that only one of these clones could be used for the 
production of transcripts with a high enough specific infectivity to allow semi-first cycle 
analysis of virus replication. This clone (pACNR-FLMODV6.1) was shown to be genetically 
stable in E. coli. The viruses derived from this clone showed similar plaque morphology 
and growth kinetics as the parental MODV virus. This first infectious cDNA clone for a 
NKV flavivirus will be a valuable tool to increase our understanding of general and virus-











Phylogenetic analysis of members of the Flavivirus genus revealed three clusters of 
related viruses that largely coincided with the route of transmission. Apart from the 
clusters of mosquito- and tick-borne flaviviruses, which contain important human 
pathogens, the third cluster comprises a less-well studied group of viruses that have 
been exclusively isolated from bats and rodents and for which no arthropod vector has 
been implicated in transmission 1,2. An increasing number of these no known vector 
(NKV) flaviviruses has been sequenced 3-5, revealing a similar organization of the ap-
proximately 10.5 kb long NKV genome as that of the arthropod-borne flaviviruses. The 
viral genome encompasses one large open reading frame that encodes the following 
proteins: (5’) C, prM, E, NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (3’). Similar to other 
flaviviruses, protease and NTPase/helicase/RNA triphosphatase domains were found in 
the NS3 N-terminal and C-terminal regions, respectively, of Modoc virus (MODV) 5. Fur-
thermore, the N-terminal region of the MODV NS5 protein was shown to encode motifs 
important for methyltransferase activity, while the C-terminal region encoded highly 
conserved RNA-dependent RNA polymerase (RdRp) domains 5. The crystal structure of 
the methyltransferase domain of MODV NS5 was recently determined 6.
The genomic RNA is not polyadenylated; instead it terminates with a large 3’ stem-loop 
structure (SL) that is characteristic for all flaviviruses. Apart from this 3’ SL structure, the 
5’ and 3’ UTRs of NKV viruses contain RNA elements that have also been identified and 
characterized in the UTRs of arthropod-borne flaviviruses, like the conserved sequence 
(CS) 2 and complementary sequences predicted to be involved in circularization of the 
viral genome 4,5. Recently, it has been shown that cells infected with NKV flaviviruses 
also produce a small subgenomic flavivirus RNA (sfRNA) 7 as was initially reported for 
arthropod-borne flavivirus infections 8-13. Synthesis of this sfRNA results from incomplete 
degradation of the genomic RNA by the host ribonuclease XRN1 10,12,7. 
NKV flaviviruses are divided into three groups: i) the Entebbe bat virus group, which 
includes viruses isolated from bats like the Entebbe bat virus, Sokuluk virus and Yokose 
virus (YOKV), ii) the Modoc virus group that comprises viruses isolated from rodents 
such as Modoc virus (MODV) and Apoi virus (APOIV) and iii) the Rio Bravo virus group 
encompassing viruses like Rio Bravo virus (RBV) and Montana myotis leukoencephalitis 
virus (MMLV) isolated from bats 14. Little is know about how NKV flaviviruses spread 
among their hosts. It has been postulated that NKV viruses are transmitted by nasal or 
oral contact between infected and uninfected animals 15-17. Initially it was thought that 
these viruses were unable to infect arthropods due to a block at the level of entry. How-
ever, recently it has been shown that at least for MODV, the inability to infect arthropods 
is not at the level of entry, but at a later stage of the viral life cycle 18.
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MODV was initially isolated from white-footed deer mouse (Peromyscus maniculatis) in 
Modoc County in California 19 and was shown to cause a persistent infection in rodents 
20. MODV has not been implicated in human disease, although there has been an indirect 
reference to an apparently fatal infection of a boy. A serological study provided evidence 
for the occurrence of natural infection without disease among human inhabitants of 
Alberta 17. MODV is neuroinvasive and causes lethal encephalitis in SCID mice and ham-
sters similar to flaviviral encephalitis in humans, making MODV a potential model virus 
to study flaviviruses infections 21. The viral prM and/or E proteins have been shown to 
be important for the neuroinvasive characteristics of MODV in SCID mice 22. Sequence 
analysis and comparison of the MODV 3’ UTR with the 3’ UTR of APOIV, RBV and MMLV 
revealed four regions with similar secondary RNA structures 4.
The construction of full-length flavivirus genome cDNAs that can be used for the in 
vitro transcription of infectious RNA can be rather challenging, as the plasmid backbone 
used and/or the bacterial host strain selected can greatly influence the outcome 23. For 
some of these viruses like Kunjin virus (KUNV) 24, West Nile virus (WNV) 25, some dengue 
(DENV) strains 26,27, and tick-borne encephalitis virus (TBEV) 28, this approach has been 
straight forward enabling the construction of stable, full-length genome cDNA copies in 
Escherichia coli. For other flaviviruses, like YFV and JEV, the in vitro production of infec-
tious RNA transcripts required the use of labor-intensive in vitro ligation procedures 29-31 
or the use of low copy number plasmid vectors 32,33 to circumvent the genetic instability 
of the full-length cDNA insert in the E. coli host. This report describes the construction 
and characterization of the first stable full-length NKV cDNA clone. RNA transcribed from 
this MODV clone yielded infectious virus upon transfection of BHK cells. Furthermore, 
the virus derived from the clone showed similar growth kinetics when compared with 
the wild-type virus. 
mAteRiAL AND methoDS
Cell culture and virus
The origin and culture conditions of the BHK-21J cells that were used throughout this 
study were described before 32. The Modoc virus strain M455 was obtained from Prof. J. 
Neyts (Leuven, Belgium) during collaborative research 22 and was originally purchased 
from the American Tissue Culture Collection (ATCC, Manassas, USA). Stocks of MODV 
M455 were produced by infecting BHK-21J cells at a multiplicity of infection (MOI) of 
0.1 in PBS containing 2% fetal calf serum (FCS) for 1 hr and subsequent incubation at 
37°C and 5% CO2 in DMEM/2%FCS. After 3 to 4 days, depending on the severity of the 










5 min to remove cell debris. The supernatant was used as a virus stock. Stocks of the 
cDNA-derived viruses were obtained by electroporating BHK-21J cells with full-length 
RNA transcripts 34. For analysis of the viral growth kinetics, BHK-21J cells were infected 
at an MOI of 1; medium was subsequently collected and replaced by the same volume 
of fresh medium at the indicated times. MODV titers were determined by plaque assays 
on BHK-21J cells as described previously 34, except for the agarose in the overlay, which 
was replaced by Avicel 35. 
Recombinant DNA techniques and plasmid constructions
General standard nucleic acid methodologies were used throughout this study 36 
unless described in more detail. Chemically competent E. coli DH5a cells were used for 
cloning 37. Nucleotide numbering of the various constructs containing MODV-derived 
inserts and the resulting full-length clones was based on the MODV sequence deposited 
in GenBank (AJ242984; 5).
MODV cDNA was prepared using a one-step RT-PCR system containing a modified 
M-MLV reversed transcriptase for the cDNA reaction and a mixture of Taq polymerase 
and Pyrococcus GB-D polymerase (Invitrogen, Carlsbad, USA) for the PCR. The RT-PCR 
reactions contained 1 mg of total RNA that was isolated from MODV-infected cells at 36 
hr post infection (p.i.), using reaction conditions as suggested by the supplier. Oligo-
nucleotides were designed based on the published MODV sequence. The most 5’ oligo-
nucleotide (NKV41, fig.1) contained the T7 Ф2.5 promoter 38, so that T7 RNA polymerase 
driven transcription would start on the “A” residue that is the first nucleotide of the 
MODV genome. In the oligonucleotide that hybridized to the extreme 3’ end of MODV 
(NKV40, fig. 1) the complement of the two last viral nucleotides were fused to 3’ TAAG 5’ 
to yield an unique Afl II restriction enzyme site. Relative positions of the oligonucleotides 
used for the cDNA reconstruction of MODV are depicted in fig. 1. 
RNA transcription
Plasmid DNA for in vitro run-off RNA transcription was purified using the Nucleobond 
AX DNA isolation kit. pACNR-FLMODV plasmids were linearized with Afl II and purified 
by proteinase K treatment and phenol/chloroform extraction. Approximately 2 µg of 
linearized DNA was used as a template for in vitro transcription using the Ampliscribe T7 
high yield transcription kit (Epicentre, Madison, USA). For the production of 5’-capped 
full-length MODV transcripts, UTP, GTP and CTP concentration was 7.5 mM, whereas the 
ATP concentration was 2 mM. G(5’)ppp(5’)A (NEB, Ipswich, USA) was added as RNA cap 
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analog to a final concentration of 6 mM. After 2 hr of incubation at 42°C, DNase I was 
added and the incubation was continued for another 15 min at 37°C. The RNA transcripts 
were subsequently purified by LiCl precipitation and the concentration was determined 
by spectrophotometry.
RNA transfection and analysis of viral RNA synthesis
BHK-21J cells were transfected with 5 µg of full-length MODV as described previously 
34. For RNA analysis, 2.5 ml (approximately 1.5 x 106 cells) of the transfected BHK-21J cell 
suspension was seeded in a 10 cm2 plate. Total RNA was isolated from the transfected 
cells at 30 hr post electroporation (p.e). Analysis of RNA synthesis by [3H]-uridine label-
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Fig. 1. Schematic representation of the construction of pACNR-moDV. 
A) The large boxes represent the viral ORF encoding the structural and non-structural proteins. The 
oligonucleotides that were used to generate the cDNA fragments for constructing the clone are indicated 
by triangles. The open circle upstream the MODV insert represents the T7 Ф2.5 promoter. The restriction 
sites that were used to assemble the clone as well as the deleted Sal I site are indicted. B) Table with detailed 
information over the sequence, position and orientation of the oligonucleotides that were used in the 










cell lysis and subsequent RNA isolation. [3H]-Uridine labelled RNAs were denatured with 
glyoxal and analyzed on 0.8% agarose gels 36.
immunofluorescence
At times indicated in the legend of the figures, control and infected cells were washed 
once with PBS and prepared for immunofluorescence as described previously 32. Com-
mercially available immune ascitic fluid obtained from mice infected with MODV (ATCC, 
Manassas, USA) was used in a 1:1000 dilution as primary antibody.
ReSULtS AND DiSCUSSioN
Construction of a full-length moDV cDNA for the in vitro transcription of 
infectious RNA
It is notoriously difficult to construct full-length cDNAs for the in vitro transcription of 
infectious RNA for many flaviviruses due to genetic instability of these clones in E. coli 
29-31,33. Therefore, the pACNR1180-derived vector backbone, previously used for the suc-
cessful construction of a stable full-length YFV-17D clone 32, was selected as the vector 
for the MODV cDNA inserts. pACNR-FLYF17Da, in which the standard Xho I run-off site is 
replaced by Afl II, was cut with BamH I and religated. Subsequently the Sal I site upstream 
the Sp6 promoter in this plasmid was inactivated by site-directed mutagenesis. The re-
sulting plasmid pACNR-FLYF17Da D2576-9294 contained unique Not I, Hind III, Sal I and 
Afl II restriction enzyme sites that were used to assemble the MODV full-length cDNA. 
Figure 1 is a schematic representation of the MODV genome and the position of the 
oligonucleotides used to prime RT-cDNA reactions on MODV RNA isolated from infected 
cells; the three PCR products that were used to assemble the full-length MODV cDNA 
are also depicted. Oligonucleotide NKV41 contained the f2.5 promoter for T7 RNA poly-
merase fused to the most 5’ 19 nucleotides of MODV, whereas in oligonucleotide NKV40, 
the 28 3’ nucleotides of MODV were fused to a unique Afl II recognition sequence, serving 
as the transcription run-off site. Construction of the full-length MODV clone in pANCR-
FLYF17Da D2576-9294 was performed in three steps in the 5’ to 3’ direction during which 
the remaining YFV-17D sequences were replaced by MODV cDNAs fragments. First, the 
2597 bp fragment obtained after Not I and Hind III digestion of the NKV41 – NKV39 PCR 
product was cloned into Not I – Hind III digested pANCR-FLYF17Da D2576-9294. Subse-
quently, the 5063 bp Hind III – Sal I fragment and the 3’ 2952 bp Sal I – Afl II fragment were 
cloned stepwise, to complete the construction of the full-length MODV cDNA. Many 
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plasmids harbouring what appeared to be a full-length MODV genome cDNA insert 
based on various restriction enzyme digests were obtained using this strategy. 
identification and characterization of an infectious moDV cDNA clone 
Plasmids that appeared to contain a full-length MODV genome cDNA insert were 
used to produce full-length genomic MODV RNAs by in vitro RNA transcription. The 
RNA transcripts were electroporated into BHK-21J cells; immunofluorescence assay (IFA) 
were performed 48 hr p.e. for MODV antigen expression. Four (clone numbers 2.4, 4.2, 
6.1 and 8.7) out of the ten original clones yielded a clearly positive signal in IFA (data 
not shown). 3H-uridine labelling of cells electroporated with in vitro transcribed RNA of 
these four plasmids revealed that only clone 6.1 allowed effective first cycle analysis of 
RNA synthesis (fig. 2). No MODV genome-sized 3H-labeled RNA could be detected in cells 
electroporated with RNA transcripts from clones 2.4, 4.2 or 8.7. From these results it was 
concluded that pACNR-FLMODV6.1 contained the most robust template for the in vitro 
production of infectious MODV RNA. This clone and its infectious RNA transcripts were 
characterized in more detail and compared to the parental MODV virus. 
The genetic stability of the full-length MODV6.1 clone in E.coli DH5a was analyzed by 
repeated passaging, i.e., growing the bacteria for more than 12 hr in 2 ml of LB medium 
plus 50 mg/ml ampicilline, followed by a streak on selective medium to obtain a single 
colony for the next cycle. After the 10th streak, a bacterial colony was picked and used to 
prepare plasmid DNA (pACNR-FLMODV6.1-p10). The purified plasmid DNA was digested 
with various restriction enzymes as an indicator for its genetic stability. No difference in 
the restriction pattern was observed from the plasmid at passage 10 compared to the 
original pACNR-FLMODV6.1 DNA (data not shown). Full-length MODV RNA transcripts 
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Fig. 2
Fig. 2. Analysis of viral RNA synthesis in BhK-21J cells 
transfected with transcripts of pACNR-moDV clones 
2.4, 4.2, 6.1 and 8.7. 
BHK-21J cells that were electroporated with full-length 
MODV transcripts were labelled with 3H-uridine from 
24 – 30 hr post transfection. Total RNA was isolated and 
analyzed after denaturation by agarose gel electrophoresis 
as described in the Materials and Methods section. BHK-
21J cells infected with the parental MODV virus (wt) were 
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Fig. 3. Characterization of the pACNR-moDV6.1 infectious cDNA clone. 
A) Viral RNA synthesis in BHK-21J cells transfected with in vitro transcribed RNA of the pACNR-MODV 6.1, 
6.1-p10 and 6.1ΔBgl II. Transfected cells were labelled with 3H-uridine from 24 - 30 hr post transfection. 
Total RNA was isolated and analyzed after denaturation by agarose gel electrophoresis as described in 
the Materials and Methods section. BHK-21J cells were infected with the parental MODV virus as a control. 
B) Immunofl uorescence staining of BHK-21J cells that were infected with wt-MODV or transfected with 
full-length MODV RNA derived from pACNR-MODV6.1 and related plasmids. Cells were fi xed at 30 hr p.e. 
and stained with the MODV hyperimmune serum. C) Viral growth kinetics; BHK cells were infected with a 
MOI of 1; the medium of the infected cells was harvested at the indicated times p.i. and the viral titer was 
determined by plaque assays. D) Plaque morphology of the wild-type MODV, pACNR-MODV6.1, pACNR-
MODV6.1 p10 and pACNR-MODV ΔBgl II in BHK-21J cells. e) Bgl II restriction analysis of the RT-PCR products 
generated from RNA isolated from BHK-21J cells infected with the indicated viruses. The sizes of the DNA 
marker (lane 1) are given on the left side.
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electroporated into BHK-21J cells. As a control, BHK cells were infected in parallel with 
the parental MODV virus. Electrophoresis of 3H-uridine-labelled total intracellular RNA 
isolated from MODV-6.1-p10 transfected cells, showed the synthesis of MODV genome 
RNA that co-migrated with the 3H-uridine labelled genome RNA isolated from MODV-
infected or MODV6.1 RNA transfected cells (fig. 3.A; lanes 2, 3 and 4). IFA on the electro-
porated cells with the MODV hyperimmune serum as the primary antibody indicated 
similar transfection efficiency with pACNR-FLMODV6.1 and pACNR-FLMODV6.1-p10 (fig. 
3.B). These results confirmed high specific infectivity as well as genetically stability of 
pACNR-FLMODV clone 6.1. Furthermore, viruses derived from both pACNR-FLMODV6.1 
and pACNR-FLMODV6.1-p10 showed similar growth kinetics when compared to the wt 
MODV (fig. 3.C). No differences in plaque morphology were observed (fig. 3.D).
In order to rule out the possibility of accidental cross-contamination of BHK-21J cells 
with the parental MODV virus, thus the obtained results, a mutation was introduced 
at position 8756 of pACNR-FLMODV6.1, abolishing the Bgl II as a genetic marker. The 
mutation was silent and did not impair viral RNA synthesis (fig. 3.A, lane 5), infectivity 
of the RNA transcript (fig. 3.B) or viral growth kinetics (fig. 3.C). The wt MODV, MODV6.1, 
MODV6.1-p10 and MODV6.1ΔBgl II virus stocks harvested for the growth curve experi-
ment (fig. 3.C) at 48 hr p.i. were used to infect BHK-21J cells at an M.O.I. 5. At 30 hr p.i., 
total intracellular RNA was isolated; a fragment spanning MODV nts. 8435 to 9176 was 
amplified by RT-PCR, followed by Bgl II digestion. As shown in fig. 3.E, the MODV6.1ΔBgl 
II still lacks this restriction site, demonstrating that the infectious clone was stable and 
the viruses generated by transfection of permissive cells with transcripts of pACNR-
FLMODV6.1 were indeed derived from the cDNA.
The nucleotide sequence of clone 6.1 was determined. Compared to the MODV 
sequence AJ242984 available in GenBank, 22 nucleotide differences were identified 
in clone 6.1. As summarized in table 1, these differences were present throughout the 
coding sequence and five of them corresponded to silent mutations. Although the E 
protein is the most variable between flaviviruses, only one amino acid difference was 
observed when comparing the MODV GenBank sequence with clone 6.1. Apart from 
a high variation in NS5, the largest protein, a relatively high number of amino acid 
changes were detected in the rather small and generally well conserved NS4B protein 
(around 254 amino acids). The function of NS4B in the flavivirus life cycle remains to be 
established, although studies have implicated the involvement of NS4B in modulating 
the host interferon response 39,40. None of the mutations found in NS3 or NS5 were part 
of the functional domains proposed for these viral proteins 5. Taken together, clone 
pACNR-MODV6.1 generated in this study can yield viable and infectious MODV particles, 











The strategy to clone the MODV inserts directly into the low copy number plasmid 
pACNR1180, which is known to accept viral sequences that are not well tolerated by E. 
coli 41,32 probably contributed significantly to the successful construction of clone 6.1. 
pACNR-FLMODV6.1 proved to be stable upon repeated passages in E.coli. Attempts to 
clone the full-length MODV insert from pACNR-FLMODV6.1 into high copy number plas-
table 1. Summary of the nucleotide differences between the MODV AJ242984 and the MODV 
clone 6.1 sequences. Changes are grouped by encoded viral proteins. Positions, actual 
nucleotide change as well as the amino acid substitutions are shown. Nucleotide or amino 
acid to the right indicates MODV NCBI AJ242984 followed by the nucleotide or amino acid 
encountered in the MODV6.1 genome. 
Gene Position Nucleotide Amino Acid
prM 610 U → C silent
Env 1543 U → G Phe → Leu
NS1 2776 C → U silent
3089 C → A Gln → Arg
NS2A 3529 A → G Ile → Met
NS2B 4410 A → G Glu → Gly
NS3 4861 A → G silent
6312 U → A Leu → Gln
NS4B 6837 U → C Ile → Thr
7098 G → A Ser → Asn
7444 C → G silent
7445 C → G Leu → Val
7503 U → A Leu → His
NS5 7756 G → A silent
7767 G → C Ser → Thr
7938 G → C Arg → Thr
8141 C → G Arg → Ala
8142 G → C Arg → Ala
8612 C → G Gln → Glu
8920 U → A Ser → Arg
9120 A → G Lys → Arg
9990 A → G Asp → Gly
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mids like pBluescribe or pUC has met no success thus far and only resulted in plasmids 
that contained recombined MODV inserts harbouring deletions (unpublished results). 
The pACNR-FLMODV6.1 clone will be a useful tool to increase our understanding of the 
molecular determinants important for flaviviral replication and tropism. The biological 
relevance of predicted conserved RNA structures in NKV viruses can now be studied 
using a reverse genetic approach. Another useful application for this clone is the con-
struction of chimeric viruses between NKVs and arthropod-borne flaviviruses that can 
provide valuable insights into host-range restrictions and pathogenicity, as illustrated 
by studies using a yellow fever virus in which prM and E were replaced by the analogous 
proteins of MODV 22,18. In addition, this clone and the viruses derived from it are likely 
to be useful in the screening of antiviral compounds. A very convenient model to moni-
tor MODV infection in the Syrian hamster has been developed to test small molecules 
with anti-flavivirus activity in a relevant small animal model 21. The availability of this 
MODV infectious clone will be a valuable addition to these studies by allowing a more 
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Chapter 6
Functions and requirements of 
conserved RNA structures in the 3’ 
untranslated region of Flaviviruses 




Flaviviruses are small enveloped viruses with a positive, single-stranded RNA genome 
of approximately 11 kb in length, with a 5’ cap structure and a 3’ non-polyadenylated 
end. The Flavivirus genus has been divided into three different clusters that correlate 
with the vector that is used for their transmission: i) mosquito-borne, ii) tick-borne, and 
iii) no known vector flaviviruses. The 3’ untranslated region (UTR) of flaviviruses can be 
roughly divided into a proximal part, which exhibits extensive heterogeneity in both 
length and sequence and is present immediately downstream of the stop codon of the 
open reading frame, and a more conserved distal part that has been defined as the core 
element of the 3’ UTR as it contains the majority of the elements involved in viral transla-
tion, replication, and assembly. A number of small but well conserved RNA sequence 
elements as well as secondary and tertiary RNA structures have been identified in the 
flaviviruses 3’ UTR. Some of these have been recognized in all flaviviruses studied thus 
far, whereas others are characteristic for a particular cluster of the genus. This review 
describes the characteristics and function of conserved RNA sequences and structures 
in the 3’ UTR of all three Flavivirus clusters. For this purpose, the flavivirus 3’ UTR was 
divided into five domains in a 3’-to-5’ direction according to the position in the genome, 
sequence and structural similarity. Special emphasis has been given to the RNA struc-








Positive-strand RNA viruses are unique in the viral world as their genome serves a 
dual role as both mRNA and as a template for minus-strand RNA synthesis. In general, 
these viral genomes are characterized by a 5’ untranslated region (UTR), one or more 
open reading frames (ORF) and a 3’ UTR. Apart from the coding information for the 
viral proteins present within the ORFs, the viral genome contains a substantial amount 
of information in the form of RNA sequences and structures that is required for RNA 
synthesis, translation and encapsidation. Identifying and characterizing the function 
of these RNA elements is important for understanding the regulation of the several, 
often mutually exclusive, activities in which the viral genome is involved. Research has 
shown that these RNA signals can in principal be anywhere in the viral genome, but that 
the 5’ and especially the 3’ UTR harbor the majority of them. This review focuses on the 
conserved RNA sequences and structures in the 3’ UTR of viruses belonging to the genus 
Flavivirus.
The Flavivirus genus belongs to the Flaviviridae family, which also includes the Pes-
tivirus and Hepacivirus genera 1. Flaviviruses are small enveloped viruses containing a 
positive, single-stranded RNA genome of approximately 11 kb in length, with a 5’ cap 
structure and a 3’ non-polyadenylated end. Nearly 80 viruses belong to the Flavivirus 
genus and many of them are considered important human pathogens, namely dengue 
virus (DENV), yellow fever virus (YFV), Japanese encephalitis virus (JEV), West Nile virus 
(WNV), and tick-borne encephalitis virus (TBEV). Phylogenetic analysis based on the 
complete coding sequence divided the flaviviruses into three clusters that correlate 
with the vector of transmission: mosquito-borne, tick-borne and no known vector (NKV) 
flaviviruses 2,3. In general, the 3’ UTR of viruses that have a similar mode of transmission 
show a higher similarity in terms of conserved sequences and RNA structures 4-8. Despite 
these differences, certain RNA elements are, however, characteristic for the 3’ UTR of 
every flavivirus. This review describes the characteristics and function of conserved RNA 
sequences and structures in the 3’ UTR of all three Flavivirus clusters. It should be em-
phasized however that this review may seem rather biased towards the mosquito-borne 
flaviviruses; this is hard to avoid since the 3’ UTR has been studied more extensively for 
these viruses in comparison to the NKV flaviviruses, and to a lesser extent, the tick-borne 
flaviviruses.
The length of the viral 3’ UTR varies from approximately 350 to 800 nts depending on 
the virus, and it can differ even between strains of the same virus. This heterogeneity in 
length originates primarily from the proximal part of the 3’ UTR, immediately following 
the stop codon of the viral ORF, where deletions, insertions, sequence repeats and even 
internal poly(A) tracts have been observed; in contrast, the distal part of the 3’ UTR ex-
hibits a more similar RNA topology and regions with significant sequence similarity 9-15. 
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This distal region has been defined as the core element of the flavivirus 3’ UTR in which 
important elements for viral translation and replication are located 5. 
In this review, the flavivirus 3’ UTR has been divided into five domains in a 3’-to-5’ di-
rection according to the position in the genome, sequence and structural similarity (fig. 
1). The identified domains are usually separated from each other by U-A rich sequences 
predicted to be single-stranded 16. 
3’ UtR region i: the 3’ stem-loop structures
Region I comprises the last 100 to 120 nucleotides of the viral genome. RNA structure 
analysis of this region revealed that it can fold into two RNA stem-loop structures. The 
more upstream structure is relatively small, encompassing only 14 to 20 nts, whereas the 
last 80 to 100 nts are predicted to form a long stem-loop structure (3’ SL; fig. 1) 4,9,14,17-22. 
Even though the general structure of 3’ SL is well conserved among all flaviviruses, the 
sequence similarity is restricted to the pentanucleotide (PN) motif 5’-CACAG-3’, that is 

























































Region V Region IV Region III Region IRegion II
PSK
Fig. 1. Schematic model of the predicted RNA folding of the 3’ UtR of the prototype flavivirus yellow 
fever virus (YFV). The 3’ UTR was divided into five different regions. Nomenclature for the individual stem-
loop (except 3’ SL) and pseudoknot structures was adopted from Olsthoorn and Bol 6. The pseudoknot 
(PSK) predicted by Shi and colleagues 22 is also depicted. The pentanucleotide motif (PN), the conserved 
sequence 2 (CS2) and the 3’ cyclization motifs CS1 and UAR (upstream AUG region) are indicated. The third 3’ 
cyclization motif DAR (downstream AUG region) overlaps with CS1 in the stem-loop A region. The predicted 
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5’-CU-3’, which is complementary to the dinucleotide 5’-AG-3’ present at the very 5’ end 
of every flavivirus genome 19-21. Limited sequence variation has been observed in the PN 
motif of the NKV flaviviruses, which either contain a “C” or a “U” residue at the second 
position. APOI virus contains an additional “C” to “U” change at the third position 7.  
Because of the absence of a poly-A tail at the 3’ end of the flavivirus genome it was sug-
gested that the 3’ SL structure was functionally replacing the poly-A tail by signalling the 
integrity of the viral genome and therefore protecting it from degradation. Experiments 
using either reporters expressing WNV replicon RNAs or synthetic mRNAs containing 
flavivirus 5’ and 3’ UTRs, yielded contradicting results varying from no effect to a modest 
stimulation on translation by the 3’ SL 23-26, to actually inhibiting translation 27,28.
Deletion of the 3’ SL showed that this conserved RNA structure is absolutely required 
for flavivirus RNA synthesis 29-34. Detailed mutagenesis of the 3’ SL revealed that the 
terminal dinucleotide 3’ CUOH is essential for efficient viral replication and that it prob-
ably functions as a recognition site for the replication complex to initiate RNA synthesis 
33,35. Deletion of the conserved PN motif does not influence translation efficiency of the 
viral genome, but is lethal for viral RNA synthesis. Mutational analysis of the 5’ CACAG 3’ 











































































































































































































Fig. 2. Structural model of the terminal 3’ SL structure of YFV, DeNV and WNV. The pentanucleotide 
motif (PN) is indicated. The shaded box 1 represents a region important for virus viability while box 2 
represents the region that is required for replication in mosquito cells. The region indicated by number 3 
corresponds to the eEF-1α-binding sequence. 
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tide at the 1st position with a complementary nucleotide four positions downstream of 
the PN motif, are the most critical elements of this conserved RNA sequence. Nucleotide 
changes at either the 2nd or 4th positions of the WNV or YFV PN motif were shown to be 
well tolerated. Mutations at the 3rd position were reported to be detrimental for WNV 
replication, but showed only a relatively minor to no effect in YFV-17D 25,33,36,37. The exact 
role of the PN motif in flavivirus RNA replication is currently unknown. It is interesting to 
note that although some mutations within the PN motif seem to be well tolerated, com-
petition experiments revealed that a virus with the wild-type PN sequence has a clear 
advantage over viruses with a mutated PN motif 37. Phosphorodiamidate morpholino 
oligomers (PMOs) targeted at regions including the PN motif inhibited the replication of 
DENV and WNV replicons 38,39. Interestingly, part of the loop that contains the PN motif 
was show to be involved in binding eukaryotic translation elongation factor-1α (eEF-1α) 
40. Recently, the RNA structure of the top of 3’ SL was resolved by NMR for representatives 
of the three flavivirus groups. Surprisingly, the results implied that the structure was not 
well conserved and indicated clear differences in the stacking pattern of the nucleotides 
that form the top of the 3’ SL, including the PN motif, among the different groups of 
flaviviruses 41. 
Immediately upstream the 3’ SL is a smaller stem-loop structure (SL-A according to the 
nomenclature of Olsthoorn and Bol 6) that comprises 14 to 18 nucleotides and that is 
present in every flavivirus. Biochemical and biophysical probing and in silico RNA model-
ling showed that the four nucleotides in the SL-A loop of mosquito-borne flaviviruses 
were involved in the formation of an RNA pseudoknot by base pairing with nucleotides 
in the lower part of the 3’ stem of 3’ SL 22 (fig. 1). This pseudoknot appears well con-
served and can also be predicted for TBEV and the NKV flaviviruses MMLV, MODV, RBV 
and APOIV. SL-A and the RNA pseudoknot were shown to be required for efficient viral 
RNA synthesis in in vitro DENV RdRp assays 30. Furthermore, a PMO targeting the pseu-
doknot interaction moderately inhibited the replication of a WNV reporter replicon 38. 
Exchanging SL-A of DENV2 by the WNV SL-A sequence was relatively well tolerated. This 
substitution, which is predicted to maintain the pseudoknot formation, illustrates that 
the formation of the structure is more important than the primary sequences 29. Deletion 
of SL-A was shown to decrease the translation efficiency of a DENV reporter construct 
26. SL-A was suggested to be a minor binding site for the host eEF-1a protein in WNV 40. 
Previous studies demonstrated that the complete DENV and WNV 3’ SL nucleotide 
sequences were not interchangeable 29,34. Specific nucleotide sequence elements within 
the 3’ SL were found to be important for viability as illustrated by the RNA elements 
indicated in fig. 2 as number 1 in the DENV 3’ SL 29, and number 3 in the WNV 3’ SL 
(5’-CACA-3’, the eEF-1a-binding sequence) 34,40. Others were found to be important in a 
host cell-specific manner; for example the RNA structure represented by number 2 (fig. 
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a mutant that grew well in monkey kidney cells but was severely restricted in mosquito 
cells 29. The U-U bulge in this region of the DENV 3’ SL was shown to be important for 
efficient replication of these WNV chimeras in C6/36 cells, suggesting that it acts as an 
enhancer for both DENV and WNV replication in mosquito cells, while it is dispensable 
for replication in mammalian cells 34. The results demonstrate that specific bulges and 
regions in the flavivirus 3’ SL are critical determinants for viral RNA replication. These 
bulges were suggested to likely represent important binding sites for viral and cellular 
proteins to assemble the flavivirus replication complex 29,34. It should be noted that the 
bottom part of the right-hand side of 3’ SL also contains other elements like the 3’ UAR 
(upstream AUG region) and the 3’ DAR (downstream AUG region) sequences which have 
been predicted to be required for cyclization of the viral genome (see a more detailed 
description on region II). 
3’ UtR region ii: the cyclization sequences
Immediately upstream of the 3’ SL, and partially overlapping with SL-A, is a 10 to 18 
nucleotides region that is predicted to be relatively unstructured but forms the key RNA 
element for the initiation of viral minus-strand RNA synthesis. The importance of this re-
gion was initially suggested by Hahn et al. 4, whom reported the presence of a conserved 
sequence shared by all the mosquito-borne flaviviruses. This conserved sequence was 
originally named CS1 (conserved sequence 1) (fig. 1). The most conserved part of CS1 is 
located upstream of SL-A but the functional part of this sequence is likely to involve the 
nucleotides of SL-A as well. The key observation has been that CS1 is complementary to 
a conserved sequence (5’ CS) within the N-terminal coding region of the capsid protein 
4. This complementarity suggested a long-range RNA interaction that would promote 
circularization of the flavivirus genome resulting in the formation of a panhandle-like RNA 
structure required for viral RNA synthesis 4. The critical role of CS1 in this 5’ – 3’ RNA interac-
tion for RNA synthesis in mosquito-borne flaviviruses has now been firmly established by 
using in vitro RdRp assays 30,42-44 and mutational analysis of infectious flavivirus cDNAs 32,45-
50. Physical evidence for the 5’CS-3’CS1 interaction in DENV was obtained by atomic force 
microscopy 50. Although formally a requirement for RNA circularization during  flavivirus 
(+) strand RNA synthesis cannot be ruled out, current data demonstrate that it is crucial 
for (-) strand RNA synthesis 44. Genome cyclization is dispensable for viral translation 26,46,49. 
Apart from the 5’CS-3’CS1 interaction, a second long-range RNA interaction was shown 
to be required for genome cyclization. In mosquito-borne flaviviruses this interaction is 
mediated by a sequence at the 5’ end, located immediately upstream of the start codon 
of the ORF, and a sequence that is part of the bottom of the 3’ SL 50-52. These comple-
mentary sequences were named 5’-3’UAR (upstream AUG region) and were shown to 
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be important for viral replication 50. Similar to the 5’CS-3’CS1 interaction, 5’-3’UAR base 
pairing was also demonstrated by atomic force microscopy 50. Current evidence suggests 
that the base pairing involving 5’CS and 3’CS1 initiates the circularization of the genome 
and promotes the 5’-3’ UARs interaction to increase the stability of this long-range RNA 
interaction 53. Interestingly, additional RNA base pairing contributing to flavivirus ge-
nome circularization were recently identified between nucleotides downstream of the 
AUG region (5’ DAR) and nucleotides downstream CS1 in the SL-A stem (3’ DAR) 54,55. The 
5’ and 3’ DAR motifs were shown to be important for genome circularization and RNA 
replication in DENV and WNV 54,56. In WNV, the 5’-3’ DAR interaction actually consists of 
two stretches of complementary sequences 55. In YFV, the DAR motifs 56 were originally 
included in the 18 nt found to be part of the 5’ CS and 3’ CS1 elements 47 (see fig. 3). A 
general model was proposed for flaviviruses in which the 5’-3’ DAR interaction extends 
the initial circularization between 5’ and 3’ CS, and together with the 5’-3’ UAR interac-
tion, unwinds the 3’ SL 54,56. The various 5’ and 3’ RNA sequences that were shown to be 
required for RNA circularization in mosquito-borne flaviviruses are shown in figure 3.
RNA cyclization sequences have also been identified in the other two flavivirus clus-
ters. In tick-borne flaviviruses these complementary sequences are named 5’-CS-A and 
3’-CS-A. 5’-CS-A is located upstream of the translation initiation codon at approximately 
100 nt from the 5’ end, whereas 3’-CS-A is present in the 3’ SL, approximately 80 nts from 
the 3’ end 21. There is no sequence similarity between the 5’- and 3’-CS-A sequences and 
5’CS and CS1 of the mosquito-borne flaviviruses 21,51 and the position of 5’- and 3’-CS-A 
actually resembles the location of the sequences involved in the 5’-3’ UAR interaction of 
mosquito-borne flaviviruses. Mutagenesis of the 5’- and 3’-CSA revealed that comple-
mentarity between these RNA sequences was required for viral RNA synthesis 21,51,57. In 
addition to the 5’–3’ CS-A interaction, another pair of complementary sequences (CS-
B) has been identified at positions in the genome of tick-borne viruses (fig. 3). These 
sequences are reminiscent of the 5’-CS and CS1 in the mosquito-borne flaviviruses 45. 
Although the 5’- and 3’-CS-B sequences are well conserved in TBEV strains and related 
viruses like Powassan, Vasilchenko and louping ill virus 10,13,21, their interaction is not 
essential for viral replication 57. Sequence complementarity between 5’ and 3’ ends in 
the NKV flaviviruses MODV and MMLV has also been reported. Complementary RNA 
sequences that could promote circularization of the viral genome were identified at 
the 5’ end of the genome, encompassing the AUG codon and the nucleotides encoding 
the N-terminus of the capsid protein; the 3’ end counterpart was located immediately 
upstream the SL-A, resembling the location of CS1 in mosquito-borne flaviviruses 7,58. 
A particular stem-loop structure (SLA) in the flavivirus 5’ UTR was found to be important 
for RNA replication 30,59-61. In fact, it was shown that this SLA structure was the responsible 
for promoting viral RNA synthesis and not the cyclization sequences per se 59. This was 
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RdRp NS5 59,60,62. These data have led to a model for the initiation of viral (-) strand RNA 
synthesis in which the viral RdRp would bind to a conserved stem-loop structure at the 5’ 
end of the genome. This binding would initiate genome circularization by the 5’CS-3’CS1 
interaction, which is subsequently extended and therefore stabilized by base pairing of 
the additional RNA UAR and DAR motifs. Because the 3’ UAR is located at the bottom of the 
3’ SL, the 5’UAR-3’UAR interaction might be responsible for destabilizing the 3’ SL struc-
ture, which enforces the 3’ end of the genome in a single-strand conformation, thereby 
making it accessible for the RdRp to use it as a template for initiation of viral (-) strand RNA 
synthesis 59,60,63. This model implies that the interaction between the 5’- and 3’ ends of the 
viral genome functions as a riboswitch that can be induced by the binding of NS5 to the 
5’ end of the genome. This ensures refolding of the RNA from a “linear” conformation that 
is used for translation and packaging, into a circular conformation that is required for the 
initiation of viral RNA synthesis 26,50,64,65. Genome circularization might be beneficial for 
viral replication for several reasons: (i) as a control mechanism to amplify only full-length 
templates, (ii) to regulate transcription versus translation in space and time, (iii) to bring 
the replication complex in close vicinity of the transcription initiation site at the 3’ end of 




















3’ DAR: 5’ – CCUGG – 3’ 5’ DAR: 5’ – CCAGG – 3’                                         
3’ UAR: 5’ – UGGGAGAUCUUCUGCUCUA – 3’5’ UAR: 5’ – UAGAACGGAAGAUAACCAUG – 3’ 
3’ CS1: 5’ – CACAUAUUGA – 3’ 5’ CS: 5’ – UCAAUAUGUG – 3’ 
JEV
3’ DAR: 5’ – CCUGG..UAGAC – 3’ 5’ DAR: 5’ – GUCUA…..CCAGG – 3’ 
3’ UAR: 5’ – GAGAUCUUCUGCU – 3’ 5’ UAR: 5’ – AGCACGAAGAUCUC – 3’ 
3’ CS1: 5’ – AGCAUAUUGACA – 3’ 5’ CS: 5’ – UGUCAAUAUGCU – 3’ 
WNV
3’ DAR: 5’ – CGCUGG – 3’ 5’ DAR: 5’ – CCAACG – 3’ 
DENV
3’ CS: 5’ – UCCUGUUAUUUUCCAAAUU – 3’ 5’ CS: 5’ – AAUGUGCGAAAAUAACAGGAMODV
3’ CS-B: 5’ – GGGAGGCCCC – 3’ 5’ CS-B: 5’ – GGGGCGGUCCC – 3’ 
3’ CS-A: 5’ – CGGUUCUUGUUCUCC – 3’5’ CS-A: 5’ – GGAGAACAAGAGCUG – 3’ 
TBEV
3’ UAR: 5’ – CAGAGAUCCUGCUGUCU – 3’ 5’ UAR: 5’ – AGAGAGCAGAUCUCUG – 3’ 
3’ CS1: 5’ – CAGCAUAUUGA – 3’ 5’ CS: 5’ – UCAAUAUGCUG – 3’ 
3’ DAR: 5’ – CCAGG – 3’5’ DAR: 5’ – CCUGG – 3’
3’ UAR: 5’ – UGGUUCUCUGCU – 3’ 5’ UAR: 5’ – AGCAGAGAACUG – 3’
3’ CS1: 5’ – ACCAUAUUGACGCCAGGG – 3’ 5’ CS: 5’ – CCCUGGGCGUCAAUAUGGU – 3’ 
YFV
Fig. 3. Potential 5’ and 3’ cyclization motifs in the mosquito-borne flaviviruses YFV, DeNV, WNV and 
JeV, the tick-borne flavivirus tBeV and the no known vector moDV. The YFV nucleotides presented 
in bold in the 5’ CS and 3’ CS1 sequences 47 correspond to nucleotides that were afterwards described 
as the DAR elements 56. The underlined nucleotides indicate unpaired nucleotides. The dots in the DAR 
elements of WNV represent the nucleotides between the two stretches of nucleotides characteristic of the 
DAR interaction of WNV.  
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3’ UtR region iii: RNA structures required for enhancement of RNA 
synthesis
This region essentially involves the nucleotides downstream of the XRN1 stalling 
signal (see region IV) and upstream of the CS1 or the circularization sequences in the 
mosquito-borne and NKV flaviviruses or 3’ CS-B in the TBE-like viruses. Even flaviviruses 
that belong to the same cluster show a significant variation in the length of this region 
due to duplication of RNA sequences. Region III varies in the mosquito-borne flaviviruses 
from approximately 100 nts for YFV to 170 nts in DENV and in the NKV viruses from ± 150 
nts for MODV to 225 nts for RBV. In terms of RNA structure, this region is characterized by 
the predicted formation of one or two so-called dumbbell-like or Y-shaped RNA stem-
loop structures 6,7,13. The dumbbell structure of the mosquito-borne flaviviruses contains 
a conserved sequence that has originally been named CS2 and has ~24 nucleotides 
in length (fig. 1). Mosquito-borne flaviviruses like JEV, WNV and DENV, which show a 
duplication of this dumbbell-like structure, contain two CS2 elements (CS2 and RCS2 
4). In NKV flaviviruses an RNA sequence with significant sequence homology to CS2 can 
be found in a similar position in the predicted Y-shaped RNA structures as to CS2 of 
the mosquito-borne flaviviruses 7,58. So far a CS2-like sequence has not been identified 
within region III of TBEV or related viruses. Deletion of CS2 has a relatively minor effect 
on viral RNA synthesis and virus production, but seems to decrease viral pathogenicity 
32,46,48,49,66.   
In addition to CS2, the region III of flaviviruses is characterized by two predicted RNA 
pseudoknots (fig. 1) 6 (Jiang, Silva, Dalebout and Bredenbeek unpublished results). These 
RNA pseudoknots, named PSK1 and PSK2, involve four to five nts of the loop on the 
left-hand side of the dumbbell structures. These nucleotides are predicted to base pair 
with a complementary sequence downstream of the dumbbell structures. Experimental 
evidence for the formation of both these pseudoknots in DENV, YFV and WNV has been 
obtained by RNA structure probing and mutational analysis 67,68 (Molenkamp, Dalebout 
and Bredenbeek, unpublished results). Disruption of either PSK1 or PSK2 significantly 
impairs viral RNA synthesis and virus production. This effect is enhanced when neither 
of the two pseudoknot structures can be formed. Formation of PSK1 and PSK2 is not 
required for efficient viral translation (Molenkamp, Dalebout and Bredenbeek, unpub-
lished results).
Many other deletion mutants involving sequences of region III have been described 
for several flaviviruses 46,48,49,66. Unfortunately, most of these deletions were not guided by 
the predicted RNA structures and/or did not take into account the potential redundancy 
of the effect of the introduced deletions due to duplication of conserved RNA elements. 
Therefore, and also due to the differences in experimental design, it is rather difficult 
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role for CS2 and the RNA pseudoknots in viral RNA synthesis. Deletion of the (nearly) 
complete dumbbell structure that contains CS2 has a more dramatic effect on viral RNA 
synthesis than deleting only CS2. This can be explained by the fact that such deletions 
exhibit the cumulative effect of disrupting one of the RNA pseudoknots and the loss 
of the CS2 sequence. Removing both dumbbell structures of region II of DENV results 
in very crippled to none-viable viruses when analyzed in mammalian cells 49,66. Surpris-
ingly, one of these DENV deletion mutants was able to replicate in C6/36 mosquito cells. 
Another mutant, in which the left part of the dumbbell structures was deleted but that 
maintained CS2 and RCS2 sequences, exhibited the reverse phenotype as it was able to 
replicate efficiently in Vero cells but not in C6/36 cells 66. The molecular basis of these ap-
parently host-specific effects of deletions in region III of DENV is unknown. YFV mutants 
that are either unable to form PSK1 or PSK2 or lack CS2 yield a similar phenotype in the 
mammalian BHK and SW13 cells and in the C6/36 mosquito cells (Molenkamp, Dalebout 
and Bredenbeek; unpublished results). 
Of particular interest is a 30-nucleotide deletion (nucleotides 10.478-10.507 in the 
dumbbell structure 1; involving PSK1) in the 3’ UTR of DENV4 genome. This rDENV4Δ30 
mutant was shown to be attenuated in rhesus monkeys 48 and well tolerated and 
highly immunogenic in human volunteers 69,70. In addition, rDENV4Δ30 also exhibited 
a limited ability to infect the midgut of mosquitoes 71. Introduction of the Δ30 muta-
tion into the homologous region of DENV1 yielded similar results as for rDENV4Δ30 72,73. 
Unfortunately, introduction of the Δ30 mutation in DENV2 and DENV3 did not result in 
significant attenuation when tested in rhesus monkeys 74,75. The molecular basis of the 
different phenotypes caused by this deletion in either DENV1 and 4 versus DENV2 and 3 
is currently unknown, but it should be the subject of further studies in order to produce 
a safe and effective tetravalent DENV vaccine based on this Δ30 deletion.
3’ UtR region iV: the XRN1-stalling region
Region IV of the flavivirus 3’ UTR varies in length due to sequence duplication espe-
cially in members of the JEV subgroup that have a third  conserved sequence (CS3), 
which is also repeated (RCS3) 4,76. These sequences were shown to be important for 
efficient RNA replication in KUNV and WNV 46,77. DENV mutants with deletions in region 
III also exhibited reduced growth properties, suggesting that this region is essential for 
an efficient viral replication 78.  
Recently it has become evident that the major characteristic of this region is an RNA 
pseudoknot structure that can be formed in all flaviviruses (fig. 4). Viruses that contain a 
sequence duplication within region IV are predicted to form two pseudoknots. This RNA 
pseudoknot structure is often followed by a small stem-loop structure (see fig. 1) with 
130
unknown function. The RNA pseudoknot has been identifi ed as an important determi-
nant for the synthesis of a small fl avivirus subgenomic RNA (sfRNA) that is colinear with 
the 3’ end of the viral genome 68,79,80. This sfRNA is not produced by viral transcription, but 
by 5’ to 3’ degradation of the viral genome by the host exoribonuclease XRN1 79,81. XRN1 
is the main host RNase associated with cellular 5’ to 3’ mRNA decay (reviewed in 82,83). 
The RNA pseudoknot has been shown to serve as a stalling site for XRN1-mediated RNA 
decay, resulting in the production of the sfRNA 68,79,81. Interestingly, this sfRNA was shown 
to be an important determinant for virus pathogenicity as recombinant fl aviviruses that 
are unable to produce the sfRNA show an attenuated phenotype. Disruption of the RNA 
pseudoknot structure has only a moderate eff ect on fl avivirus genome RNA synthesis 
68,79,81. 
These results provide a prime example of how an RNA structure can (in)directly be 
involved in viral pathogenesis. The mechanism by which the sfRNA infl uences the viral 
pathogenicity is not known. It has been suggested that it may act as decoy for host 
miRNAs or proteins that are directed against the viral genome to decrease replication 
Chapter 6 
Fig. 4. RNA sequence and predicted RNA structures for the part of region iii that is required for 
stalling XRN1. RNA structures were predicted using a combinatorial approach involving Mfold, phylogeny 
and manual sequence-structure analysis. The predicted RNA pseudoknot formation by interaction of the pk 
and pk’ sequences are indicated by grey boxes and dotted lines. The NCBI accession numbers are X03700 




 structures in the 3’ U
TR of flaviviruses
Chapter 6
81,84. Another intriguing hypothesis is that the sfRNA itself may serve as a precursor for 
the production of a virus-encoded miRNA 79. It is interesting to note that XRN1-mediated 
RNA decay occurs within the subcellular P bodies that among others also contain Dicer 
and Argonaute proteins, which are required for the production of functional miRNAs 
(reviewed in 82,83). It is important to realize that the sfRNA contains all the RNA sequences 
and most likely the RNA structures that are characteristic for the distal part of the flavivi-
rus 3’ UTR. Therefore, the effect of mutations within this region is not necessarily linked 
to the viral genome, but can be the result of their effect on the function of the sfRNA.            
3’ UtR region V: the variable region
The RNA sequence that starts immediately downstream of the stop codon of the viral 
ORF up to the XRN1-stalling site is known as the variable region (VR). Natural isolates 
of arthropod-borne flaviviruses often show a significant sequence and size variability 
due to relatively large nucleotide insertions and deletions in this region of the 3’ UTR 
9-12,15,85. The heterogeneity of the VR in natural isolates is well documented for YFV. The 
originally reported YFV-17D VR corresponds to a unique set of three closely spaced 
repeated sequences (RYF1, RYF2 and RYF3), each of approximately 40 nucleotides in 
length 17 (fig. 1) that were shown to be characteristic for West-African strains of YFV 86. 
It was subsequently demonstrated that Central and East-African strains had only two 
repeats (RYF1 and RYF3), whereas South America genotypes had one single copy (RYF3) 
12,87. Interestingly, passaging of an YFV strain harboring all three repeats in mice and cell 
culture resulted in the deletion of both RYF1 and RYF2 87. Similar results were reported 
for TBEV isolates, as they were also shown to accumulate deletions in the VR region dur-
ing propagation in either cell lines or mice 13,88. These results suggest that the majority of 
the 3’ VR is not essential for efficient replication of natural virus isolates. Deletions in the 
background of infectious cDNA clones of YFV-17D, KUNV, and TBEV demonstrated that 
actually the complete 3’ VR could be deleted without significant impact on replication 
or virulence for these mutant viruses in either cell culture or mice 32,77,88-90. Mutagenesis 
studies on the 3’ VR of DENV resulted in a slightly more complicated picture. Relatively 
small deletions up to 19 nts did not in general have any significant effect on virus 
replication in either insect or mammalian cell lines 91. However, larger deletions in the 
VR resulted in a significant decrease in RNA synthesis and virus production especially 
in mammalian cells 49,78. The significance of these often subtle differences is currently 
unknown and may in part result from the use of different cell lines and virus isolates as 
well as the rationale of the introduced deletions. 
No characteristic conserved RNA structure has been predicted in the VR. It has been 
suggested that the VR acts as a spacer element to allow proper folding of the RNA struc-
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tures in the distal part of the 3’ UTR 16. However, in the case of NKV flaviviruses, the VR 
sequences are in general rather short for serving as a spacer element (e.g. 20 and 41 nts 
for MODV and MMLV, respectively), although they are relatively A-U rich and therefore 
likely to be unstructured 7. 
In order to truly understand the importance of the VR in the 3’ UTR of flaviviruses, re-
combinant deletion mutants should be assessed in vivo in mosquitoes/ticks and animal 
models. The fact that this region is present in almost every flavivirus known indicates 
that it serves a purpose in the viral life cycle in nature. Furthermore, the fact that natural 
isolates tend to have a longer VR suggests a selective advantage that is either associated 
with replication or pathogenicity in the natural situation. 
Flavivirus 3’ UtR-binding proteins
Many host proteins have been found to play an important role in flavivirus infection 
(for a review see 92). Several of these proteins were shown to interact with the viral 5’ and 
3’ UTRs. Unfortunately, for only a few of these host factors the function of the interaction 
has been identified. This section briefly describes the host and viral proteins that were 
reported to interact specifically with the flavivirus 3’ UTR and summarizes our limited 
knowledge about their role in the flavivirus life cycle. 
host proteins interacting with the 3’ UtR of the viral genome
Apart from the usual suspects like polypyrimidine tract-binding protein (PTB), La and 
to some extend Poly(A)-binding protein (PABP), only a few host proteins that specifically 
interact with the 3’ UTR of the flavivirus genome have been identified. These include the 
eukaryotic translation elongation factor-1α (EF-1α), Y box binding protein-1 (YB-1) and 
the protein Mov34. 
The eukaryotic translation elongation factor-1α (EF-1α) was shown to bind specifically 
to the right-hand side of the 3’ SL region of WNV 40 and DENV4 93. The binding of EF-1α 
to the 3’ SL is primarily determined by an only four nucleotides long 5’-CACA-3’ motif, 
although additional sequences that are located in the top 3’ SL loop and in the smaller 
adjacent stem-loop SL-A are also involved 40. Mutational analysis of a WNV infectious 
cDNA clone revealed that the interaction between eEF-1α and the WNV 3’ SL was re-
quired for viral (-) strand RNA synthesis 94. In addition, in WNV and DENV4 infected cells, 
eEF-1α colocalized with dsRNA and the viral proteins NS3 and NS5, suggesting that this 
host protein was required for specific recognition of the 3’ SL by the RdRp to promote (-) 
strand RNA synthesis 94. It is currently unknown whether, apart from DENV4, eEF-1α also 
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Y box binding protein-1 (YB-1) is a member of the highly conserved Y box proteins and 
functions as pleiotropic transcription factor that is mainly involved in the regulation of 
the expression of stress induced genes. YB-1 was shown to bind specifically to the DENV 
3’ SL and to repress replication. This antiviral effect can in part be explained by YB-1 
mediated inhibition of DENV RNA translation 95. In addition, it is speculated that the YB-1 
serves as a transcription factor to promote activation of innate immune response genes 
such as ISG54 and ISG56, which can down-regulate translation. It is currently unknown 
whether YB-1 binds to the 3’ UTR of other flaviviruses, or whether its role as virus repres-
sor is limited to DENV4 virus.
Mouse Mov34 protein is another cellular protein that was reported to bind to the 3’ SL 
RNA of JEV 96. It belongs to a family of proteins that share a so-called MPN-like domain. 
Mov34 serves as regulatory subunit of the 26 proteasome and it is therefore not clear 
why this protein would interact with the flavivirus 3’ SL. 
In addition to the above proteins, various nuclear ribonucleoproteins like hnRNP A1, 
hnRNPA2/B1 and hnRNP Q were also shown to bind to the DENV 3’ SL by RNA affinity 
chromatography 95. However, no in vivo data that demonstrate the relevance of these 
hnRNP- 3’ SL interactions is available.   
The promiscuous RNA-binding proteins polypyrimidine tract-binding (PTB) and La 
protein have also been shown to interact with the 3’ UTR of several flaviviruses like DENV 
and JEV 93,97. These proteins are normally restricted to the nucleus, but were shown to 
translocate to the cytoplasm upon infection 98,99. Binding for both La and PTB is mapped 
in the CS1, SL-A and 3’ SL RNA structures in which putative binding sites have been 
suggested 93. However, the precise binding sites for these proteins in the viral 3’ UTR 
remain to be determined. Several studies suggest that PTB is part of the viral replication 
complex 93,99-101. However, the experimental data on the role of PTB in the viral life cycle 
is often conflicting as illustrated by experiments in which inhibition of the expression 
of PTB by siRNA did not have a significant effect on YFV replication, whereas it severely 
inhibited DENV production 100. There appears to be consensus that La is required for ef-
ficient virus replication, although the suggested functions are rather diverse 93,97,98,102,103. 
Several studies suggest that La serves as an RNA chaperone or an indirect factor that 
by interacting with NS3 and NS5 helps in the transition from the “linear” translation 
competent RNA structure to the circular RNA structure that is required for transcrip-
tion/replication 93,98,102. Other studies suggest that the La-associated helicase activity is 
required in the flavivirus replication complex 97,103. This would be rather surprising since 
the viral NS3 protein, which is present in the viral replication complex, also contains a 
helicase activity. 
Poly(A)-binding protein (PABP) is a unique translation initiation factor that stimulates 
translation by promoting mRNA circularization through simultaneous interactions with 
eIF4G and the 3’ poly(A) tail (reviewed in 104). Despite the fact that the genome RNA of 
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flaviviruses is not polyadenylated, PABP was shown to bind to the DENV 3’ UTR 105. This 
binding most likely involves the relatively A-rich sequences flanking the RNA dumbbell 
structures in region III of the viral 3’ UTR. PABP interaction with the 3’ UTR appears to be 
required for efficient translation initiation of the viral genome 105.
Viral proteins interacting with the 3’ UtR of the viral genome 
Purified recombinant NS5 protein that contains the viral RdRp activity   was shown to 
interact in vitro with the 3’ UTR, especially the 3’ SL, of JEV and DENV 106,107. In addition to 
NS5, purified recombinant NS3 that contained the viral RNA helicase activity, was also 
reported to interact with the 3’ UTR of DENV 108. The NS3 and NS5 interactions with the 3’ 
SL were also demonstrated by UV cross-linking of proteins from JEV-infected cell lysates 
with RNA probes mimicking the viral 3’ UTR 109. The studies cited above suggested that 
the interaction of NS3 and NS5 with RNA sequences or structures of region I or II reflect 
the (partial) formation of the viral replication complex on the 3’ UTR to initiate viral (-) 
strand RNA synthesis. However, these data are contradicted by recent data on the forma-
tion of DENV replication complex, which shows that DENV NS5 has a strong affinity for 
stem-loop A at the 5’ UTR of the viral genome 59. The binding of NS5 to and/or the forma-
tion of a replication complex at the 5’ UTR is postulated to serve as a trigger to initiate 
the circularization of the viral genome that is required for flavivirus RNA synthesis. This 
resulted in a very attractive model that explains many of the experimental data on the 
initiation of flavivirus (-) strand RNA replication (reviewed in 65,110). Taking into account 
their function as viral RNA helicase and RdRp it is not surprising that both NS3 and NS5 
demonstrated affinity for RNA, but the biological relevance of these interactions with 
RNA elements in the 3’ UTR is in our opinion questionable. Specific binding of KUNV 
recombinant NS2A with the 3’ UTR of this virus has also been reported 111. 
A FiNAL Note
Understanding the biology of flaviviruses at the molecular level is crucial for the devel-
opment of new vaccines and the rational design of novel antiviral strategies. Although 
the E protein is recognized as a major determinant for the tropism and virulence of fla-
viviruses (reviewed in 112), it is evident that RNA sequences and structures located in the 
3’ UTRs can also influence their virulence 48,88,113-118. Several of these RNA elements within 
the viral 3’ UTR represent interesting targets for an antiviral strategy based on antisense 
oligonucleotides that either inhibit translation or replication, or serve as siRNA 38,39,119-123.
The overall structural integrity of the flavivirus 3’ UTR is clearly important for efficient 
replication of the virus 16. Deletion or mutation of RNA elements that do not appear to 
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actually show a crippled replication or pathogenicity of the virus when analyzed in a 
more relevant model system or in competition with the wt-virus 37,68,79,81. 
The biological significance and molecular function of many of the RNA structures 
within the viral 3’ UTR, as well as the interactions between host and/or viral proteins 
with the viral 3’ UTR, are still unknown. Future research should verify the predicted RNA 
structures and determine their role in the virus life cycle, as well as the role of certain 
protein interactions with the flavivirus RNA under in vivo conditions. Furthermore, the 
composition and assembly of the viral replication complex and the mechanism by which 
this complex initiates the transcription of viral RNA should also be studied in more de-
tail. The results from such studies will increase our understanding over the role of RNA 
structures in flavivirus replication, and help us in identifying and validating new targets 
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Positive-stranded RNA viruses represent the biggest fraction of all known viruses 1 
and are responsible for many human and animal diseases. RNA viruses have the highest 
mutation rate among living species, which explains why they can adapt relatively easy 
to new environments (reviewed in 2). As Stuart Nichol 3 wrote “There is a sense that RNA 
viruses enjoy life in the evolutionary fast lane; however we, slow-moving DNA-based 
life forms, may have some opportunities to outwit them yet”. In order to achieve this, 
a thorough understanding of the virus life cycle in general and the molecular interac-
tions between the virus and the host is required. Certain steps in the viral life cycle were 
found to correlate closely with conformational changes in the viral RNA 4. RNA elements 
present in the 3’ untranslated region (3’ UTR) of the genome in particular, are known to 
undergo such dynamic conformational changes and to play a role in critical steps such 
as translation and replication. In this thesis, RNA structures and motifs present in the 3’ 
UTR of flaviviruses were studied in more detail, including their role in the virus life cycle. 
The 3’ UTR of the flavivirus genome is predicted to fold into a complex structure that 
includes well conserved primary sequences, multiple RNA stem-loop structures as well as 
a number of RNA pseudoknots 5,6 (chapter 6 of this thesis). Some of these RNA structures 
have been studied extensively, while others have only been predicted based on phyloge-
netic studies and computer-aided RNA folding and still require functional characterization. 
As shown in chapter 2 and discussed in chapter 6, the well conserved pentanucleotide 
(PN) sequence CACAG at the top bulge of the 3’ terminal stem-loop (3’ SL) is an essential 
element for viral RNA synthesis 7-9. Unfortunately, the function of this PN motif is not 
known. Several studies have indicated that it is part of the binding site for certain host 
proteins such as the eukaryotic translation elongation factor-1α (eEF-1α) in West Nile 
virus (WNV) 10,11, Y box binding protein-1 (YB-1) in dengue virus (DENV) 12 and La protein 
in Japanese encephalitis virus (JEV) 13. Although none of these studies claim that the PN 
motif is the major interface for this protein-RNA interaction, it is rather surprising that 
such a conserved sequence appears to be part of the binding site for these different and 
functionally unrelated proteins. An alternative explanation is that the PN motif is actu-
ally part of an RNA kissing or pseudoknot interaction; however, the fact that the yellow 
fever virus (YFV) PN motif tolerates point mutations at almost every position would also 
argue against this hypothesis. Recently, the structure of the top of the 3’ SL including 
the PN motif was solved for mosquito-borne, tick-borne and no known vector (NKV) 
flaviviruses by nuclear magnetic resonance (NMR) spectroscopy 14. Different from what 
was expected, the NMR analysis did not yield a conserved RNA structure for the studied 
viruses. This lack of conservation can be explained by the current technical limitations 
associated to NMR. Only the very top part of the 3’ SL was analyzed, therefore i) the 
folding might have been incorrect in comparison with the natural situation, ii) relevant 
long-range RNA-RNA interactions involving the top of the 3’ SL structure could not be 
taken into account. Alternatively, the absence of particular host or viral proteins may 
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have prevented the RNA from adopting the natural conformation. Our study and those 
of others have clearly demonstrated that the PN motif is crucial for flaviviruses RNA syn-
thesis and showed that the wild-type CACAG sequence confers a selective advantage. 
The mutational analysis of this region mainly involved point mutations. Therefore, it will 
be interesting to perform an in vivo RNA SELEX experiment to reveal the actual sequence 
requirements of the PN motif as well as of the nucleotides immediately downstream. 
Viable virus mutants could be selected by their ability to form plaques. Continued pas-
saging of poorly replicating mutants isolated from such a screen can potentially identify 
efficiently replicating “second-site revertant” viruses that may yield valuable information 
about the function and interaction partners of the PN motif.    
The RNA pseudoknot that serves as a stalling site for XRN1, resulting in the generation 
of a small flavivirus (sf ) RNA, is another RNA element in the flavivirus 3’ UTR that was de-
scribed in detail in this thesis 15. An RNA pseudoknot is essentially an RNA structure that 
is minimally composed of two helical segments, which are connected by single stranded 
regions 16. These tertiary RNA structures were initially recognized in the 3’ UTR of tur-
nip yellow mosaic virus 17 and subsequently found to be one of the most widespread 
structural RNA domains. Currently, pseudoknots have been shown to be essential in the 
catalytic center of the hepatitis delta virus and related ribozymes, telomerases, the regu-
lation of gene expression by ribosomal frameshifting, IRES-driven translation initiation, 
and to be involved in the transcription and replication of many RNA viruses (reviewed in 
16,18). The stalling of the host ribonuclease XRN1 by an RNA pseudoknot in the flavivirus 3’ 
UTR (chapters 3 and 4 of this thesis and by others 19,20), points yet to another function of 
these RNA structures. Although the role of XRN1 in 5’ to 3’ RNA decay is well documented 
(reviewed in 21-24), these particular RNA pseudoknots are the first tertiary RNA structures 
that are capable of stalling XRN1. In addition, these results provide an interesting link 
between RNA structure and pathogenicity, as the sfRNA that results from the incom-
plete degradation of the viral genome has been demonstrated to play an important 
role in the pathogenicity of mosquito-borne flaviviruses in cell culture and in mice 15,19,20. 
The precise role of the sfRNA in the viral life cycle is currently unknown. It has been 
speculated that the sfRNA is involved in evading the host innate immune response, for 
instance by antagonizing cellular RNA sensors like RIG-I and MDA5 25. Alternatively, it has 
been suggested that the sfRNA could serve as a decoy to protect the genomic RNA from 
cellular proteins or miRNAs that would otherwise bind to the 3’ UTR of the viral genome 
and inhibit viral RNA synthesis or translation 25. There is currently no evidence that sup-
ports any of the above hypotheses. It is, however, interesting to note in this context that 
the cellular YB-1 protein, which binds to the DENV 3’ SL structure, has been suggested to 
mediate antiviral activity 12.
An intriguing alternative hypothesis is that the sfRNA itself serves as a precursor for a 




sfRNA, is enriched in cytoplasmic P bodies that also harbor proteins like Dicer, GW182 
and Argonaute, which are involved in RNA interference 21-23,26. Fluorescence in situ hy-
bridization (FISH) analysis of Kunjin-infected cells suggested accumulation of the sfRNA 
in these P bodies 19. Recent experiments have shown that recombinant flaviviruses con-
taining the sequence of a cellular miRNA can produce functional miRNAs upon infection 
27,28. These results demonstrate that flavivirus RNA is somehow able to enter the miRNA 
biogenesis pathway. However, in apparent contradiction with the above hypothesis, 
is a progressive decrease in the number of P bodies that has been observed in cells 
during the time course of DENV-2 and WNV infections 29. To increase our understanding 
regarding sfRNA production, a more detailed analysis of the kinetics and the subcellular 
sites of sfRNA synthesis is required. Important questions that need to be address are: 
i) How do flavivirus genomes end up in P bodies and are these important for sfRNA 
generation ii) Are the sfRNAs the final product or are they intermediates that undergo 
further processing iii) Do sfRNAs or their derivatives leave the P bodies and is this re-
quired for their function? Various experiments can be envisioned to deal with these 
questions. “Pulse-chase”-like experiments using temperature-sensitive viruses impaired 
in viral RNA synthesis or small molecule inhibitors of flavivirus replication are required to 
determine the kinetics of sfRNA production and turn-over. Reagents that either induce 
or disrupt P bodies and the associated stress granules should be tested as they can be 
useful in determining the role of these subcellular structures in sfRNA synthesis. In addi-
tion, expanding the RNA silencing experiments that so far have been limited to XRN1, by 
including other targets like stress granules markers [e.g. Ras-GTPase-activating protein 
SH3-domain-binding protein (G3BP), T-cell intracellular antigen 1 (TIA-1) or TIA-1-related 
protein (TIAR)], P body markers (e.g. RNA decapping enzymes DCP1 and 2) and various 
proteins involved miRNA production (Dicer as an obvious candidate).  
One of the important findings of the research described in this thesis is that sfRNA 
production is not limited to arthropod-borne flaviviruses, but instead is a rather unique 
feature of all flaviviruses irrespective of the nature of their transmission cycle. This does 
not only imply that sfRNA production can be used as an unique additional criterion to 
define currently unassigned and newly discovered RNA viruses to the Flavivirus genus, 
but also indicates that the sfRNA production is required in the natural life cycle of all 
these viruses. It remains to be established whether the sfRNA of the different flaviviruses 
serves a similar function in the different hosts or whether it has evolved to meet specific 
virus requirements related to (a) particular host(s). The fact that CFAV produces an sfRNA 
hints at the possibility that the sfRNA of the arthropod-borne flaviviruses may not only 
be required in the vertebrate host but also in mosquitoes or ticks. One way to address 
these questions is by expression of sfRNAs in trans in cells that are infected with mutant 
viruses that no longer produce the sfRNA 19. Such a system can be used not only to deter-
mine whether a heterologous sfRNA is able to complement the defect in pathogenicity 
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of an sfRNA-minus flavivirus mutant, but will also allow to determine which part of the 
sfRNA is required for its biological function.
It will be interesting to discover whether any of the conserved sequences or RNA struc-
tures in the flavivirus 3’ UTR is actually required for sfRNA function. One possible can-
didate is the conserved sequence CS2 which currently has no clearly defined function. 
Deletion of CS2 in mosquito-borne flaviviruses was shown to yield viable mutants, albeit 
with a slightly delayed replication 30-33. It is interesting to note that in YFV, deletion of CS2 
results in turbid plaques on SW13 cells when compared to the clear plaques observed 
with the wild-type virus 30. This turbidity in the plaques can be interpreted as a sign of 
decreased pathogenicity, similar to what is observed with mutants deficient in sfRNA 
production. However, it should also be noted that CS2 is absent from TBEV and CFAV. 
Flaviviruses are not the only RNA viruses that apparently use a host ribonuclease 
for the production of viral subgenomic RNA. Plants and protoplasts infected with the 
positive-strand RNA Red clover necrotic mosaic virus (RCNMV) produce a small viral 
noncoding RNA, designated SR1f, by incomplete degradation of the genomic RNA 1 
possibly by a host enzyme with 5’-3’ exoribonuclease activity 34. SR1f has no effect on 
the pathogenicity of the virus but it inhibits translation of the viral proteins resulting in 
a decrease in negative-strain RNA synthesis 34. A 58-nucleotide sequence at the 5’ end of 
this RCNMV is sufficient to stall the host ribonuclease and yield SR1f. There is currently 
no evidence that XRN1 is involved in SR1f production, but it is interesting to note that 
the 5’ end of SR1f can fold into a pseudoknot structure that could act as a stalling site for 
the involved ribonuclease (P.A.G.C. Silva and P.J. Bredenbeek; data not shown).
The involvement of XRN1 in the life cycle of viruses is not without precedent. XRN1 has 
also been shown to act as a suppressor of viral RNA recombination by rapidly degrading 5’ 
truncated RNAs that can serve as substrates for viral recombination in tomato bushy stunt 
virus, a positive-stranded plant RNA virus belonging to Tombusviridae 35.  
The last experimental chapter of this thesis describes the construction and character-
ization of a full-length MODV cDNA that can be used to transcribe infectious MODV RNA. 
The development of these tools is important in order to truly understand the molecular 
biology of the flaviviruses and to identify the key factors that determine host range and 
tropism.
Many unanswered questions still remain. In the end, a full understanding of the 3’ UTR 
structures and specific conformation adopted during the virus life cycle and the func-
tion they perform will require the determination of their three-dimensional structure. 
In this respect, X-ray crystallography and NMR spectroscopy are major challenges to be 
conquered in future studies. Such knowledge will provide us with further insight into 
the regulatory mechanisms behind the viral life cycle and can ultimately reveal targets 
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Due to the highly mobile and interconnected societies of today’s world there are 
countless opportunities for the spread of infectious diseases. According to the World 
Health Organization (WHO), infectious diseases are now spreading much faster than at 
any time in history. RNA viruses in particular, are the causative agents of many of the 
emerging and re-emerging diseases of the past few decades. Among the RNA viruses, 
a dramatic increase in frequency and magnitude of flavivirus infections has been ob-
served. This is most likely potentiated by factors like the increase in human population 
density, urbanization, transportation of goods, animals and agricultural products, global 
warming and the wider dispersal of competent vectors. Flaviviruses are responsible for 
important human and animal diseases that are usually characterized by hemorrhagic 
fever or encephalitis. A brief description of the flaviviruses biology and the burden that 
these viruses represent is presented in chapter 1. Flaviviruses of major global concern 
include yellow fever virus (YFV), dengue virus (DENV), Japanese encephalitis virus (JEV), 
West Nile virus (WNV), and tick-borne encephalitis virus (TBEV). Currently, vaccination 
to protect humans from disease caused by flaviviruses is limited to YFV, JEV, and TBEV. 
To reduce and prevent the impact of flavivirus infection on society, vaccines against 
other flaviviruses (especially DENV) and effective therapies are required. However, this 
can only be achieved by increasing our knowledge regarding fundamental aspects of 
the molecular biology of flaviviruses and a better understanding of the interactions 
between the virus, the host and the vector. 
The 3’ UTR of RNA viruses is known to be important for several steps of the viral life 
cycle, namely in translation, replication and assembly. The flavivirus 3’ UTR contains 
well conserved RNA sequences and is predicted to fold into a highly complex structure 
involving several stem-loop structures and RNA pseudoknots. Some of these motifs and 
structures have been studied in detail and attributed a biological function. The aim of 
this thesis was to characterize and determine the biological function of some of the RNA 
elements in the flavivirus 3’ UTR. The 3’ terminal 80 – 90 nucleotides of every flavivirus 
are predicted to form a conserved stem-loop structure (3’ SL). The 3’ SL is not conserved 
in the nucleotide sequence, except for the pentanucleotide CACAG in a bulge at the top 
of the SL, and the dinucleotide “CU” at the 3’ end of the genome. Studies by others using 
WNV indicated that except for the nucleotides at the 2nd and 4th position, all the other 
nucleotides of the pentanucleotide motif are required for viral RNA replication. Surpris-
ingly, we discovered that the sequence requirements for the YFV pentanucleotide motif 
were less strict than for WNV. In chapter 2 we showed that point mutations at either 
the 2nd, 3rd, or 4th position were generally well tolerated. Only the “G” residue at the 5th 
position and base pairing of the nucleotide at the 1st position were absolutely required 
for efficient replication. Although these mutations at the 2nd, 3rd, and 4th position did not 
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seem to have a significant effect on viral RNA synthesis and virus production, the wild-
type pentanucleotide sequence CACAG offers an advantage for YFV-17D in cell culture 
as the mutant viruses were generally outcompeted by the parental virus upon repeated 
passaging in competition experiments.
In addition to the positive- and negative-stranded genome length RNAs, the produc-
tion of a positive-stranded, small flavivirus (sf ) RNA in both mammalian and insect cells 
as well as in mice infected with arthropod-borne flaviviruses is now well documented. 
The length of these sfRNAs varies from 0.3 kb to 0.5 kb and they are collinear with the 
distal part of the viral 3’ UTR. It was shown recently that sfRNA production results from 
incomplete degradation of the viral genome by the host 5’-3’ exoribonuclease XRN1 
and that the sfRNA is an important determinant for viral pathogenicity. In chapter 3 
we determined the molecular signal in the 3’ UTR that is required for the production 
of the sfRNA by stalling XRN1. A detailed analysis of sfRNA production in YFV-infected 
cells revealed that, different from other arthropod-borne flaviviruses, YFV generates 
not one but two sfRNAs that unexpectedly form a 5’ nested set. The precise 5’ end of 
the YFV sfRNAs was mapped and found to be just upstream of a previously predicted 
RNA pseudoknot (PSK3). RNA structure probing and mutagenesis studies supported the 
actual formation of this RNA pseudoknot and demonstrated that it functioned as the 
molecular signal to stall XRN1. An important consequence of this emerging picture on 
sfRNA production and function is that previous reports describing the effects of muta-
tions in the distal part of the flavivirus 3’ UTR solely in the context of the viral genome, 
have to be re-evaluated in light of the potential effect of these same mutations on either 
the sfRNA production or function. Furthermore, we propose that abolishing sfRNA 
generation by simple disruption of this pseudoknot should be carefully analyzed as an 
additional target to develop flaviviruses vaccines based on attenuated viruses.
Production of sfRNA was previously shown only for the mosquito- and tick-borne 
members of the flaviviruses. However, the genus Flavivirus also comprises a 3rd group of 
viruses that do not appear to require an arthropod vector for their transmission. To deter-
mine if sfRNA production is restricted to the arthropod-borne flaviviruses or whether it 
is a hallmark of every flavivirus, we have analyzed sfRNA production in cells infected with 
no known vector (NKV) flaviviruses as well as with the insect virus cell fusing agent virus 
(CFAV) that has tentatively been assigned to the Flavivirus genus (chapter 4). From these 
experiments we concluded that sfRNA production is a hallmark of flaviviruses since all 
the analyzed NKV viruses, as well as CFAV, produced an sfRNA. Detailed analysis of the 
molecular determinants of sfRNA production in cells infected with NKV viruses or CFAV 
is hampered by the lack of an infectious clone for any of these viruses. However, by using 
in vitro assays we were able to show that, like for the arthropod-borne flaviviruses, the 
host protein XRN1 is likely required for sfRNA production. In addition, we used a Sindbis 





in these viruses. The presented data predict that also in the 3’ UTR of NKV viruses and 
CFAV an RNA pseudoknot serves as a stalling site for XRN1. These results are not only im-
portant in identifying sfRNA production as a new, additional hallmark to assign viruses 
with a similar genomic organization to the Flavivirus genus; but more importantly, they 
indicate that the sfRNA may serve an essential and perhaps different function during the 
life cycle in the mammalian as well as in the insect host of these viruses.     
Flavivirus full-length cDNA clones that can be used for the production of infectious 
RNA are often notoriously difficult to construct due to genetic instability in prokaryotic 
hosts. In chapter 5 we describe the construction and characterization of the first infec-
tious cDNA clone for a NKV flavivirus. Using the low-copy number vector pACNR1180, 
that was previously used to construct a stable full-length YFV clone, we have been 
able to construct and propagate a stable infectious cDNA of Modoc virus. As shown in 
chapter 5, RNA transcribed from this full-length cDNA clone is highly infectious upon 
transfection of suitable host cells and produced virus with similar characteristics in cell 
culture as the parental MODV virus that was used to generate the full-length cDNA copy. 
This infectious cDNA clone can serve as a valuable tool for a detailed comparison of the 
life cycle of the apparently mammals restricted NKV flaviviruses versus the less host-
restricted arthropod-borne flaviviruses. 
Chapter 6 provides an extensive literature review of the published data on structural 
and functional characterization of the various RNA elements that have been identified 
within the 3’ UTR of mosquito- and tick-borne flaviviruses, as well as of NKV flaviviruses. 
Special emphasis has been given to the RNA structures that were reported to play a role 
in viral replication and pathogenicity.
The final chapter of this thesis is a short epilogue in which the results that are pre-
sented in the chapters 2 to 5 are discussed against the background of recently published 
findings and in which future research directions are indicated to address the new hy-






Door de grote toename van onze mobiliteit en de toenemende verwevenheid van 
de verschillende samenlevingen zijn er tegenwoordig meer mogelijkheden voor de 
verspreiding van besmettelijke ziekten. Volgens de Wereldgezondheidsorganisatie 
(World Health Organization, WHO) is de snelheid waarmee infectieziekten zich momen-
teel verspreiden groter dan ooit. Met name RNA virussen zijn een belangrijke oorzaak 
van deze nieuwe, dan wel hernieuwde, en zich steeds verder verspreidende virusuit-
braken. Flavivirussen vormen hierop geen uitzondering. Met name de verspreiding 
van dengue virus (DENV) en West Nile virus (WNV) is in het laatste decennium sterk 
toegenomen en daarmee ook het aantal geïnfecteerde individuen. Deze toenemende 
overlast door flavivirusinfecties is waarschijnlijk het gevolg van factoren als de groei 
van de wereldbevolking, toenemende verstedelijking, dieren- en goederentransport 
en het broeikaseffect met als gevolg een grotere verspreiding van geschikte vectoren. 
Flavivirussen zijn verantwoordelijk voor een aantal belangrijke ziekten, welke gepaard 
kunnen gaan met ernstige hemorrhagische koorts of encephalitis. Hoofdstuk 1 van dit 
proefschrift geeft een samenvatting van de biologie van flavivirussen. De moleculaire 
biologie en genexpressie-strategie, alsmede de onderlinge verwantschap van deze vi-
russen en de transmissieroute van de verschillende flavivirussen wordt in dit hoofdstuk 
beschreven. De voor de mens belangrijkste flavivirussen zijn: gele koorts virus (YFV), 
knokkelkoorts (ook wel dengue virus genoemd; DENV), Japanse encefalitis virus (JEV), 
West Nile virus (WNV) en tickborne encefalitis virus (TBEV). Momenteel is bescherming 
tegen ziekten door vaccinatie alleen mogelijk voor YFV, JEV en TBEV. Om de invloed van 
flavivirusinfecties op de samenleving te voorkomen dan wel te beperken zijn vaccins 
en effectieve therapieën tegen andere flavivirussen, met name DENV, noodzakelijk. Om 
dit te bereiken is een uitgebreide kennis omtrent de fundamentele aspecten van de 
biologie van flavivirussen, inclusief de interacties tussen het virus, de gastheer en de 
vector, essentieel. 
De sequentie en structuur van de 3’ untranslated region (3’ UTR) van het genoom van 
RNA virussen is van groot belang voor verschillende stappen in de virale levenscyclus 
en speelt een belangrijke rol bij de regulatie van de RNA synthese, translatie en de as-
semblage van nieuwe virusdeeltjes. De flavivirus 3’ UTR kenmerkt zich door een aantal 
geconserveerde RNA sequenties en een complexe secundaire en tertiaire RNA structuur, 
die verschillende stem-loop structuren en een aantal RNA pseudoknots omvat. Aan 
sommige van deze sequentiemotieven en RNA structuren is op basis van experimen-
teel onderzoek een biologische functie toegeschreven, van andere RNA elementen is 
de functie nog onbekend. Het doel van het in dit proefschrift beschreven onderzoek 
was gericht op het vergroten van onze kennis van de functie van de verschillende RNA 
structuren in de flavivirus 3’ UTR. De laatste 80 tot 90 nucleotiden van het 3’ uiteinde van 
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het genoom van ieder flavivirus vormen een geconserveerde haarspeld structuur (3’ SL). 
Met uitzondering van de pentanucleotide sequentie (PN) “CACAG” in een uitstulping aan 
de top van de 3’ SL structuur en het dinucleotide “CU” aan het uiteinde van het virale ge-
noom, is de primaire sequentie van de 3’ SL structuur niet geconserveerd. Uit onderzoek 
aan de PN sequentie van WNV is gebleken dat, met uitzondering van de nucleotiden 
op de 2e en 4e positie, alle overige nucleotiden van het PN motief noodzakelijk zijn voor 
efficiënte replicatie van het virale RNA. Hoofdstuk 2 van dit proefschrift beschrijft een 
gedetailleerde analyse van de PN sequentie in de 3’ SL structuur van YFV-17D. Uit onze 
resultaten blijkt dat conservering van het PN motief in YFV minder noodzakelijk lijkt dan 
voor WNV. Niet alleen puntmutaties van de nucleotiden op de 2e en 4e positie, maar ook 
op de 3e positie van het PN motief blijken toegestaan. Alleen het “G” residu op positie 5 
en baseparing van de nucleotide op de 1ste positie zijn strikt noodzakelijk voor efficiënte 
replicatie. Ondanks dat de mutaties op de 2e, 3e en 4e positie van de PN sequentie in cel-
kweek geen significant effect lijken te hebben op virale RNA synthese en virusproductie, 
blijkt uit competitie-experimenten dat het wildtype (wt) virus toch beter repliceert dan 
de virussen met een mutatie in het PN motief. Bij herhaald passeren worden de mutante 
virussen door het niet gemuteerde gele koorts virus verdrongen uit de viruspopulatie. 
In de afgelopen jaren is uit verschillende studies met door muggen en teken over-
gebrachte flavivirussen gebleken dat, zowel in celkweek als in geïnfecteerde muizen, 
naast het positief- en negatief-strengige genoom RNA ook een klein positief-strengig 
subgenoom RNA maken. Dit “small flavivirus” (sf ) RNA heeft een lengte van 0,3 tot 0,5 
kb en is co-lineair met het distale gedeelte van de virale 3’ UTR. Onlangs is aangetoond 
dat dit sfRNA ontstaat als gevolg van onvolledige afbraak van het virale genoom RNA 
door het 5’-3’ exoribonuclease XRN1 van de gastheer. Productie van het sfRNA blijkt een 
belangrijke determinant voor de pathogeniciteit van het virus. In hoofdstuk 3 worden 
de karakteristieken van de YFV sfRNAs in detail beschreven. In tegenstelling tot de 
andere arthropod-borne flavivirussen worden in YFV-17D geïnfecteerde cellen niet één, 
maar twee sfRNAs geproduceerd, die hetzelfde 5’ uiteinde hebben. De positie van dit 
5’ uiteinde op het virale genoom werd bepaald en bleek juist stroomopwaarts van een 
eerder voorspelde RNA pseudoknot (PSK3) te liggen. Uit de resultaten van biochemische 
experimenten en mutagenese studies kan worden geconcludeerd dat deze voorspelde 
RNA pseudoknot daadwerkelijk wordt gevormd en functioneert als een signaal om XRN1 
te blokkeren. Een belangrijk gevolg van deze en andere resultaten met betrekking tot 
sfRNA productie en –functie is dat eerder gepubliceerde artikelen, waarin de effecten 
van mutaties in het distale gedeelte van de 3’ UTR binnen de context van het virale 
genoom worden beschreven, kritisch tegen het licht moeten worden gehouden. Het 
is nu immers onduidelijk of de gerapporteerde effecten gerelateerd zijn aan effecten 
op de functie van de bestudeerde RNA structuren op het virale genoom dan wel op 




flavivirussen die niet langer een sfRNA maken een geattenueerd phenotype hebben. 
Dit opent interessante mogelijkheden voor de constructie van nieuwe of verbeterde 
flavivirus vaccins.  
In eerdere studies is de productie van een sfRNA aangetoond voor flavivirussen die 
door muggen en teken worden verspreid. Er is echter nog een derde groep van zgn. no 
known vector (NKV) flavivirussen waarbij voor virusoverdracht geen vector nodig lijkt 
te zijn. In hoofdstuk 4 wordt het onderzoek naar mogelijke sfRNA productie in cellen 
die geïnfecteerd zijn met NKV flavirussen beschreven. Deze studie omvat ook het cell 
fusing agent virus (CFAV), dat alleen in insectencellen groeit en vermoedelijk ook tot de 
flavivirussen behoort. Uit de verkregen resultaten kan worden geconcludeerd dat sfRNA 
productie een karakteristieke eigenschap is voor alle flavivirussen. De geanalyseerde 
NKV flavivirussen en ook CFAV produceren allen sfRNAs. Een analyse van de moleculaire 
mechanismen van de sfRNA productie van met NKV flavivirus of CFAV geïnfecteerde 
cellen wordt bemoeilijkt door het ontbreken van een infectieuze cDNA kloon voor deze 
virussen. Uit de analyse van de in vitro experimenten met gezuiverd XRN1 en in vitro 
vervaardigde RNA transcipten als substraat kan echter worden geconcludeerd dat XRN1 
ook verantwoordelijk is voor de sfRNA productie van de NKV flavivirussen en CFAV. 
Door gebruik te maken van een op het Sindbis virus gebaseerd expressiesysteem is 
vervolgens de RNA structuur in het gebied net stroomafwaarts van de plaats waar XRN1 
vastloopt bij de productie van de sfRNAs van de NKV virussen en CFAV onderzocht. Deze 
experimenten, gecombineerd met een voorspelling van de plaatselijke RNA structuur, 
suggereren dat ook bij deze virussen een RNA pseudoknot verantwoordelijk is voor 
het blokkeren van XRN1. Uit de verkregen resultaten kan geconcludeerd worden dat 
de produktie van een sfRNA een uniek kenmerk is voor alle flavivirussen en dat het als 
zodanig gebruikt kan worden om virussen met een gelijksoortige genoomorganisatie 
aan het genus Flavivirus toe te wijzen. Uit deze studie blijkt ook dat het mechanisme 
voor de productie van flavivirus sfRNAs geconserveerd is. Dit wil echter niet zeggen dat 
de geproduceerde sfRNAs een zelfde functie hebben in de verschillende gastheren.
Volledige cDNA klonen van flavivirussen worden vaak geplaagd door genetische 
instabiliteit in prokaryote gastheren. Al naar gelang het virus kan het daarom zeer lastig 
zijn om een dergelijke kloon te maken. In hoofdstuk 5 wordt de succesvolle constructie 
en karakterisatie van de eerste infectieuze cDNA kloon van een NKV virus beschreven. 
Door gebruik te maken van het low-copy number plasmide pACNR1180, dat al eerder is 
gebruikt om stabiele, volledige YFV cDNA klonen te ontwikkelen, is het gelukt om een 
stabiel, infectieus cDNA te maken van Modoc virus (MODV). In vitro vervaardigde RNA 
transcripten van deze MODV cDNA blijken na transfectie in een geschikte gastheercel-
lijn infectieus en de getransfecteerde cellen produceren MODV met overeenkomstige 
karakteristieken als het oorspronkelijke virus. Deze infectieuze cDNA kloon is een be-
langrijk hulpmiddel voor een gedetailleerde vergelijking van de replicatie signalen en 
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virus-gastheer interacties tussen de tot zoogdieren beperkte NKV flavivirussen en de 
minder gastheer gelimiteerde arthropod-borne flavivirussen.
Hoofdstuk 6 bevat een uitgebreid literatuuroverzicht van gepubliceerde data over 
de structurele- en functionele karakterisatie van de verschillende RNA elementen die 
geïdentificeerd zijn in de 3’ UTR van de arthopod-borne - en NKV flavivirussen. De na-
druk in dit overzichtsartikel ligt op de RNA sequenties en structuren, waarvan bekend 
is dat ze een effect hebben op de replicatie en translatie van het virale RNA of op de 
pathogeniciteit van deze virussen.
Het laatste hoofdstuk van dit proefschrift is een epiloog, waarin de in hoofdstuk 2 t/m 
5 beschreven resultaten worden bediscussieerd in de context van recent gepubliceerde 
data en waarin suggesties worden gedaan met betrekking tot toekomstig onderzoek 
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